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4ABSTRACT
The aim of this thesis is to determine whether exposure to low levels of
organophosphate pesticides (OPs) causes neuropsychological or psychiatric impairment.
The thesis is arranged in three parts. Part 1 provides an introduction to neurotoxicology,
the role of the psychologist, and the toxicity of OPs; Part 2 provides a historical review
of the existing scientific evidence regarding the impact on human health of low level
exposure to organophosphate pesticides. A major unresolved issue in the toxicity
literature is whether repeated, low level exposure to OPs, in the absence of a history of
acute toxicity, is harmful to human health. Part 3 presents the findings of a four year
empirical study designed to address this issue. A cross-sectional study was undertaken
in which the performance on neuropsychological tests of 127 sheep farmers with a
history of low level exposure to organophosphate pesticides was compared with 78 non-
exposed healthy volunteers (rural police workers) matched for age, gender, years in
education and level of intelligence. Methodological weaknesses of earlier studies were
addressed in the study design, such as inclusion of study participants who had retired on
ill health grounds to take account of the ‘healthy worker effect’; exclusion of study
participants with a history of acute poisoning and those with a psychiatric or medical
history that might otherwise account for ill health; and exploration of factors that may
render some individuals more vulnerable to the effects of OPs than others (e.g. genetic
differences in the capacity to metabolise and detoxify OPs). In the final chapter the
findings are summarised and discussed, the study design is critically appraised and the
implications of the findings are listed along with recommendations for future research.
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PART 1
An introduction to neurotoxicology,
the role of the psychologist, and
the toxicity of organophosphate pesticides.
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Chapter 1 : An introduction to neuropsychological toxicology
1.1 History of toxicology
Toxicology is a multi-disciplinary science which draws on a number of disciplines
(including psychology) to determine the adverse effects of chemicals in living
organisms (xenobiotics). The discipline grew rapidly during World War II when the
production of drugs and chemicals increased and expanded further in the 1960s
following the thalidomide disaster, in which thousands of children were born with birth
defects because their mothers were prescribed this sedative to control morning sickness
during pregnancy. In 1962 the book Silent Spring, by Rachel Carson argued that
pesticides were harming the environment, animals and humans. The book was widely
read and resulted in growing recognition that many industrial chemicals (solvents,
pesticides, fuels) and environmental pollutants are potentially damaging to animal and
human health and that stricter regulations were needed to control the use of potentially
toxic chemicals (Klaassen, 2008). Over the last forty years concerns have been raised
about the possible effects of exposure to the increasing number of industrial and
environmental chemicals being produced every year.
1.2 The scale of the problem
There are literally thousands of substances that possess the capacity to do harm in
sufficient doses. It has been estimated that there are over 100,000 toxic substances in
commercial use and approximately 2,300 new chemicals developed and submitted for
registration every year (Environmental Protection Agency Office of Pollution
Prevention and Toxics (OPPT), 2011; European Commission Joint Research Centre
Institute for Health and Consumer Protection, 2011). The capacity of industry to
produce chemical substances outstrips research which means our knowledge regarding
the health effects of many substances is limited. This gives rise to differences in opinion
and controversies regarding the effects of a number of substances.
1.3 Toxicity testing and safety standards
Although regulatory bodies require premarket toxicological testing in animals, the
adequacy of toxicity testing is open to question since it is designed to characterise the
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toxic effects of chemicals, not to demonstrate their safety. There is no set testing
procedure with standardised tests that chemicals must pass to allow their commercial
use, rather a tiered approach is used in which the testing protocol is determined by (1)
consideration of the predicted substance effects given the chemical structure of the
product and (2) findings from initial, short-term, animal studies. Toxicological testing
is based on the relatively short-term administration of a single active ingredient in
animals whereas human exposures are often to complex mixtures of compounds over a
lifetime. There are a wide range of potential health effects which could be studied
(mortality, carcinogenicity, reproductive effects, physical ill health, neurological
symptoms, neurobehavioural symptoms) but financial constraints, concern for the
welfare of animals and methodological issues mean not all of these outcomes are
studied (Klaassen, 2008). Few chemicals are subjected to behavioural analysis and the
neurotoxicity of many substances has never been tested (Hartman 1995). Animal testing
alone is not sufficient to protect public health as epidemiological studies suggest many
products which pass basic screening tests have the capacity to affect human health
(Alavanja, Hoppin & Kamel, 2004). In order to gain a thorough understanding of the
toxic effects of chemical substances, it is essential to carry out human studies (e.g. case
studies, epidemiological studies, clinical trials of new pharmaceutical products).
Different species may have different responses to particular chemicals and an infrequent
effect may only become apparent in a large population study as opposed to a limited
number of animal experiments (Klaassen & Watkins, 1999).
Establishing safe exposure standards for many substances is fraught with difficulty and
depends on the outcome of interest (e.g. acute toxicity, chronic ill health, reproductive
or developmental effects etc). In an ideal world we would know the dose/response
relationship for each potential effect, but this is seldom the case. Recently important
questions have been raised about the validity of exposure standards as many are
changed as new information becomes available. Lead is a classic example of this. Over
time it has come to be seen as harmful at lower levels than originally thought, and more
recently it has been suggested that there is no safe level of exposure to lead (Hartman
1995; Schwartz, 1994). To complicate matters further, it is extremely difficult to
establish a safe standard that will protect everyone due to inter-individual differences in
susceptibility and genes which affect our ability to metabolise chemicals. In addition
the possible synergistic effects of chemical combinations are rarely assessed (i.e.
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chemical interactions) despite the fact that exposure to chemicals rarely occurs in
isolation.
1.4 Detection and health care professionals
Many people are exposed to harmful substances in the workplace (e.g. farm workers,
chemical plant workers, laboratory workers, motor mechanics, other transport industry
workers, painters) but exposure to neurotoxic substances can also occur in the home
(e.g. to carbon monoxide, paints/solvents, pesticides). Some individuals will experience
symptoms of acute toxicity or develop chronic ill health but few will attribute their
symptoms to toxic exposure unless they have been advised of the risks associated with
chemical products they are working with (Hartman, 1995). To complicate matters
further, few health care professionals receive training in toxicology and are unlikely to
consider a toxic cause for a patient’s symptoms. This is especially problematic as the
results of routine medical examinations are frequently normal as many toxic substances
are rapidly metabolised and excreted from the human bloodstream (Hartman, 1995).
This means a definitive diagnosis for patient’s complaints may never be reached.
Neuropsychology is a discipline which has an important role to play in evaluating
patients and establishing an explanation for their symptoms. Indeed, neuropsychological
testing has been described as the most sensitive means of examining the effects of toxic
exposure (Lezak, 1984).
1.5 The role of neuropsychological research
Many chemicals can interfere with nervous system function and chemical injury often
results in cognitive, emotional and behavioural change (Hartman, 1995). For this reason
the neuropsychologist has an important role to play in detecting and evaluating the
effects of neurotoxic substances. Neuropsychological tests can be used to assess
impairment after exposure to toxic substances known to affect cognitive functioning and
they are often included in research studies to contrast neuropsychological abilities in
exposed and unexposed populations. They also have the advantage of being relatively
inexpensive, non-invasive, portable, objective, reliable, sensitive and capable of
detecting signs of neurotoxic damage in the absence of other neurological signs (Berent
& Albers, 2005; Hartman 1995; Lezak, Howieson & Loring 2004). However,
neuropsychological assessment has its limitations. Test results in isolation are non-
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specific, and the neuropsychologist must make inferences beyond the test results to
reach conclusions. They need to consider evidence from other disciplines and they need
to be aware of specific issues which are pertinent to the field of toxicology.
1.6 Common issues in neuropsychological toxicology
1.6.1 Proving a link with exposure
Establishing a causal link between neuropsychological impairment and exposure to
neurotoxic substances is not easy. Patients frequently present long after exposure has
ceased and the toxic substance has been eliminated from the body which means
objective evidence of exposure (i.e. a biomarker) is seldom available (Hartman, 1995).
Instead, the clinician has to rely on the patient’s history to determine whether they have
been exposed to a neurotoxic substance, the likely amount they have been exposed to
(dose), how often (frequency) and over what time period (duration). Unfortunately
patient’s testimony can be unreliable because of the limits of human memory, and
processes such as recall bias and attribution error. Often the most that can be achieved is
to document the opportunity for exposure and evidence suggestive of a causal
relationship, such as the timing and onset of symptoms, biological plausibility and
specificity of symptoms (Berent & Albers, 2005).
1.6.2 Spectrum of effects
Neurotoxic substances can cause generalised damage involving many different bodily
systems or highly selective damage to particular regions (Karalliedde, Feldman, Henry
& Marrs, 2001; Klaassen & Watkins, 1999). Neurotoxic substances may injure the
nervous system directly by damaging dendrites, axons, myelin, neurons and supporting
cells or by interfering with neurotransmission; or they may have indirect effects on
other organs such as the liver and kidneys resulting in a build up of toxic substances and
metabolites in the body (Karalliedde et al, 2001; Klaassen & Watkins, 1999). They may
also interfere with other processes such as immune system function, protein synthesis,
energy conversion, oxygen transport and gene expression. Hence, they usually give rise
to a host of non-specific symptoms which are similar to those associated with other
degenerative and metabolic illnesses. The neuropsychologist needs to consider whether
symptoms make medical sense given the mechanism of action of specific chemicals (i.e
are symptoms biologically plausible) and must rule out alternative diagnoses before
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proposing a toxic cause for a patients symptoms (Berent & Albers, 2005).
1.6.3 Acute vs chronic effects
Neurotoxic substances have immediate effects on the nervous system, but some are
capable of producing additional delayed effects days or weeks later such as the
organophosphates and carbon monoxide (Karalliedde et al, 2001; Penney, 2008). For
many chemicals the toxic effects of a single, acute, high level exposure are known from
animal testing or case studies involving incidents of severe poisoning (Klaassen &
Watkins, 1999). In contrast, less is usually known about the effects of repeated, low
level exposure, which may produce quite different effects from high level exposure as
the mechanisms underlying acute and chronic effects may differ. As a consequence,
considerable controversy surrounds the possibility that chemicals which have passed
basic screening tests may be harmful in low or repeated doses.
1.6.4 Individual differences
Considerable inter-individual differences exist in the capacity to metabolise and
detoxify certain chemicals and therefore some individuals may be more effected by
lower doses than others and symptom profiles and/or severity of symptoms may vary
amongst patients (Berent & Albers, 2005; Hartman, 1995, Klaassen, 2008). Children
and the elderly may be at greater risk than young adults; there may be gender
differences in the ability to detoxify certain substances (e.g. alcohol); and genetic
differences between individuals in terms of their capacity to metabolise certain
substances (e.g. organophosphates). Finally, individuals in particular occupations such
as farming, painters, transportation workers, and electronic workers, may be at greater
risk than others (Karalliedde et al, 2001; Klaassen, 2008; Penney, 2008). These factors
can alter the severity of the toxic response and lead to variations in symptom profile and
severity that frequently confuse healthcare professionals and researchers (Berent &
Albers, 2005; Klaassen, 2008).
1.7 Concluding remarks
Despite these difficulties, the neuropsychologist has an important role to play in both
clinical and research settings when it comes to evaluating the effects of toxic substances
(Lezak at al, 2004; Lucchini, Albini, Benedetti & Alession, 2005). Many substances
interfere with nervous system function and therefore psychological processes (Hartman,
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1995). Neuropsychology has devised standardised tests, capable of detecting subtle
abnormalities associated with neurotoxic exposure and neuropsychologists are trained in
scientific method which means they are able to use scientific methodology and a
systematic approach to address the various clinical and research challenges inherent in
neurobehavioural toxicology.
The primary objective of this thesis is to determine whether evidence exists to support
the view that long-term, low level exposure to organophosphate pesticides is associated
with the development of chronic neurobehavioural problems. Organophosphates are
increasingly used around the world for a variety of agricultural, domestic, military and
industrial purposes and concerns have been raised about the effects of these chemicals
on human health. The next chapter summarises the development, consumption and
toxicology of organophosphates (OPs) and discusses factors that influence toxicity
which need consideration by clinicians and researchers.
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Chapter 2 : Organophosphates
2.1 Development and consumption of organophosphates
Organophosphate pesticides were derived from World War II nerve gas agents (sarin,
soman, tabun) and were modified during the 1950s and 1960s to have selective toxicity
to insects and lower toxicity to mammals (Karalliedde et al, 2001; Klaassen, 2008).
They have since become the most widely used group of pesticides / insecticides in the
world and are extensively used in agriculture, horticulture and veterinary medicine, and
for domestic purposes to control insects around the home and garden. They are also
used for public hygiene purposes to control insects in public buildings such as offices,
schools and hospitals, and they are even used on commercial aircraft travelling to and
from tropical countries. OPs continue to be used by the military as both chemical
weapons and pesticides; and they are also used by industry as solvents, plasticizers,
flame retardants and extreme pressure additives (lubricants). This means a very large
number of people will be exposed to these chemicals in some form during their lifetime,
and questions have been raised about the effects OPs may have on human health
(Committee on Toxicity of Chemicals in Food, Consumer Products and the
Environment (COT) Report 1999; Karalliedde et al, 2001; Royal Colleges of
Physicians, Psychiatrists and General Practitioners Report, 1998).
Demand for OP pesticides has increased over the last three decades because they are
kinder to the environment and have less biopersistence than their predecessors (i.e. the
organochlorines; Karalliedde et al, 2001). However, concern about the effects of these
pesticides has been growing with their increasing use throughout the world, but there is
a lack of reliable epidemiological data on the impact of OP pesticides on human health.
It is estimated that approximately 3-5 million pesticide poisonings occur annually
worldwide and pesticide poisoning is around 13 times more likely in developing
countries than highly industrialised ones (Baxter, Adams, Aw, Cockcroft & Harrington,
2000; Karalliede et al, 2001; Rosenstock, Keifer, Daniell, McConnell & Claypoole,
1991; World Health Organisation (WHO), 1990). More people are at risk of long term,
low level exposure but cases of adverse effects may not be reported unless affected
individuals recognise their symptoms are due to pesticide exposure and seek medical
help (Ecobichon & Joy, 1994; European Centre for Ecotoxicology and Toxicology of
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Chemicals (ECETOC) Report, 1998; WHO Report, 1990).
2.2 Organophosphate use in the UK
In the UK, OPs have been used in agriculture, horticulture and veterinary products to
control sheep scab, blow fly, ticks and warble fly. They were first licensed for use in the
1970s and sales dramatically increased during the 1980s following the introduction of
compulsory sheep dipping to control sheep scab, an infectious disease which spoils
fleece (Stephens, 1996; Watterson, 1999). Scab mite was eradicated in the UK in the
1950s but reappeared in the 1970s. As a result, the Ministry of Agriculture, Fisheries
and Food (MAFF) made it compulsory to dip sheep twice a year between 1984-1988
and once a year between 1988-1991. Compulsory dipping was discontinued in 1991.
The most common OP compounds used in sheep dip formulations at that time were
diazinon, propetamphos and chlorenvinphos. Between 1985 and 1998 over 600 reports
of ill health following exposure to sheep dip were received by a government ‘adverse
reaction surveillance scheme’ (Dunn, 2002; Tahmaz, Soutar & Cherrie, 2003). In 1999
an organophosphate working group was commissioned by the Department of Health to
review the available evidence concerning the toxicity of OPs and hear evidence from
sheep farmers regarding symptoms of ill health attributed to exposure to sheep dip. The
committee concluded that evidence exists to suggest acute poisoning from OPs can
result in ill health, but the possibility that low level exposure causes similar effects is
unproven (COT report, 1999) and recommended the UK government commission
further research to address this issue.
2.3 Process of dipping
Sheep dipping is a process whereby sheep are immersed in a bath (either indoors or
outdoors) which has been filled with pesticides to eradicate parasites. Sheep dip is
purchased by the farmer as a concentrate which needs to be diluted before use. Farm
workers prepare the dipping bath by filling it with water and concentrate and there is a
high risk of skin contamination during this process (Institute of Occupational Medicine
(IOM) Report, 1999). The dip bath is replenished several times during the day so farm
workers may handle concentrate on more than one occasion during the day. Several
individuals are involved in the process of dipping. Sheep are gathered and forced into
the bath (the worker who does this is often referred to as a ‘chucker’) and a farm worker
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usually submerges the sheep under the water using an implement (this person is called a
‘paddler’) and may be splashed by sheep dip as the animal struggles. Some protective
clothing is usually worn, such as wellington boots, waterproof leggings and rubber
gloves, but gloves frequently disintegrate after brief use because OP formulations based
on organic solvents and containing phenols are liable to penetrate clothing and degrade
rubber unless washed off properly (IOM Report 1999). Farm workers are often unable
to rinse sheep dip from their clothes or skin until the end of the day when they return
home so the risk of skin contamination is high. Those who smoke or eat during the day
risk ingesting OPs (IOM, 1999).
After dipping, sheep are held in a pen (outside or inside) and then either released onto
grassland or herded on to lorries for transport. Sheep dip fumes may evaporate as a mist
from the fleece when sheep are held indoors after dipping, increasing the risk of
contamination by inhalation. Sheep dip remains in fleece for up to three months after
dipping so the risk of skin contamination does not cease immediately after dipping.
Therefore, the handling of fleece (e.g. when shearing, rolling fleeces or examining
animals prior to/at market) is also potentially hazardous (letter from the Chief Vet at
Coopers Animal Health, 1988).
2.4 Health effects
Farmers refer to a condition of general malaise which often follows sheep dipping,
which they call ‘dippers flu’ (headaches, aching limbs, runny nose, nausea, tightness of
chest, diarrhoea, increased sweating and salivation). It follows the time of dipping and
can last for up to 48 hours. Rees (1996) measured the incidence of symptoms following
exposure to sheep dip in a group of 24 farmers in the UK. None of the subjects used
adequate personal protective clothing as it limited mobility. Many reported symptoms
of urinary frequency, diarrhoea, insomnia, headache, wheezing and tremor in the 24
hours following exposure to sheep dip. Subsequent studies of UK sheep farmers
utilising different methodologies (including case series analyses, postal questionnaires
and clinical evaluations) found many individuals complain of persistent ill health long
after exposure has ceased including neuropsychological and neurological abnormalities,
mood disorder, headache, chronic fatigue and weakness (Ahmed & Davies 1997; Beach
et al, 1996; Davies, Ahmed & Freer, 2000; Dunn, 2002; Jamal, Hansen & Julu, 2002;
Mackenzie Ross, Clark, Harrison & Abraham, 2007; Pilkington et al, 2001; Solomon,
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Poole, Palmer, Peveler & Coggon 2007; Stephens et al, 1995; Tahmaz et al 2003).
However the results of these studies caused much controversy and debate as to whether
OP pesticides were responsible for these symptoms. Sheep farmers are considered to
have relatively low level exposure to OPs and whilst it is generally established that high
level, acute exposure to OPs can cause short-term adverse effects (mediated by
cholinergic excitation which disrupts nervous system function), the possibility that long-
term, low level exposure to OPs may cause ill health remains controversial (COT
Report, 1999; Royal Colleges’ Report, 1998).
2.5 Toxicology of organophosphate pesticides
An OP is a chemical compound which contains both carbon and phosphorous. There are
a large number of OP chemicals with a diverse range of chemical structures and
activities, but OP pesticides all have in common the ability to inhibit
acetylcholinesterase (AChE). Human exposure to OP pesticides can result from eye or
skin contact, inhalation or oral intake and may be accidental or intentional (i.e. suicide).
Organophosphates are absorbed rapidly through the skin, lungs, gastrointestinal tract
and conjunctiva (Karalliedde et al, 2001; Klaassen, 2008). Once absorbed, OP
pesticides inhibit the enzyme acetylcholinesterase (AChE) which is responsible for
metabolising acetylcholine (ACh), an important neurotransmitter in the central,
peripheral and autonomic nervous systems. Inhibition of the enzyme results in
accumulation of acetylcholine at synapses and over-stimulation of nerves and muscles,
resulting in a constellation of acute symptoms, followed by paralysis of transmission if
supplies of ACh become depleted (Ecobichon and Joy, 1994; Karalliedde et al, 2001;
Royal Colleges’ Report, 1998). OPs do not only bind to AChE but also other esterases
and their inhibitory impact on esterases can result in four syndromes, the acute
cholinergic crisis, the intermediate syndrome, organophosphate delayed polyneuropathy
and chronic neurobehavioural damage. These syndromes can occur independently of
one another and may have different underlying mechanisms (Abou-Donia, 2005).
2.5.1 Acute poisoning – the cholinergic crisis
Characteristic symptoms of mild poisoning include fatigue, headache, weakness,
dizziness, sweating, wheezing, coughing and have been well documented (Baxter et al,
2000; COT Report, 1999; ECETOC Report, 1998; Royal Colleges’ Report, 1998; WHO
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Report, 1990). The symptoms are not unlike influenza and are frequently not
recognised as being caused by exposure to OPs. Moderate poisoning may result in
abdominal cramps, nausea, vomiting, muscular tremors, bradycardia, lowered heart rate
and blood pressure; and severe poisoning may cause respiratory difficulty, cardiac
arrest, convulsions, coma and possibly death.
Recovery from mild poisoning usually occurs within 24-48 hours and it is widely
believed that if an individual survives the initial life threatening crisis they will make a
complete recovery. However, patients have been presenting to clinicians with symptoms
which have persisted long after resolution of the cholinergic crisis. The subtle delayed
effects of OP poisoning on both the central and peripheral nervous system are not well
known or understood and may be unrelated to the cholinergic effects. OPs are capable
of producing several delayed physical and neurological syndromes.
2.5.2 The Intermediate Syndrome
The intermediate syndrome (IS) may follow successful treatment of an acute cholinergic
crisis and consists of proximal flaccid limb paralysis typically starting 1-4 days after
poisoning. The effects last from 5-18 days. One explanation of IS is persistent blockade
of the neuromuscular junction, but it seems that muscle necrosis may be implicated. The
syndrome is reported fairly frequently in developing countries (Senanayake &
Karalliedde, 1987).
2.5.3 Organophosphate induced delayed polyneuropathy
Organophosphate induced delayed polyneuropathy (OPIDN) is a delayed sensory and
motor polyneuropathy affecting predominantly the lower limbs, but in severe cases the
upper limbs as well. Onset is 2-4 weeks after exposure. Degeneration of the distal ends
of longer axons is followed by myelin breakdown, Schwann cell proliferation and
macrophage accumulation. OPIDN does not appear to be related to the
anticholinesterase action of OPs, but rather the phosphorylation, ageing and subsequent
inhibition of an enzyme in neurons called neuropathy target esterase (NTE). Recovery is
slow and often incomplete, particularly in the central nervous system (CNS) where
changes are often present in the medulla oblongata of the brain, spinal cord and CNS
which seem irreversible (Jamal, 1997; Royal College’s Report, 1998). Not all OPs cause
OPIDN and regulatory bodies in the Western World no longer allow OP pesticides
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causing polyneuropathy to be marketed. However, sheep dip products containing two
OPs that can cause OPIDN (chlorpyrifos and coumaphos) were available until 1989 and
1991 respectively.
2.5.4 Chronic neurological and neurobehavioural changes
Neurobehavioural changes involving subtle cognitive impairment, greater psychiatric
morbidity and chronic fatigue have been reported (Ahmed & Davies, 1997; Davies,
Ahmed & Freer, 1999; Hartman, 1995; Karalliedde et al, 2001; Klaassen, 2008;
Mackenzie Ross et al, 2007; Ray, 1998a; 1998b; Solomonet al, 2007; Stephens et al,
1995). How OPs might cause such effects is unknown, but several mechanisms have
been proposed; such as changes in receptor sensitivity, non-cholinergic effects (e.g. on
dopaminergic or adrenergic sites; Fatehyab-Ali, Hassan & Tariq, 1979), inhibition of
other enzymes and proteins (Jamal, 1997; Pancetti, Olmos, Dagino-Subiabre, Rozas &
Morales, 2007; Pope, 1999) and apopotic neuronal cell death (i.e. programmed cell
death involving free radical generation and oxidative stress; Abou-Donia, 2005; Kapur,
Radotra, Minz & Gill, 2007). The research evidence concerning neurobehavioural
changes following exposure to OPs will be discussed in greater detail in the next
chapter of this thesis.
2.6 Factors influencing toxicity in humans
2.6.1 Measurement of exposure
Accurate estimation of severity of exposure is critical for the validity and power of
studies investigating the adverse effects of OPs. A large number of factors have been
identified which can influence the toxicity of OPs and efforts should be made to collect
data on as many of these variables as possible (Karalliedde et al, 2001; Klaassen 2008).
The particular OP compound an individual is exposed to and the level/duration of
exposure are frequently assumed to be the most relevant/critical variables (Karalliedde
et al, 2001; Klaassen 2008). There are a large number of OP pesticides of differing
chemical composition and although all have some toxic effects in humans, these can
vary widely. Other important factors which influence toxicity include route of exposure
(i.e. oral, dermal, inhalation), concentration and duration of exposure, rates of
metabolism and elimination of OPs from the human body. However it is extremely
difficult to obtain reliable information regarding these variables in human occupational
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exposures as objective indices of exposure, such as external monitoring of contaminants
in the atmosphere and/or internal biological monitoring of workers (to determine level
of exposure) is extremely rare in most occupations (Karalliedde et al, 2001; Klaassen
2008). Biological monitoring (i.e. urine and blood analysis of OP metabolites) is of
limited value in studies of long-term health effects as the human body rapidly
metabolises and eliminates toxins, making biological monitoring useful for assessing
severity of recent but not long-term exposure. Often the most that can be achieved is a
rough estimate regarding level and duration of exposure based on an individual’s
testimony / self report regarding the number of years they have worked with a specific
chemical product, how frequently they used it and over what time frame. Given the
limits of human memory, exposure information collected in this way may be unreliable.
Some researchers create job exposure indexes in an attempt to consider all of the
different aspects of exposure history which may be relevant (such as those listed above:
Buchanan et al, 2001; Cherrie & Robertson, 1995; London & Myers, 1998; Stewart,
Prince, Colt & Ward, 2001). Exposure metrics vary greatly in terms of which variables
they consider important and range from simple methods whereby different measures of
frequency and duration of exposure are multiplied together to provide an overall rating;
to more complex formulae which attempt to estimate intensity of exposure in addition to
duration by incorporating weightings for variables such as job activity, use of protective
clothing and so on. Exposure metrics do not reflect absolute exposure but provide a
ranking within a population under study. They are often considered to be an
improvement over simple measures of exposure such as ever/never been exposed or
duration of exposure, but the validity of such measures is dependent on the assumptions
underlying the metric, the variables considered, the weighting assigned to variables and
the accuracy of information provided by respondents.
The inability of clinicians and researchers to acquire precise information about dose,
frequency and duration of exposure probably explains, at least in part, the continuing
debate regarding the relative contribution these variables make in producing toxic
effects. A major unresolved issue in the toxicity literature is whether repeated, low level
exposure to OPs is harmful to human health (COT Report, 1999). Although it has been
established that acute, high level exposure is harmful, it remains unclear whether
chronic health problems are a result of a history of acute exposure (dose) or frequency
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and duration of low level exposure (cumulative damage acquired over time). In
addition, there is no clear cut definition of ‘high level’ and ‘low level’ exposure and
studies purporting to be examining the effects of low level exposure may include people
with a history of acute poisoning. At present, the definition of high level exposure
revolves around whether individuals seek medical help (COT Report, 1999), yet
research has shown that variables other then severity of illness determine whether
individuals consult physicians (Pitts & Phillips, 1991). A definition of this kind may
under-estimate instances of acute poisoning as medical health seeking behaviours are
lower in rural communities (British Medical Association, 2005).
2.6.2 Route of exposure
Route of exposure influences the severity of toxic effects and varies across occupations.
For example, orchard workers and crop sprayers apply pesticides by spray, and are at
greater risk of inhalation exposure than sheep dippers who are at greater risk of dermal
penetration (Buchanan, et al, 2001). Having said that, some workers may be exposed by
more than one route, for example sheep farmers who engage in several roles such as
dipping and herding sheep into containers and who smoke/eat when working are at risk
of dermal, oral and inhalation exposure. Dermal and oral absorption result in less
toxicity than inhalation as OPs undergo a degree of metabolism in the gut and liver
before reaching the systemic circulation following these routes of exposure. In contrast,
absorption following inhalation is rapid and almost complete as the OPs pass into
circulation without having been metabolised by the liver (Karalliedde et al, 2001).
2.6.3 Rates of metabolism, individual differences & interactions with other chemicals
Following uptake, OPs are distributed widely throughout the body. Although they are
lipophilic and have the potential to form depots in fat, skin and bone tissue (Karalliedde
et al, 2001), they are generally degraded rapidly and most of the products are excreted
in urine within about 2 days (Klaassen, 2008). This makes it difficult to obtain
biological markers of exposure from blood or urine samples, unless an individual is
examined shortly after exposure. Metabolism of OPs involves a number of enzyme
systems which usually make the pesticide more water-soluble and easier to excrete but
in some cases metabolism increases toxicity (Costa & Furlong, 2002; Klaassen, 2008).
To complicate matters further several of the enzymes involved in metabolising OPs are
involved in metabolising other substances which means their ability to metabolise OPs
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may be altered if an individual is exposed to compounds that share the same metabolic
pathway of detoxification such as certain prescribed medicines, by dietary factors (e.g.
alcohol, grapefruit juice) or exposure to other industrial chemicals at the same time as
OPs (Abou-Donia et al, 1996; Costa & Furlong, 2002; van Himbergen, et al, 2008).
Genetic predisposition can influence an individual’s capacity to metabolise OPs as there
is considerable individual variability in the activity of enzyme systems involved in the
detoxification of OPs. For example, paraoxonase (PON1) is a liver and plasma enzyme
which contributes significantly to the detoxification of OPs and may be a useful
biomarker of individual susceptibility to OP toxicity. Paraoxonase activity shows wide
differences within Caucasians and other ethnic groups and a subgroup (40-50%) of the
UK and US population have low activity with 4% of the population being deficient in
this enzyme (COT report 1999; Costa et al, 2000; Mackness et al, 2003; Richter &
Furlong, 1999). Hence an individual’s response to exposure may be affected by
polymorphisms in genes involved in pesticide metabolism (Cherry et al, 2002; Costa et
al, 2003; Mackness et al, 2003).
Polymorphisms of PON1 have been found to modulate the toxicity of OPs in animal
studies (Costa & Furlong, 2002). In human populations, two common polymorphisms
have been identified in the coding sequence of PON1: L55M and R192Q. Costa and
Furlong (2002) found that there are large inter-individual differences in level of plasma
PON1 activity such that individuals with the same genotype may have different levels
of protection. Therefore, it is important to measure the level of protein expressed in an
individual’s plasma in addition to determining genotype. Cherry et al (2002) and
Mackness et al (2003) investigated the relationship between PON1 genetic
polymorphisms and activity levels in farmers reporting chronic ill health attributed to
OP exposure in sheep dip (cases) and sheep farmers who carried out similar activities
but remained well (controls). They found that the PON1 192 polymorphism was more
common in people reporting ill health and that these individuals were more likely to
have the R or L PON1 alleles than similarly employed controls who believed
themselves to be healthy. Furthermore, cases were more likely than referents to have
low serum hydrolytic activity for diazoxon. Indeed, Mackness et al (2003) reported that
farmers in the lowest quintile of diazoxon hydrolysis were 2.5 times more likely to
report ill health (which they attributed to sheep dipping) than farmers in the highest
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quintile. These findings suggest that PON1 status (i.e. genotype and PON1 level) is an
important biomarker of individual susceptibility to OP toxicity and an important
consideration for any future studies seeking to address the health effects of OP
exposure.
2.6.4 Use of protective measures and cross cultural differences
The risk of exposure to chemical substances can be reduced by the use of protective
clothing, but many workers, particularly those in developing countries, cannot afford
personal protective equipment (PPE) and/or find it unbearable to wear in hot humid
conditions. Many UK sheep farmers found PPE impractical to wear and in some cases
PPE actually exacerbated exposure for example when rubber gloves became degraded
by the solvents and phenols in pesticide formulations which allowed OP pesticides to
penetrate the gloves and become trapped against the skin layer, thereby prolonging
dermal exposure. Legislation regarding the use of pesticides and minimisation of health
hazards varies considerably between developed and developing countries, with the most
stringent legislation occurring in the USA where some states stipulate that agricultural
workers wear protective clothing and are biologically monitored during the course of
their work (Karalliedde et al, 2001). In contrast workers in some developing countries
are driven by poverty to work long hours and may be unable to read instructions
regarding the dilution, application, storage and safe disposal of pesticides. Many are
exploited by employers and compelled to use equipment and pesticides provided with
total disregard of precautionary measures (Karalliede et al, 2001).
2.6.5 Outcome measures
As mentioned in Chapter 1, there are a range of potential health effects following
exposure to OPs (mortality, carcinogenicity, reproductive effects, physical ill health,
neurological symptoms, neurobehavioural symptoms) but financial constraints, concern
for the welfare of animals and methodological issues mean not all of these outcomes are
studied (Klaassen, 2008). There are a large number of OP pesticides which differ in
their chemical composition and capacity to produce some of these effects making it hard
to form an overall view on the toxicity of certain compounds as it depends on the
outcome of interest.
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2.7 Concluding comments
OPs have complex effects on the human body and are capable of producing a variety of
acute and chronic effects. There is a need for further research as millions of workers and
an unknown number of individuals will be exposed to OPs at some point in their lives.
Outstanding issues remain in the toxicity literature such as whether repeated, low level
exposure to OPs, in the absence of a history of acute toxicity, is harmful to human
health. Unfortunately, only a crude definition of high versus low level exposure exists
and quantification of exposure is fraught with difficulty. Level of exposure is
frequently assumed to be the only biologically critical variable, but this chapter has
reviewed several other variables which can influence toxicity. Future researchers need
to account for these variables in their study design. The next chapter reviews the
available scientific evidence concerning the effects of long-term, low level exposure to
OPs and illustrates the methodological issues and challenges facing researchers.
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PART 2
Neurobehavioural problems following low level
exposure to organophosphate pesticides.
A systematic & meta-analytic review.
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Chapter 3 : Neurobehavioural problems following low level exposure
to organophosphate pesticides: A systematic review.
3.1 Background
Pesticides prevent millions of people from starving to death and from disease, but they
are harmful to humans under certain circumstances. Organophosphate pesticides are the
most widely used insecticides in the world and are considered by the World Health
Organisation to be one of the most hazardous pesticides to vertebrate animals,
responsible for many cases of poisoning worldwide, particularly in developing countries
where adequate protective measures are lacking (De Silva, Samarawickrema &
Wickremasinghe, 2006; WHO report 1990). Concern about the effects of
organophosphates on human health has been growing as they are increasingly used
throughout the world for a variety of agricultural, domestic and industrial purposes. The
neurotoxic effects of high level acute poisoning are well established and involve
inhibition of the enzyme acetylcholinesterase (AChE) causing changes in peripheral,
autonomic and central nervous system function (cholinergic crisis; see previous chapter
for more detail). However, the possibility that long-term low-level exposure to OPs in
doses below that causing acute toxicity causes ill health is controversial.
A number of researchers have addressed this question using a variety of different
methodologies and populations, but previous research has produced inconsistent
findings, with some studies finding evidence of ill health and cognitive impairment
following low level organophosphate exposure while others have not (see reviews by
Alavanja et al 2004; Arcury & Quandt 1998; Colosio, Tiramani & Maroni, 2003; COT
Report 1999; De Silva et al 2006; ECETOC Report 1998; Kamel & Hoppin 2004;
Mearns, Dunn & Lees-Haley, 1994; Ontario College of Family Physicians (OCFP)
Report 2004; Ray, 1998a; 1998b; Royal Colleges’ Report, 1998). Major methodological
differences may account for these inconsistencies such as examination of different
occupational groups with different levels and routes of exposure, use of protective
clothing, from different cultural backgrounds examined over different time periods (e.g.
following a single episode of exposure, several years of exposure or over a lifetime).
Since many more individuals are likely to be at risk of long-term, low level exposure,
rather than acute poisoning it is important to get a clear answer to the question of
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whether low level exposure is harmful to human health. The aim of this chapter is to
review the available evidence concerning the neurotoxicity of long-term, low level
exposure to organophosphate pesticides. A systematic review of the literature was
undertaken using Medline, Embase and Psychinfo databases without date limitation. A
large body of literature exists concerning the neurotoxicity of OPs incorporating
different methodologies, populations examined and outcome measures, so strict
inclusion and exclusion criteria were applied to limit the review to relevant, high quality
studies of human adult populations.
3.2 Methods
3.2.1 Objectives
The overall aim of this chapter is to review and evaluate the available evidence
concerning the neurotoxicity of long-term, low level exposure to OPs in order to
determine whether low level exposure to OPs is associated with neurobehavioural
dysfunction.
3.2.2 Criteria for considering studies for this review
There is a large body of literature concerning the neurotoxicity of OPs including animal
studies, single case-studies, group studies, questionnaire and telephone surveys, studies
which have included objective clinical examinations, retrospective and prospective
studies. Subtle differences in study aims influence the selection of study participants.
For example, some studies have examined the effects of acute poisoning or the chronic
health effects which may follow a prior history of one or more episodes of acute
poisoning; whilst others have investigated the short-term effects of a single season of
pesticide use in individuals who may or may not have a history of prior acute
intoxication; or the consequences of long-term, low level exposure in the absence of a
history of acute intoxication. Different study participants have been selected including
children, adults, individuals from industrialised and developing countries, individuals
from different occupational groups with different routes of exposure. Different
outcomes have been evaluated, such as mortality, pathology, physical symptoms (e.g.
chronic fatigue), reproductive outcomes, cancer, neurotoxicity, behaviour. These
different methodologies are not strictly comparable and probably account for the
inconsistent findings of previous research.
38
This review will focus on the effects of low level exposure to OPs on neurobehavioural
function in the absence of a history of acute poisoning. The review will not include
studies concerning the neurobehavioural effects that may follow one or more episodes
of acute poisoning. This review will also limit itself to neurobehavioural effects on
human adult populations. Studies concerning children and adolescents will not be
included as developmental issues complicate interpretation of neurobehavioural data.
Children may be particularly susceptible to the effects of toxic substances because of
their developing nervous system (Hartman, 1995). This review will be limited to studies
which meet the following criteria.
Table 3.1 Inclusion/exclusion criteria for studies in this review
Inclusion criteria Exclusion criteria
Studies of OP exposure Pesticides other than OPs
Effects of long-term, low level exposure in
the absence of an episode of acute
poisoning.
Immediate or long-term health effects
following acute poisoning.
Long-term exposure over a lifetime Short-term, acute effects following a
single season of pesticide use
Observational group studies of human
adults
Animal studies, studies of children, single
case reports
Neurobehavioural outcome measures Only used outcome measures which are
not neurobehavioural eg carcinogenicity,
mortality
Outcome measures which involve
symptom questionnaires rather than
objective measures.
Non-English language papers
3.2.3 Search methods for identification of relevant studies
Relevant studies from the 1960s onwards were identified from MEDLINE, EMBASE
and PsycINFO databases (via Ovid interface) using both subject headings and textword
search strategies on the 27th August 2009 (please see Appendix 1 for full details).
Retrieved articles were reviewed to evaluate title and abstract content and to eliminate
articles that were not relevant for this review and to remove duplicates. Government
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working party reports, relevant textbooks and references cited at the end of articles were
also examined to ensure all relevant material was included in this review.
3.2.4 Data synthesis and quality assessment
Details of relevant studies were entered into summary tables showing study objectives,
study populations, exposure and outcome measures. Study methodology varies
considerably so the following factors were taken into consideration when evaluating
studies:
1. Does the study design adequately address the question of whether long-term, low
level exposure to OPs has adverse effects on neurbehavioural function - is the study
design appropriate for the stated research question?
2. Does the study provide adequate information concerning the exposure history of
study participants?
Does the study evaluate the effects of exposure to organophosphates or does it
concern exposure to a mixture of pesticides, including OPs?
Does the study evaluate the effects of long-term, low level exposure to OPs in
the absence of a history of acute exposure?
Does the study include participants with a history of acute exposure? If so, do
they take this into account in their analysis by analysing these individuals as a
separate group?
3. Does the study evaluate human, adult populations and if so, from which country,
cultural and ethnic backgrounds were the study participants from?
4. Was a suitable, matched comparison group of unexposed individuals examined?
5. Were objective, reliable, valid, standardised, outcome measures included?
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3.3 Results
3.3.1. Numbers of articles retrieved from database searches
A total of 562 articles were identified as potentially relevant by the three databases.
Appendix 1 shows the number of articles identified by the different databases according
to search strategies used (MEDLINE identified the greatest number of potentially
relevant articles). The titles and abstracts of these articles were subsequently reviewed
and 483 were excluded for the following reasons: the article concerned a pesticide
which was not an organophosphate, the article concerned the effects of acute OP
poisoning, the outcome measures were not neurobehavioural, study populations
included children, adolescents or animals, the article concerned the treatment of OP
poisoning or the benefits of biological monitoring or protective clothing; the article was
a review article rather than an original research study (the latter were reviewed
thoroughly however, particularly the reference lists cited at the end of these articles to
ensure all relevant papers were retrieved). After removing articles which had been
duplicated between the three databases and search strategies a final sample of 36 articles
were selected and reviewed thoroughly. A further 7 studies were added to the review
which had not been identified by the database searches. These articles were noted in the
references cited at the end of other articles. This left a final sample of 43 original
articles for review (please see Appendix 1 for study details and sources).
3.3.2 Excluded studies
The first step of the review process was to determine whether all 43 articles selected
from the initial screening of titles and abstracts, met inclusion criteria for this review.
This was not always apparent from a review of titles and abstracts. Sixteen studies were
excluded following this second stage of the review because they did not meet the
inclusion criteria listed in Table 1 (see Appendix 1 for further details).
A further twelve studies were excluded because the study design did not adequately
address the question of whether long-term, low level exposure to OPs impairs
neurbehavioural function. The literature concerning this issue encompasses considerable
variation in study methodology. It is possible to group studies according to design and
three broad study designs are apparent in the literature; (1) epidemiological studies
which use proxy measures of exposure such as occupational group (2) pre/post episode
41
or season of exposure evaluations (3) epidemiological studies which provide
quantitative information about exposure history. However the first two study designs do
not adequately address the issue of whether low level exposure to OPs is harmful.
Hence, six studies were excluded because they used proxy measures of exposure such as
occupational group or residency in a particular geographical region and although they
found evidence to suggest a link between farm work and the development of ill health
causality could not be determined (Beseler et al 2006; Browne et al 2006; Cole et al
1997; Kamel et al 2003; Parron, Hernandez & Villanueva, 1996; Rohlman et al 2007).
Assumptions were made that deficits identified related to pesticide exposure, but in all
of these studies participants were exposed to a wide range of pesticides making it
difficult to determine whether adverse effects relate to a single pesticide such as OPs or
the use of pesticides in combination. Dose-response relationships could not be
determined and the influence of variables which do not relate to exposure such as
lifestyle or stress, couldn’t be ruled out. For this reason, studies which used proxy
measures of exposure do not appear in this review.
Some studies have attempted to address the issue of whether chronic exposure to OPs
causes ill health by examining workers before and after an episode or season of
pesticide use (Albers et al, 2004; Bazylewicz-Walczak, Majczakowa & Szymczak,
1999; Daniell et al, 1992; Maizlish, Schenker, Weisskopf, Seiber & Samuels, 1987;
Misra, Prasad & Pandy, 1994; Rothlien et al, 2006; Salvi et al, 2003). The advantage of
pre/post season study designs is that they allow a more detailed analysis of dose-
response relationships to be made than other study designs and they are particularly
useful for determining whether (1) a single episode of exposure affects health (2)
symptoms persist, worsen or resolve over time (Salvi et al, 2003) and (3) evaluating the
utility of biological monitoring and the relationship between biological markers of
exposure and onset of symptoms.
However, most fail to address the issue of whether long-term, low level exposure to
OPs causes ill health and are therefore beyond the remit of this review. The exception is
the study by Bazlewicz-Walczak et al (1999) in which two types of analyses were
undertaken, both pre and post season evaluations looking for change in performance
over time, but also comparisons of exposed and unexposed cohorts prior to the spraying
season, matched on important variables which might otherwise affect cognitive
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function. The latter analysis is crucial for establishing whether cumulative, low level
exposure is the causative factor, since any cohort comparisons undertaken following
spraying seasons may simply pick up immediate, acute effects of exposure. This study
was retained in the meta-analysis.
562
Articles found
79
Remaining
43 Examined
15
Articles
included
483
Excluded
43
Duplicates
removed
Add 7
28
Excluded
Figure 3.1 Number of potentially relevant articles identified during initial literature searches,
exclusion and inclusion figures.
3.3.3 Findings of the review: Epidemiological studies that provide quantitative
measures of exposure
Fifteen epidemiological studies were identified as being suitable for inclusion in a meta-
analysis. All addressed the issue of whether long term, low level exposure to OPs is
associated with neurobehavioural deficits, but different populations of people were
examined including chemical plant workers, greenhouse workers, pest control
operatives, pesticide applicators (sheep dippers, fruit tree sprayers, crop sprayers). Study
participants came from both developed and developing nations. They were exposed to a
range of different OPs and duration of exposure ranged from an average of 2 years to
over 20 years.
This review will now describe these studies. They will be grouped according to the
occupational status of study participants and country of origin because level and route
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of exposure varies between jobs and in developing and developed nations. Details are
also provided concerning the neurobehavioural measures used in the study and whether
the control subjects were matched on important variables, known to affect performance
on cognitive tests, such as age and years in education. All of this information is
summarised in Tables 3.2.
3.3.3.1 Chemical plant manufacturers
3.3.3.1.1 Developing countries
Srivastava et al (2000) examined 59 Indian workers recently exposed to different
chemicals during the manufacture of ‘quinalphos’ and 17 control subjects. Groups were
matched for age and sex, but controls were more educated than exposed subjects. None
of the subjects had a history of acute OP poisoning over the preceding years. All
participants underwent a general medical examination, blood tests to assess recent
exposure and psychometric testing. Although mean blood AChE levels in the exposed
and control groups were not significantly different, exposed subjects reported more
symptoms of fatigue and weakness; had a higher prevalence of abnormal plantar and
ankle reflex; and lower scores on digit span, digit symbol and Bourdon Weirsma
vigilance test. The authors conclude that exposure to OPs can cause nervous system
damage and that AChE monitoring of chemical plant workers may not be adequate,
because OPs may inhibit enzymes other than cholinesterase. The main limitation of this
study is the fact that the control group was not matched to the exposed group for level
of education and would be expected to outperform the exposed cohort. A further
criticism concerns the limited amount of information provided about exposure history.
Amr, Halim and Moussa (1997) examined 208 Egyptian pesticide formulators, 172
pesticide applicators and compared them to 233 controls (matched for age, social class
and education). Formulators and Applicators had been exposed to a range of pesticides
(including OPs, organochlorines, carbamates and synthetic pyrethroids) for at least 2
years. All study participants were assessed by a psychiatrist with reference to the
American Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R;
American Psychiatric Association, 1994) and completed the General Health
Questionnaire. Psychiatric disorders were significantly higher among pesticide
formulators and applicators than controls and in those with a longer duration of
exposure (e.g. more than 20 years). Furthermore, the incidence of reactive depression
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was nearly equal in all groups, but the incidence of neurotic or dysthymic disorder was
higher in exposed subjects than in controls and higher than that seen in the general
population of Egypt. The authors conclude that the increase in psychiatric morbidity
relates to the cholinergic effects of pesticides. A major weakness of this study is the
failure to provide any information about exposure history, other than to describe the
exposed subjects as having heavy and continuous exposure. It is impossible to
determine whether they have a history of acute poisoning. Furthermore, the authors
missed an opportunity to compare applicators with formulators directly. Working
practices, use of protective clothing and routes of exposure may differ in these groups.
3.3.3.2 Pest control operators
3.3.3.2.1 Developed countries
Steenland et al (2000) looked at the effects of low-level exposure to an OP pesticide
called ‘chlorpyrifos’ by examining 191 termiticide applicators who had applied this
pesticide for an average of 2.4 years, with 189 non exposed controls. Groups were
matched for age and sex, but controls were more educated than exposed subjects. All
participants underwent an extensive range of tests including clinical examination, urine
and blood tests to assess recent exposure and genotype (in regard to paraoxonase),
vibrotactile sensitivity, postural sway, manual dexterity, eye-hand coordination,
arm/hand tremor, vision and olfaction tests, nerve conduction velocity and cognitive
function. The exposed subjects reported more symptoms including memory problems,
emotional states, fatigue and loss of muscle strength, but few significant differences
were found on quantitative tests. The exposed subjects performed more poorly than
controls on pegboard turning tests and some postural sway tests, but there were no
significant differences between the exposed and nonexposed groups on most of the
cognitive tests. Eight study participants reported a past history of acute poisoning, but
only one sought medical help. These men showed a pattern of worse performance on a
range of tests including simple RT and continuous performance, when compared to
other applicators. The authors conclude that increased symptom reporting in the
exposed group is cause for concern, that their neurologic tests may not have been
sensitive enough to detect some of the effects of exposure and that there is evidence for
delayed effects in subjects with a history of poisoning. The main limitation of this
study is the fact that study participants had a relatively short history of exposure to OPs.
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3.3.3.3 Farm workers & pesticide applicators
3.3.3.3.1 Developed countries
Rodnitzky, Levin and Mick (1975) studied 23 farmers and commercial pesticide
applicators in Iowa who regularly used OP compounds (and had done so within 2 weeks
of testing), but were asymptomatic and compared them with 23 non-exposed farmers.
Mean plasma AChE levels were within normal limits (but slightly lower in exposed
farmers) but the groups did not differ significantly on tests of memory or reaction time
(RT). However, applicators had higher levels of anxiety. Limitations of this study
include the possibility that the control group, who were also farmers, had significant
levels of exposure to OPs in the past and lifetime exposure history of study participants
was not provided and the sample size is very small.
Ames, Steenland, Jenkins, Chrislip and Russo (1995) examined 45 Californian
pesticide applicators with a prior history of documented cholinesterase inhibition
(according to medical supervision records), but with no clinical symptoms of acute
poisoning and compared them to controls. The groups were not matched for age or
education, the exposed cohort being older and less educated. Subjects underwent nerve
conduction studies, vibrotactile sensitivity tests, a test of postural sway and eight
neuropsychological tests of psychomotor speed, attention, fine motor control, memory
and mood state. No evidence of neurobehavioural problems was found in the exposed
cohort and the authors conclude that neurological sequelae can be prevented by
avoiding acute poisoning. However, no information is provided about exposure history
other than the fact workers had been exposed to cholinesterase inhibiting pesticides and
the duration of time workers were exposed to pesticides is unclear.
3.3.3.3.2 Developing countries
Farahat et al (2003) examined 52 Egyptian pesticide applicators during the spraying
season and compared them to 50 non-exposed controls (matched for age, years of
education and social class). None of the applicators reported an incident of acute
poisoning which led to hospitalization. All participants underwent a clinical
examination, blood tests to assess recent exposure and psychometric testing. The mean
level of serum AChE was significantly lower in exposed subjects but within normal
limits and did not relate to performance on psychometric tests. After adjusting for
potentially confounding factors (age and education) the performance of the exposed
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subjects was significantly lower on similarities, digit symbol, digit span, Trails A and B,
letter cancellation and the Benton visual retention test (Benton, Sivan, des Hamsher,
Varney & Spreen, 1994). This was related to duration of exposure. The authors
conclude that the effects of low to moderate exposure to OPs over a prolonged period of
time (10-20 years) may be more wide ranging than previously realized, that workers can
exhibit mild symptoms of intoxication without any change in blood AChE activity and
that psychometric assessment is a useful method for the early detection of chronic
effects of OP pesticide exposure.
3.3.3.4 Fruit Tree Sprayers
3.3.3.4.1 Developed countries
Stephens and Sreenivasan (2004) looked at the neuropsychological effects of long-
term low level exposure to OPs in 37 English orchard sprayers, none of whom had a
history of acute poisoning. Their performance on 7 neuropsychological tests was
compared with 26 pig farmers and 31 construction workers, matched for age and
education. Pig farmers had a history of exposure to pesticides. Orchard sprayers (and
pig farmers) differed from unexposed construction workers in terms of the time taken to
complete negative statements of the ACTS syntactic reasoning test. However,
psychometric test findings did not correlate with the index of cumulative exposure used
in this study, but the authors suggest this may be due to measurement error inherent in
the index.
Fiedler, Kipen, Kelly-McNeil & Fenske (1997) compared 57 fruit tree sprayers in
New Jersey (with no history of acute poisoning resulting in hospitalisation) with
controls. Groups were matched for age, but controls were more educated and had higher
reading scores than the exposed subjects. The exposed cohort had slower reaction time
(although age predicted some of the variance in RT scores), but no other differences
between the groups on neuropsychological testing were found. However, Fiedler et al
corrected their data for the influence of reading scores, used to assess premorbid IQ.
This may have confounded the results as reading scores may be affected by exposure to
OPs.
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3.3.3.4.2 Developing countries
London, Myers, Nell, Taylor and Thompson (1997) looked at the neurobehavioural
effects of long-term, low level exposure to OPs by examining 163 African fruit tree
sprayers and comparing them with 84 unexposed labourers. Groups were matched for
age, years in education and levels of illiteracy. Neuropsychological tests had to be
adapted for the study population due to cultural differences reported by previous studies
which influence performance on standard tests and because participants had little formal
education. Nine percent had a history of acute poisoning with OPs and over eleven
percent had a history of exposure to other neurotoxic chemicals. Alcohol consumption
was high. Nine controls had a history of pesticide exposure through agricultural work.
Small occupational effects were observed on two out of seven tests but may have been
the result of multiple comparisons. The authors suggest the failure to find significant
association between exposure and neurobehavioural performance may have been a
result of exposure misclassification or the fact that workers with poor neurobehavioural
performance may have quit their jobs and not been included in the study. Cross cultural
issues make this study very difficult to interpret.
3.3.3.5 Greenhouse workers
3.3.3.5.1 Developed countries
Roldan-Tapia, Parron and Sanchez Santed (2005) conducted a cross sectional survey
of 40 Spanish pesticide applicators who had been employed for 6 months to 30 years,
who did not have a history of recorded poisoning events. They were compared to 26
non-exposed controls (matched for age and education). Data were collected at a time of
high exposure but serum cholinesterase levels were not significantly different between
exposed and non-exposed subjects. A relationship was observed between cumulative
exposure and delayed verbal memory, visual memory and anxiety levels. Subjects who
had been exposed to pesticides for more than 10 years obtained lower scores on tests of
integrative perception and visuo-constructional praxis. The authors conclude that long-
term exposure to pesticides can cause neurobehavioural problems.
Roldan-Tapia et al (2006) examined the effects of different degrees of pesticide
exposure on neuropsychological performance. Data from 24 acutely poisoned workers
and 40 non-poisoned but chronically exposed Spanish greenhouse sprayers were
compared to 26 controls. Groups were matched for education but the low exposure
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group was significantly younger than the other two groups. The pesticides used included
OPs and carbamates. Chronically exposed subjects were split into two subgroups, high
exposure (more than 10 years handling pesticides) and low exposure (less than 10 years
handling pesticides). Acutely poisoned subjects had been poisoned in the last 3 months
and required treatment in the local hospital at the time of poisoning.
Neuropsychological assessment found evidence of reduced visuo-motor , perceptual and
constructive abilities, verbal learning and speed of processing and increased rates of
anxiety. Subjects with high chronic exposure had similar neuropsychological profiles
whilst those with low chronic exposure were similar to controls.
Bazylewicz-Walczak et al (1999) sought to determine the behavioural effects of
chronic exposure to OPs by examining 51 women employed in gardening enterprises
and compared them to 25 unexposed controls, matched for age, years in education,
smoking and alcohol use. None of the exposed subjects had a history of acute
poisoning. Psychological examinations were carried out before and after the spraying
season using the Neurobehavioural Core Test Battery recommended by the WHO. No
deterioration in cognitive or emotional function was found after one spraying season.
However, exposed and unexposed cohorts differed on both occasions with OP exposed
subjects showing slowing of perceptuo-motor functions and reported a higher degree of
anxiety, depression, irritability, fatigue and memory problems. The authors conclude
that a single season of pesticide use may not cause immediate behavioural effects, but
repeated low level exposure to OPs over extended periods of time may produce chronic
neurobehavioural effects.
3.3.3.6 Studies of UK Farmers
In the UK, a number of studies have been carried out of sheep farmers who used
organophosphate pesticides to destroy parasites on sheep. Farmers were required by law
to dip sheep once or twice a year between 1976 and 1991. A number of individuals
reported ill health following dipping which they attributed to exposure to OP pesticides.
Although previous studies undertaken in the UK suggest a link between exposure to
sheep dip and the development of neurobehavioral problems, it is unclear whether this
is due to a history of acute poisoning or a result of cumulative low level exposure.
The Institute of Occupational Medicine (1999) carried out three phases of research
into the relationship between long-term, low-level exposure to OPs and ill health. The
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first phase of the study was designed to quantify the uptake of OPs in relation to
procedural and behavioural aspects of sheep dipping. The results showed that the most
important source of exposure was skin contact with concentrated sheep dip, which
almost always occurred when the farmer handled concentrate containers in order to
dilute the product and replenish the dipping bath. The second phase was a cross-
sectional study of exposure to OPs and symptoms of peripheral neuropathy. The third
phase of the study is most relevant to the current review and was reported by Jamal et
al (2001). 74 individuals who participated in phase 2 were classified into three groups
according to whether they had signs of peripheral neuropathy (‘no’, ‘possible’ and
‘probable/definite’ signs) and their performance on neuropsychological tests was related
to these groupings. Those with neuropathy had poorer mental health. Tests of memory,
attention and reaction time were administered. No consistent differences between the
groups were found on any of these measures. The IOM acknowledged that their sample
size was too small to allow a meaningful analysis of the relationship between cognitive
function and exposure history. Exposure history was not specified or used as a variable
in the analysis. The majority of psychometric tests administered were visual and only
one verbal memory test was included despite the fact that previous studies suggest
verbal functions may be affected. The study design is unusual in that it assumes there
should be a relationship between peripheral nerve damage (neuropathy) and central
nervous system damage (cognitive function) but this may not be the case, indeed recent
studies suggest that peripheral nerve damage and central nervous system damage can be
dissociated and that the mechanism underlying each condition may be different (Abou-
Donia, 2005). Indeed, cognitive impairment may precede other forms of ill health
(Bowers and Goodman, 1981). Overall, the value of phase 3 of this study is limited.
Stephens et al (1995) studied the effect of low-level chronic exposure in 146 Farmers
who had been exposed to OP sheep dip and compared them with 143 controls. The
farmers performed significantly worse than controls on tests of sustained visual
attention, speed of information processing and syntactic reasoning (a finding replicated
by Stephens and Sreenivasan, 2004). They did not perform worse on tests of memory.
They also showed greater vulnerability to psychiatric disorder. The authors concluded
that repeated exposure to OPs appears to be associated with subtle changes in the
nervous system, but that these are unlikely to be manifest as clinical symptoms.
However, the farmers and controls differed in terms of educational level, alcohol
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consumption, and first language. Stephens et al did not report whether any of their
farmers had a history of dippers flu, making it impossible to determine whether any
participants had a history of acute poisoning. Nevertheless, this study raised concern
about the effects of chronic exposure to OPs. Indeed, Beach et al (1996) followed up 20
of these farmers and split them into two groups according to how many symptoms they
reported after dipping. The 10 most symptomatic and 10 least symptomatic farmers then
underwent a neurological examination several months after dipping and were compared
to 10 unexposed controls. Although the prevalence of neurological abnormalities was
low amongst the farmers, subtle adverse neurological effects were detected involving
two point discrimination in the hands and feet and calf circumference. Stephens,
Spurgeon and Berry (1996) also investigated whether a relationship exists between
acute symptoms suffered immediately after dipping and the development of chronic
neurbehavioural problems later. However, they did not find any evidence of an
association and they suggest chronic neurobehavioural effects occur independently of
acute symptoms of exposure.
Mackenzie Ross et al (2007) compared 25 farm workers with a history of apparent low
level exposure to sheep dip with 22 non-exposed healthy volunteers on
neuropsychological tests. Two thirds of farm workers had retired or reduced their
workload on ill health grounds and all were involved in litigation. They performed
significantly worse than non-exposed healthy volunteers on tests of mental flexibility,
response speed and memory; and over 70% suffered from mood disorder. Although this
study included participants who had retired on ill health grounds, the sample size was
small and self selected making it unclear how representative they are of the farming
community as a whole. Furthermore, many farm workers appeared to have a history of
undiagnosed acute poisoning.
3.3.3.7 Summary
The 15 epidemiological studies described in this chapter have produced inconsistent
results. Twelve out of fifteen studies reviewed found evidence of neurobehavioural
impairment following long-term, low level exposure to OPs, ranging from subtle
deficits in one or more areas (usually reaction time and fine motor control: Fiedler et al,
1997; London et al, 1997;Steenland et al, 2000; Stephens et al, 2004) to major deficits
in several cognitive domains (memory, attention, reaction time and visuo-spatial
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deficits; Bazylewicz-Walczak et al, 1999; Farahat et al, 2003; Mackenzie Ross et al,
2007; Roldan-Tapia et al 2005 and 2006; Srivastava et al, 2000; Stephens et al, 1995).
Emotional difficulties were also frequently reported (Amr et al, 1997; Farahat et al,
2003; Mackenzie Ross et al, 2007; Steenland et al, 2000; Stephens et al, 1995).
Only three out of fifteen studies failed to find any differences between exposed and
unexposed populations. All three studies examined agricultural workers and had a
number of methodological weaknesses. Both Ames et al (1995) and Rodnitzky et al
(1975) failed to provide adequate information about exposure history making it
impossible to determine whether the findings relate to short or long-term exposure to
OPs. Neither provide any information about the work undertaken by their subjects (e.g.
spraying, dipping, ground application); and both involve small sample sizes. Rodnitzky
et al’s (1975) study was limited further by the inclusion of individuals with a history of
exposure to pesticides in the control group. The third study to report negative findings
was by Jamal et al (2001) who grouped subjects according to whether they had
peripheral nerve damage and then looked for corresponding evidence of central nervous
system damage (i.e. cognitive impairment), which they did not find. Exposure history
was not specified or used as a variable in this study. The overall value of these three
studies is limited by major methodological weaknesses.
3.3.3.7.1 Potentially critical exposure variables
Studies which found subtle neurobehavioural deficits following exposure were of pest
control operators (Steenland et al, 2000) and fruit tree farmers (Fiedler et al, 1997;
London et al, 1997; Stephens et al, 2004). All studies included adequate outcome
measures, although London et al (1997) had to modify their measures because of cross
cultural issues. The study of pest control operators by Steenland et al (2000) involved
study participants who had a relatively short history of exposure to OPs (average of 2.4
years) and this may account for the minimal findings. Studies by Stephens et al (2004)
and Fiedler et al (1997) involved small sample sizes with limited power to detect
associations, particularly small effect sizes. The study by London et al (1997) is
particularly hard to interpret due to a number of methodological weaknesses including
the inclusion of exposed persons in the control group and persons with a history of acute
exposure in the exposed groups. It is possible that the exposure history of fruit tree
farmers and pest control operators differs in some important way from other types of
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agricultural work (e.g. sheep dipping or greenhouse work) or the manufacture of OPs,
but more detailed information about the working practices of these different
occupational groups would be required to determine if this is the case and could account
for the different findings.
Remaining studies indicate that both intensity and/or duration of exposure may be
important variables underlying the development of neurobehavioural problems. Studies
by Srivastava et al (2000) and Amr et al (1997) of chemical plant manufacturers and
Farahat et al (2003) of Egyptian pesticide applicators describe their study participants as
having fairly prolonged, continuous, daily exposure to OPs as opposed to brief seasonal
exposures reported in other occupational groups. Formulators work 40 hour days, every
day and Egyptian applicators work 120 days per year. This contrasts with sheep dippers
who may only be exposed to OPs on four occasions a year. Srivastava et al (2000), Amr
et al (1997) and Farahat et al (2003) all found evidence of significant neurobehavioural
problems following long-term exposure to OPs. Studies by Roldan Tapia et al (2005
and 2006) and Bazylewicz-Walczak et al (1999) of greenhouse workers found an
association between cumulative exposure and neurobehavioural problems, particularly
in those exposed for more than 10 years. The importance of ‘prolonged exposure’ was
echoed by Mackenzie Ross et al (2007) who found an association between duration of
exposure and impaired memory and motor function in a group of sheep dippers with an
average of 14 years of exposure to OPs. All of these studies suggest neurobehavioural
problems develop over several years and not after a single episode or season of
exposure and that intensity and/or duration of exposure are critical causal factors.
With regard to the neurobehavioural domains affected, this review found considerable
agreement between studies, for example, slowing of reaction times and impaired fine
motor skills are almost universally found in all studies. Individuals who are more
severely affected may show additional deficits in short-term memory and executive
function. None of the studies reviewed report deficits in general intellectual functioning,
semantic or autobiographical memory, perception or aphasias, agnosias or apraxias; and
none report a positive association between cognitive function and exposure to OPs.
Consistency of findings across many studies add strength to the hypothesis that
exposure to OPs is linked to deficits in cognitive function and indicate that results are
unlikely to be explained by random chance or bias.
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3.3.3.7.2 How robust is this synthesis?
Clearly the individual studies described in this narrative review differ in terms of
methodological quality and study populations and these factors may explain the
variability in study findings. Although the majority of studies find an association
between long term, low level exposure to OPs and impaired neurobehavioural function
it is not clear which results are most reliable and should be used as the basis of policy
decisions. It is important to get a clear answer to the question of whether low level
exposure is harmful to human health, as many more individuals are likely to be at risk
of long-term, low level exposure, rather than acute poisoning. Meta analysis is a useful
method of summarising, integrating and quantifying the results of different studies to
establish if an association exists between specified variables in a group of studies. It
combines information across studies thereby increasing the number of participants,
reducing random error, narrowing confidence intervals and increasing statistical power
to detect small effects that may be missed by individual studies which are too small to
yield a valid conclusion (Zhou et al, 2002; Centre for Reviews and Dissemination
(CRD), 2009). It represents each study’s findings in the form of effect sizes. Combining
the results of several studies in this way gives a more reliable estimate of whether a
significant association exists between specified variables, than one study alone. Meta-
analysis moves discussion away from individual studies towards an overview of a body
of literature and it is considered to be the method of choice in situations where research
findings may be used to inform public policy (CRD, 2009). The next chapter of this
thesis reports the findings of a meta-analysis of the literature described in this chapter.
As far as this author is aware, this will be the first systematic review of the literature to
attempt quantitative evaluation of study findings using meta-analysis.
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Chapter 4 : Neurobehavioural problems following low level exposure
to organophosphate pesticides: A meta-analytic investigation.
4.1 Background
A meta-analytic investigation was undertaken to assimilate the data from the studies
described in the previous chapter in order to determine the extent and nature of any
association between exposure to OPs and cognitive impairment. Meta-analysis is a
useful method of quantifying the results of different studies to establish if an association
exists between specified variables in a group of studies. It does this by representing each
study’s findings in the form of effect sizes which are a statistical standardisation of
study findings based on standard deviation units. Combining information across studies
in this way increases statistical power to detect small effects that may be missed by
individual studies which are too small to yield a valid conclusion (Zhou, Obuchowski &
Obuchowski, 2002).
4.2 Selection of studies
While the 15 epidemiological studies described in the previous chapter were identified
as being suitable for inclusion in a meta-analysis, two of the identified studies (Jamal et
al 2001; London et al 1997) failed to include sufficient data to calculate effects sizes
such as sample sizes, means or standard deviations and had to be excluded. For
example, London et al (1997) did not provide means and standard deviations for
exposed and control subjects separately, but aggregated the data in their published
paper. Jamal et al (2001) classified 74 UK sheep dippers into three groups according to
whether they had signs of peripheral neuropathy, however exposure history was not
specified or used as a variable in the analysis and data from appropriately matched
controls was not provided. The overall study design is quite different from that involved
in the other studies included in the review which undertook group contrasts involving
exposed and unexposed populations. Jamal et al’s study was therefore not considered
comparable to the others included in the meta-analysis and was excluded from this
review.
Three other studies either failed to report means and standard deviations for all of the
group contrasts undertaken (Ames et al 1995; Rodnitzky et al 1975; Steenland et al) and
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merely stated their findings were non significant, in which case an effect size of zero
was assigned rather than omitting the study altogether, since this might have biased the
results. However, it is important to note that this procedure leads to effect size estimates
that are too small and is very conservative in nature (Rosenthal, 1995).
Finally, the study by Amr et al 1997 was included in only one part of the meta-anlaysis
as it had a limited focus which was to determine the incidence of psychiatric disorder in
pesticide applicators and formulators. Assessment of cognitive functioning was not
undertaken. This left a final sample of 12 studies for inclusion in the first stage of the
meta-analysis and these are summarised below (see Table 4.1). The aim of all of these
studies was to determine the effect of long term, low level exposure to OPs on
neurobehavioural function, but researchers examined a broad range of populations from
chemical plant workers, pest control operatives, greenhouse workers, crop sprayers,
sheep dippers and fruit tree sprayers. Studies were carried out on individuals from
developed and developing nations and exposure history varied considerably from being
continuous i.e. on a daily basis, to seasonal or infrequent (e.g. twice a year). Lifetime
exposure also varied from an average of two to over twenty years.
4.3 Meta-analysis
The primary objective in undertaking a meta-analysis is to determine whether long-
term, low level exposure to OPs is associated with neurobehavioural problems and if so,
how strong the effect size is in terms of the mean effect size. A further research question
is whether neuropsychological tests differ in their sensitivity to, or ability to identify
nervous system effects of OP exposure in human populations.
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Table 4.1 Table of studies included in the meta-analysis
Study Research
question
Participants Controls
matched
OP compounds Exposure
Measures
Years of
exposure
Measures Results
MANUFACTURERS
Srivastava et al 2000 Health risks
associated with
the manufacture
of OP
59 Indian
chemical plant
workers
17 controls
Matched for age,
sex. Controls
better educated.
OP (quinalphos) &
other
EHQ
AChE
Average 6
yrs
Medical exam
Digit Span
Digit symbol
Vigilance task
Similar AChE levels in both
groups, but exposed had
altered reflexes and
neurobehavioural deficits, i.e.
lower scores on digit span,
digit symbol & vigilance task.
Amr et al 1997 Psychiatric
morbidity
amongst
applicators &
formulators
208
formulators
172
applicators
233 controls
(mix of urban
textile
workers and
rural
residents)
Matched for age,
socio-economic
status,
education.
OP,
Organochlorines
Carbamates,
Pyrethroids
Years of
exposure
Average 2
yrs
Psychiatric
assessment - GHQ,
DSM-IIIR
Frequency of psychiatric
disorder (depression) higher
amongst PF & PA than
controls and those with longer
duration of exposure (>20
years).
Rates or reactive depression
equivalent between groups,
but rate of dysthymic not &
higher than in general
population.
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Study
Research
question Participants
Controls
matched OP compounds
Exposure
Measures
Years of
exposure Measures Results
PEST CONTROL
Steenland et al 2000 Chronic
neurological
effects of OP
exposure
191 current &
former
termiticide
applicators
189 controls
Matched for age,
sex. Controls
better educated.
OP (Chlorpyrifos) EHQ
Urinary
metabolites
PON1
Average
2.4 yrs
Nerve conduction
Clinical exam
NES Battery:
Finger tapping
Hand-eye co-ord
Reaction Time
Continuous
performance
Symbol digit
BVRT
Pattern comparison
Pattern memory
Switching attention
Digit span
Serial digit
Associate learning
Associate recall
Mood scales.
Exposed group reported more
problems with memory,
emotional state, fatigue and
muscle strength but few
differences noted on
quantitative tests. Exposed
were impaired on pegboard
turning and some postural
sway tests but were not
significantly different from
controls on other cognitive
tests. 8 subjects who were
acutely exposed had impaired
reaction time and continuous
performance.
OP organophosphate; NB neurobehavioural; PA pesticide applicator; PF pesticide formulator; AChE acetylcholinesterase; BuChE serum cholinesterase; PON1 paraoxonase
1; EHQ exposure history questionnaire; GHQ general health questionnaire; DSM-III diagnostic and statistical manual 3rd edition; AMIPB adult memory and information
processing battery; HAD hospital anxiety and depression scale; WHO world health organisation NB core test battery; NES NB evaluation system battery.
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Study Research
question
Participants Controls
matched
OP compounds Exposure
Measures
Years of
exposure
Measures Results
FRUIT TREE
Stephens & Sreenivasan
2004
Effect of long-
term, low level
exposure to OPs
on NB function
37 orchard
sprayers
26 pig farmers
31
construction
workers
Matched for age
& education
OP (chlorpyrifos) EHQ Average
14 yrs
NB battery same as
1995 study.
Orchard workers slower
on syntactic reasoning
than controls but no
relationship with
exposure index.
Fiedler et al 1997 Effect of long-
term, low level
exposure to OPs
on NB function
27 US Fruit
Farmers
42 cranberry
& blueberry
farmers and
hardware store
controls
Matched for age.
Controls more
educated.
OP no further data EHQ Average
27 yrs
Medical Exam
Reaction time
Stroop
Pegboard
Eye/hand co-ord
Trails
Digit span
Digit symbol
CVLT Visual
reproduction
Continuous visual
memory test
Information
Naming
Token Test
MMPI-2
Exposed and controls
had different reading
scores and levels of
education, so reading
score was used as a
covariate in the
analyses. Fruit farmers
have slower simple RT
than controls. Fruit
farmers split into high
vs low exposure and
groups differ in simple
RT. No other
differences found or
alterations in
mood/personality
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Study Research
question
Participants Controls matched OP compounds Exposure
Measures
Years of
exposure
Measures Results
GREENHOUSE WORKERS (GHW)
Roldan-Tapia et al
2005
Continuous
exposure to OPs
(subsymtomatic)
and NB effects
40 Spanish
GHW
26 matched
controls
Matched for age &
education.
OP & Carbamates BuChE
EHQ
Average
11 yrs
Medical exam WHO
core battery:
Reaction time
Digit Symbol
Digit span
BVRT
Santa Ana Aiming
Mood
Symptoms Q
Association between
cumulative exposure and
lower performance on
verbal memory, visual
memory and increased
anxiety. Those exposed
for more than 10 years
also have lower scores
on tests of visuo-spatial
ability.
Roldan-Tapia et al
2006
Association
between
different levels
of exposure to
OPs & NB
function
24 Spanish
GHW with a
history of
acute
exposure.
40 workers
with low level
exposure
(high vs low
groups)
26 controls
Matched for age &
education, but low
level exposure
group younger
than other two
groups.
OP (metamidophos,
fenamiphos,
malathion, fosetyl,
dimethoate) &
Carbamates
BuChE
EHQ
Average
11 yrs
Medical exam WHO
core battery:
Reaction time
Digit Symbol
Digit span
BVRT
Santa Ana Aiming
Mood
Symptoms Q
Subjects had reduced
visuo-motor, perceptual
& constructive abilities,
verbal learning, speed of
processing and increased
anxiety. Acutely exposed
and those exposed for >
10yrs had similar profile
of deficits. Those
exposed for <10yrs and
controls had similar
profiles.
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Study Research
question
Participants Controls matched OP compounds Exposure
Measures
Years of
exposure
Measures Results
Bazylewicz-Walczak
et al 1999
Behavioural
effects of chronic
exposure to OPs
51 Polish
GHW
(female)
25 controls
(admin,
canteen
workers)
matched for
age,educ
Matched for age,
education, alcohol
use & smoking.
OP
(dichlorvos,
methamidophos,
methidathion,
pirimiphos-methyl)
Carbamates
Pyrethroids
Dithiocarbamates
Air sampling
Concentration
on clothes
Average
12 yrs
WHO battery:
Reaction time
Digit Symbol
Digit span
BVRT
Santa Ana Aiming
Mood
Symptoms Q
No change in
performance on NB tests
pre/post season, but
differences between
controls and exposure
groups on both occasions
suggesting lifetime
cumulative exposure
affects NB function, but
not a single episode of
exposure.
OP organophosphate; NB neurobehavioural; PA pesticide applicator; PF pesticide formulator; AChE acetylcholinesterase; BuChE serum cholinesterase; PON1 paraoxonase
1; EHQ exposure history questionnaire; GHQ general health questionnaire; DSM-III diagnostic and statistical manual 3rd edition; AMIPB adult memory and information
processing battery; HAD hospital anxiety and depression scale; WHO world health organisation NB core test battery; NES NB evaluation system battery.
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Study Research
question
Participants Controls matched OP compounds Exposure
Measures
Years of
exposure
Measures Results
PESTICIDE APPLICATORS
Rodnitzky et al 1975 NB changes
following
chronic exposure
to OPs
23 farm
workers (12
farmers & 11
PA)
23 farmers not
exposed in last
2 weeks, but
may have a
history of
exposure
during
lifetime.
Matched for age &
education.
Controls have a
history of
exposure.
OP no further data AChE.
Exposed in last
2 weeks
Not
reported
Verbal recall
RT/vigilance task
Choice reaction time
Sentence repetition
Proprioception
No significant
differences
between groups on
cognitive tests but
applicators had
higher rates of
anxiety than
controls.
AChE within
normal limits but
plasma levels
slightly lower in
PA than controls.
Ames et al 1995 Long-term, low
level exposure to
OPs and NB
function. Does
prevention of
acute poisoning
prevent chronic
ill health
45 US (incl
Hispanic) PA
with history of
AChE
depression
90 controls
(friends)
Controls younger
and more educated
pesticides in general
- no other data
Records -
looking for
cholinesterase
inhibition
without
symptoms
Not
reported
Nerve conduction
Finger tapping
Sustained attention
Eye-hand co-ord
Reaction time
Digit symbol
Digit span
Pattern memory
Santa Ana dexterity
Pursuit aiming
No group
differences.
Preventing acute
poisoning prevents
chronic sequelae
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Study Research
question
Participants Controls matched OP compounds Exposure
Measures
Years of
exposure
Measures Results
Farahat et al 2005 NB effects of
pesticide
exposure
52 Egyptian
PA
50 controls
(admin clerks)
Matched for age,
sex, education
OP (chlorpyrifos,
Dusban, Curacran,
Hostathion, Thimet,
Profenofos,
Triaziphos,
Phorate),
Carbamates,
Pyrethroids
AChE
EHQ
Average
18 yrs
Medical Exam
Similarities
Digit symbol
Trails
Block Design
PASAT
Letter cancel
Digit span
Benton visual form
discrimination test
Story recall
EPQ
PA obtained lower
scores on
similarities, tests
of attention, visual
memory and timed
tests than controls
and this did not
correlate with
AChE levels (so
not due to current
exposure) but did
correlate with
lifetime exposure.
Neuroticism
higher and
symptoms of
numbness &
dizziness.
OP organophosphate; NB neurobehavioural; PA pesticide applicator; PF pesticide formulator; AChE acetylcholinesterase; BuChE serum cholinesterase; PON1 paraoxonase
1; EHQ exposure history questionnaire; GHQ general health questionnaire; DSM-III diagnostic and statistical manual 3rd edition; AMIPB adult memory and information
processing battery; HAD hospital anxiety and depression scale; WHO world health organisation NB core test battery; NES NB evaluation system battery.
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Study Research
question
Participants Controls matched OP compounds Exposure
Measures
Years of
exposure
Measures Results
SHEEP DIPPERS
Stephens et al 1995 Repeated, long
term exposure to
OPs & NB
function
146 sheep
farmers
143 controls
(quarry
workers)
Farmers older and
more educated.
Controls consume
more alcohol.
OP
(diazinon,
chlorfenvinphos,
propetamphos)
EHQ Average
15 yrs
Digit span
Visual memory
Reaction time
Digit symbol
Syntactic reasoning
Word learning
Category search
Farmers slower than
controls on all timed
tests, impaired attention
but memory intact. Split
into 5 levels of exposure
groups and highest
exposure group worst on
syntactic reasoning
(even after controlling
for covariates)
Greater vulnerability to
psychiatric disorder.
Mackenzie Ross et al 2007 Nature & extent
of NB problems
in farmers who
report chronic ill
health.
25 sheep
dippers
22 controls
Matched for age,
sex, years in
education.
OP (diazinon,
chlorfenvinphos,
propetamphos)
EHQ Average
14 yrs
WAIS-R
AMIPB
Trails A&B
Face recognition
Line orientation
verbal fluency
NART
Stroop
HAD (mood)
Exposed had lower
scores on tests of mental
flexibility, verbal
memory and 70% had
mood disorder. Many
reported 'dippers flu'
which may be indicative
of unrecognised acute
toxicity.
OP organophosphate; NB neurobehavioural; PA pesticide applicator; PF pesticide formulator; AChE acetylcholinesterase; BuChE serum cholinesterase; PON1 paraoxonase
1; EHQ exposure history questionnaire; GHQ general health questionnaire; DSM-III diagnostic and statistical manual 3rd edition; AMIPB adult memory and information
processing battery; HAD hospital anxiety and depression scale; WHO world health organisation NB core test battery; NES NB evaluation system battery.
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4.3.1 Calculation of effect sizes and effect size formulas
Many measures of effect size have been proposed and the most common are Pearson’s
correlation coefficient, r, Cohen’s d (and its multiple variants such as Hedges’ g,
Glass’s Delta etc), and the odds ratio (OR) (Field & Gillett, 2010). Since all of the
papers selected for meta-analysis involve group contrasts, Cohen’s d seems the most
appropriate formula for the current meta-analysis as it is based on the standardised
difference between two means. It is calculated by subtracting the mean of one group
from the mean of another and standardising it by dividing by the population standard
deviation.
d = M1-M2
σ 
However, several different methods of estimating the population standard deviation
from sample data exist, such as using the root mean square standard deviation, the
pooled standard deviation or the control group standard deviation. Previous research
suggests that exposure to OPs may have differential effects on different individuals and
therefore exposure will not only affect the mean of any outcome variables used in a
study but also the variance. In such cases it is best to estimate the ES using only the
standard deviation of the control group because it is a better estimate of the population
variance (Lipsey & Wilson, 2001). Glass’s Delta is a variation of Cohen’s d which uses
the standard deviation for the control group when calculating effect sizes:
 = M1-M2
σcontrol
Effect sizes are usually calculated using population means but in this study effect sizes
were also calculated using population medians to ensure that any significant effect sizes
identified in the analyses were not due to outliers. In this case, effect sizes were
calculated using the two abovementioned formulae but substituting mean scores for
medians. The median (middle value) is used as a measure of central tendency when a
data distribution is skewed because it is considered to be a better indicator of the central
location of data than the arithmetic mean, when the data contains outliers. However, a
potential disadvantage of using the median occurs when there are scores of zero in a
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data set, as the median value can become ‘swamped’ by them and is likely to be lower
and more conservative than the arithmetic mean.
The meta- analysis was performed in several stages. Firstly (step 1), multiple effect
sizes were calculated for each study incorporating data from all of the psychometric
tests administered in a given study, but omitting the data from mood questionnaires as
the latter is based on subjective self report rather than objective measures of cognition.
However, results could be biased by a small number of studies producing multiple
effect sizes, so an overall effect size was calculated per study so that each study
contributed a single effect size. Thus a single mean effect size within each study was
computed before undertaking the meta-analysis across studies. Four methods of
calculating effect size were used (Cohen’s d utilising mean scores; Cohen’s d utilising
median scores; Glass’s delta utilising mean scores; and Glass’s delta utilising median
scores). Analyses were undertaken to establish whether any particular method used to
calculate effect sizes alters the overall findings. The second stage of analysis (step 2)
involves examination of effect sizes found in different studies and establishing the
variance of effect size distributions (heterogeneity) to determine whether studies are
comparable. Finally the influence of potential moderator variables on the overall
findings was considered such as task parameters (outcome measures) and population
characteristics (of both exposed and control samples).
4.3.2 Method of meta-analysis
All analyses were conducted using custom-written syntax for SPSS. The meta-analysis
was computed by the Mix 1.7 programme and a random effects model was used as it is
assumed that there will be random differences between studies which are not solely due
to sampling error, but are associated with variations in procedures. Random effects
models are generally considered to be more appropriate than fixed effects models when
analysing behavioural, social and health science data (Field & Gillett, 2010).
Step 1 – establishing whether the method used to calculate effect sizes affects the
overall findings.
Table 4.2 shows the included studies, overall single effect sizes for each study based on
the mean and median. Effect size calculations using both Cohen’s d and Glass’s formula
are reported and the number of psychometric tests administered in each study upon
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which the ES calculations were based appear in the final column. Findings appear
similar regardless of whether Cohen’s d or Glass’s Delta formula are used, and
regardless of whether effect size calculations are based on population means or
medians, but meta-analysis were undertaken on all of the different effect size
calculations to determine whether any particular formula produces different findings.
All 12 studies were entered into the meta-analysis and all four formulae for calculating
effect sizes were used. Meta-analysis revealed similar findings regardless of whether
Cohen’s d or Glass’s Delta formula were used, and regardless of whether effect size
calculations were based on population means or medians (see Tables 4.2 and 4.3).
All future analyses were undertaken using Glass’s Delta, based on population means to
allow all of the data to be incorporated. The rationale for this is as follows. As
previously explained in Section 4.3.1 the meta-analysis was performed in several stages.
Firstly, multiple effect sizes were calculated for each study incorporating data from all
of the psychometric tests administered in a given study. Secondly, an overall effect size
was calculated per study. As the initial data sets upon which an overall effect size was
calculated for each study contained a number of zero effect sizes, median scores were
deemed less appropriate for use in this meta-analysis. Glass’s delta seems the more
appropriate measure for neurotoxicological research because it is important to take
account of the possibility that exposure to OPs may have differential effects on different
individuals and is likely to impact on variance. In such cases it is better to estimate the
ES using only the standard deviation of the control group.
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Table 4.2 Effect size calculations using Cohen’s d and Glass Delta formulas, based on population means and medians.
Author Ref Study
date
Participants Sample size;
Exposed vs
controls
Cohen’s d
Median
Cohen’s d
Mean
Glass Delta
Median
Glass Delta
Mean
Standard
error
No of ES
per study
Rodnitzky 6 1975 US farmers
And PA
46
23/23 0.00 0.00451 0.00 -0.00437 0.295 15
Ames 3 1995 US PA 135
45/90 0.00 0.0516 0.00 0.0515 0.183 7
Stephens 4 1995 UK sheep dippers 289
146/143 -0.0148 -0.0956 0.0154 -0.135 0.118 13
Fiedler 12 1997 US Fruit Tree
Sprayers
99
57/42 -0.0997 -0.0969 -0.103 -0.0975 0.203 18
Bazylewicz-
Walczak
9 1999 Polish GH workers 51
26/25 -0.338 -0.282 -0.364 -0.282 0.280 22
Srivastava 1 2000 Indian
manufacturers
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59/17 -0.921 -1.007 -0.869 -1.0119 0.275 3
Steenland 13 2000 Termiticide PA 380
191/189 -0.00 -0.0327 0.00 -0.0327 0.103 11
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Farahat 2 2003 Egyptian PA 102
52/50 -0.548 -0.536 -0.553 -0.541 0.198 12
Stephens 8 2004 UK FT sprayers 68
37/31 -0.126 -0.0344 -0.118 -0.0538 0.243 11
Roldan-Tapia 11 2005 Spanish GH
workers
66
40/26 0.0289 0.0102 -0.0294 0.0435 0.252 21
Roldan-Tapia 10 2006 Spanish GH
workers
46
20/26 -0.0747 -0.0167 0.0753 -0.0296 0.297 42
Mackenzie Ross 5 2007 UK sheep dippers 47
25/22 -1.264 -1.198 -1.530 -1.617 0.292 21
PA = pesticide applicators; GH = greenhouse workers; FT = fruit tree sprayers
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Table 4.3 Meta-analysis using a random effects model incorporating 12 studies and 1,405
participants and involving four different methods of calculating effect size.
Cohen’s d
Mean
Cohen’s d
Median
Glass Delta
Mean
Glass Delta
Median
Overall ES -0.236 -0.237 -0.279 -0.259
95% CI lower -0.429 -0.446 -0.506 -0.486
95% CI upper -0.042 -0.027 -0.052 -0.031
z 2.386* 2.217* 2.413* 2.227*
t^2 0.673 0.086 0.109 0.110
-Asterisks denote significant effects: * p<.05
Step 2 – analysis of the findings by study- Glass’s Delta, based on the population mean
is reported.
Various graphical techniques exist to illustrate the central tendency, variability and
normality of effect size distributions and the stem and leaf, forest and funnel plots are
particularly popular. Figure 4.1 is a stem and leaf plot depicting the effect sizes (based
on Glass’s delta and the population mean) for each of the 12 studies included in the
meta-analyses. Figure 4.2 is a forest plot depicting the effect sizes, 95% confidence
intervals and the amount of variation between studies.
Stem Leaf
1
0 0,0
-0 0,0,0,0,1,1,3,5,
-1 0,6
Figure 4.1 Stem and leaf display of effect size data from 12 studies investigating the effect of low
level exposure to OPs on neuropsychological functioning.
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Figure 4.2 Forest plot depicting overall effect sizes (based on Glass’s delta) derived from 12 studies
in date order and corresponding 95% confidence intervals.
The first thing to note is the direction of the effect sizes. Of the12 studies, ten showed a
negative effect, and two showed a positive effect. If no consistent pattern existed then
one would expect to see a random pattern of effect sizes scattered in both directions at a
50:50 ratio. A 2-tailed binomial test (with .5 set as the test proportion) revealed that the
proportion of negative effects sizes seen in these studies were significantly higher than
expected (p=.04). This predominantly negative pattern indicates poorer performance in
exposed workers than unexposed controls. There were only two exceptions to this.
Firstly, Ames et al (1995) failed to report necessary statistical parameters for the
majority of the psychometric tests in the study. In these cases effect sizes of zero were
assigned before undertaking the meta-analysis. This is a conservative approach which
is likely to have lowered the overall effect size for this study. Secondly, Roldan-Tapia
et al (2005) failed to find significant differences in performance between exposed and
unexposed populations on the vast majority, but by no means all, of the tests included in
their assessment battery. Most of the effect sizes illustrated in Figure 4.2 cluster around-
.03 (overall ES -0.279, p=0.0158) but there is some variation in effect sizes (t^2 0.1089)
et al 1975
Stephens et al 1995
Walczak et al 1999
et al 2000
et al 2000
Stephens et al 2004
Tapia et al 2005
Tapia et al 2006
Mackenzie Ross et al 2007
Rodnitzky et al 1975
Ames et al 1995
Stephens et al 1995
Fiedler et al 1997
Bazylewicz-Walczak et al 1999
Srivastava et al 2000
Steenland et al 2000
Farahat et al 2003
Stephens et al 2004
Roldan-Tapia et al 2005
Roldan-Tapia et al 2006
Mackenzie Ross et al 2007
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with studies by Srivastava et al (2000) and Mackenzie Ross el al (2007) showing the
largest effect sizes.
Srivastava et al (2000) examined 59 Indian workers recently exposed to different
chemicals during the manufacture of ‘quinalphos’ and 17 control subjects. Exposed
subjects reported more symptoms of fatigue and weakness; had a higher prevalence of
abnormal plantar and ankle reflex; and lower scores on digit span, digit symbol and
Bourdon Weirsma vigilance test. The authors conclude that exposure to OPs can cause
nervous system damage. However, controls were not matched to the exposed group for
level of education and would be expected to outperform the exposed cohort and this
may explain why the effect size produced by this study was larger than that observed in
other studies. Having said that, a number of other studies have utilised unmatched
control groups (Ames et al, 1995; Fiedler et al, 1997; Steenland et al 2000; Stephens et
al, 1995) and the first two of these produced low or zero effect sizes; so an alternative
explanation might be that Srivastava et al’s study participants had more prolonged
exposure than other groups as they were involved in the manufacture of OPs on a daily
basis rather than the occasional, seasonal application of OPs.
Mackenzie Ross et al (2007) compared 25 farm workers with a history of apparent low
level exposure to sheep dip with 22 non-exposed healthy volunteers on
neuropsychological tests. Farm workers performed significantly worse than non-
exposed healthy volunteers on tests of mental flexibility, response speed and memory;
and over 70% suffered from mood disorder. However, the sample size was small and
self selected making it unclear how representative they are of the farming community as
a whole. The sample is different from others reported in the literature in that a large
proportion of study participants had retired on ill health grounds, whereas other studies
recruited participants who were still fit enough to be in employment. Furthermore,
participants in the Mackenzie Ross study were involved in litigation and so there are a
number of factors such as potential secondary gain or the possibility that participants
constitute a subgroup of people who are particularly vulnerable to the effects of OPs,
which could explain the large effect size produced by this study.
In order to determine whether the Mackenzie Ross et al study, which produced the
largest effect size, was biasing the findings, analyses were repeated excluding this
study. It is possible to statistically test for homogeneity to determine whether effect
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sizes from different studies show more variation than would be expected from sampling
error alone and gives an indication of whether studies are broadly comparable (Lipsey
and Wilson, 2001). Random effects meta-analyses provide a measure of absolute
variance reported as t^2. If it is near to zero then any dispersion in effect sizes is due to
random error. When t^2 moves away from zero it suggests some of the variance is real
and due to fundamental methodological differences between studies.
Table 4.4 Meta-analysis using a random effects model illustrating the effect of excluding the study
by Mackenzie Ross et al.
Glass Delta Mean
Mackenzie Ross et al study
excluded
Glass Delta Mean
Mackenzie Ross et al study
included
Overall ES -0.1656 -0.279
95% CI
lower
-0.3232 -0.5056
95% CI
upper
-0.008 -0.0524
z 2.0601* 2.4129*
t^2 0.0278 0.1089
-Asterisks denote significant effects: * p<.05
Excluding the study by Mackenzie Ross et al does not render the overall findings non
significant, but does result in a large reduction in the heterogeneity rating. Removal of
this study alters the overall balance and comparability of remaining studies which
appear more homogeneous once it has been excluded; but the overall effect size
produced by the meta-analysis remains significant. The convention with regard to
interpreting effect sizes is that d=0.2 to 0.5 is ‘small’; 0.5-0.8 is medium and >0.8 is
large; hence the overall effect size found in the current analyses of between -0.1656 and
-0.279 (depending upon whether the study by Mackenzie Ross is included or not) can be
classified as small.
4.3.3 Influence of study publication date
Another interesting observation from the forest plot depicted in Figure 4.2 is the fact
that nine out of ten studies published after 1995 found negative effect sizes between -
73
0.03 and -1.62, the only exception being a study by Roldan Tapia et al in 2005 which
produced a positive effect size of 0.04. The earlier studies by Ames et al (1995) and
Rodnitzky et al (1975) which produced the lowest effect sizes were beset by
methodological weaknesses which might account for their findings. For example Ames
et al (1995) examined US farm workers, some of who had a history of cholinesterase
inhibition and some who did not. None had a history of frank poisoning. No group
differences were found and the authors conclude that prevention of acute poisoning
prevents development of chronic neurobehavioural impairment. Unfortunately, Ames et
al failed to provide any information about exposure history for their cohort and did not
report means and standard deviations for all of the group contrasts undertaken. They
merely stated their findings were non-significant which meant an effect size of zero had
to be assigned to a number of group contrasts for meta-analytic purposes which is very
conservative. Rodnitzky et al (1975) examined 23 farmers / commercial pesticide
applicators in Iowa who had used OP compounds within 2 weeks of testing, but were
asymptomatic and compared them with 23 non-exposed farmers. Groups did not differ
significantly on tests of memory or RT. However, Rodnitzky et al (1975) also failed to
provide adequate information about exposure history making it impossible to determine
whether the findings relate to short or long-term exposure to OPs. Neither Ames et al or
Rodnitzky et al provide any information about the work undertaken by their subjects
(e.g. spraying, dipping, ground application); and both involve small sample sizes.
Rodnitzky et al’s (1975) study was limited further by the inclusion of individuals with a
history of exposure to pesticides in the control group, which means the two groups
would not be expected to differ significantly on tests of neurobehavioural functioning.
The only other study which produced an overall positive effect size was Roldan-Tapia
et al 2005. They conducted a cross sectional survey of 40 Spanish pesticide applicators
who had been employed for 6 months to 30 years, who did not have a history of
recorded poisoning events. They were compared to 26 non-exposed controls (matched
for age and education). More than twenty tests of neurobehavioural functioning were
included in the assessment battery, but exposed and control subjects obtained similar
scores on the vast majority of tests. This may be why overall, a negative effect size was
not apparent. However, participants with a history of exposure to OPs, particularly of
more than 10 years duration, were found to obtain lower scores on tests of delayed
verbal memory, visual memory, integrative perception and visuo-constructional praxis
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and measures of anxiety and the authors conclude that long-term exposure to pesticides
can cause specific neurobehavioural problems.
4.3.4 Does the type of control group affect the strength of the ES.
The majority of studies included in this meta-analysis matched their exposed and
unexposed groups on important variables which are known to influence performance on
neuropsychological tests such as age, gender and years of education. The exceptions
being Ames et al (1995), Srivastava et al (2000) and Fiedler et al (1997) who utilised
control groups with a greater degree of education than the exposed group. This may
have biased their results since differences between the groups may be due to pre-
existing differences in premorbid IQ rather than exposure history. In terms of how this
might affect the results of the current meta-analysis, an effect size of zero was assigned
to a number of group contrasts in the study by Ames et al for the reasons cited earlier
which means the results of the meta-analysis will not have been affected by the fact that
their exposed and unexposed cohorts were not matched. However, the effect sizes
produced by Srivastava et al and Fiedler et al may be inflated by the fact that their
exposed and unexposed cohorts were not matched in terms of education. Fiedler et al
went on to explore the amount of variance in reaction time which was due to the
confounding effects of education and age by undertaking regression analyses. They
found that the exposed cohort had significantly slower reaction times (dominant hand)
than the controls even after controlling for the influence of age and education on
neuropsychological function.
4.3.5 File drawer analysis
One potential bias in meta-analysis arises from the fact that significant findings are
more likely to be published than non significant findings and this is known as
publication bias or the’ file drawer problem’ (Field & Gillett 2010; Rosenthal, 1979).
The funnel plot is a graphical technique for exploring publication bias. It displays effect
sizes plotted against the inverse standard error. An unbiased population would show a
cloud of data points that is symmetric around the population effect size and should have
the shape of a funnel. An asymmetric funnel suggests either publication bias, a
difference between smaller and larger studies or an inappropriate effect measure (Field
& Gillett 2010). Figure 4.3 displays a funnel of effect sizes from the current analysis.
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The vertical axis displays the inverse standard error, the horizontal axis the effect size
and the line in the middle is the pooled estimate from the meta-analysis. Most of the
studies included in the analysis produce effect sizes which are close to the pooled
estimate and the funnel is relatively symmetrical. The exception being the two studies
which produced effect sizes to the left of the common effect and outside of the funnel.
These are the studies by Mackenzie Ross et al (2007) and Srivastava et al (2000)
described earlier which were performed on particularly high risk populations which
produced unusually large effect sizes.
Figure 4.3 Funnel plot displaying effect sizes plotted against the inverse standard error.
Other methods of exploring publication bias that have been developed since the funnel
plot can be difficult to interpret as funnel asymmetry may be due to publication bias,
clinical or methodological heterogeneity between studies (Lipsey & Wilson 2001). In
order to address the specific concern that studies with negative findings may not be
published Rosenthal (1979) developed a statistic known as the fail safe N which
estimates the number of unpublished studies reporting null results that would need to
exist to turn a significant population effect size estimate into a non-significant one
(Field & Gillett 2010). The fail safe N formula is:
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The number of studies with a zero effect needed to make the results of the current meta-
analysis non significant would be 45. Thus publication bias is not a significant concern.
4.3.6 Effect of cognitive task
Neuropsychological tests are useful tools for exploring the early effects from exposure
to toxic substances (Lezak, 1984; Lucchini et al, 2005) but tests vary in terms of their
sensitivity to neurotoxic effects and clinical utility for toxicity diagnoses (Hartman,
1995). Some cognitive functions appear to be affected to a greater degree than others by
exposure to OPs and tests of psychomotor speed, reaction time, fine motor control,
attention and memory are particularly sensitive to OP exposure. Non verbal abilities
tend to be affected to a greater degree than verbal abilities although why this should be
the case is poorly understood (Anger, Otto & Letz, 1996; Anger et al, 1997; Anger et al,
2000; Hartman 1995; Lucchini et al 2005). In contrast tests of vocabulary and general
knowledge do not appear sensitive to neurotoxic effects, but are often included in
assessment batteries as estimates of premorbid ability.
The current meta-analysis incorporated data from all of the psychometric tests
administered in a given study (i.e. multiple effect sizes were calculated) and then a
single mean effect size within each study was computed before undertaking the meta-
analysis. To determine whether task parameters might influence effect sizes the meta-
analysis was repeated but this time cognitive tests were grouped into cognitive domains
and a single effect size was calculated for each domain by averaging the effect sizes
across all measures within that domain. Table 4.5 summarises the results of meta-
analysis by cognitive domain. For each domain, the first row illustrates the effect sizes
produced by all studies whilst the second row illustrates the findings when the study by
Mackenzie Ross et al (2007) which produces the largest effect sizes, is removed.
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Table 4.5 Meta- analyses by cognitive domain (italics illustrate the findings when the study by
Mackenzie Ross et al (2007) is removed).
Cognitive Domain No studies Overall ES Lower CI Upper CI z t^2
Working Memory 11 -0.311 -0.584 -0.037 2.224* 0.160
10 -0.226 -0.478 0.027 1.735 0.148
Visual Memory 9 -.0206 -0.521 -0.012 0.041* 0.101
8 -0.163 -0.365 0.038 1.592 0.040
Verbal Memory 8 -0.103 -0.467 0.261 0.555 0.225
7 -0.085 -0.071 0.242 1.070 0.006
Attention 8 -0.307 -0.598 -0.016 2.070* 0.126
7 -0.174 -0.393 0.046 1.549 0.045
Speed 12 -0.505 -0.905 -0.105 2.472* 0.445
11 -0.263 -0.472 -0.055 2.473* 0.077
Executive function 9 -0.331 -0.748 0.085 1.561 0.353
8 -0.105 -0.361 0.152 0.802 0.092
Visuo-spatial 4 -0.504 -0.749 -0.26 4.042*** 0
3 -0.452 -0.723 -0.182 3.278*** 0
Language 6 -0.269 -0.619 0.081 1.507 0.134
5 -0.042 -0.198 0.114 0.529 0
FMC 3 -0.177 -0.348 -0.007 2.036* 0
Mood 4 -0.308 -0.987 0.371 0.889 0.419
-Asterisks denote significant effects: * p<.05, ** p<.01 and ***p<.001
The neuropsychological tests which produced the largest effect sizes included tests of
working memory (digit span), psychomotor speed, fine motor control and visuo-spatial
ability. Figure 4.4 shows stem and leaf displays of effect size data for the cognitive
domains which produced the largest effect sizes.
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Psychomotor speed (11 studies) Working memory (10 studies)
Stem Leaf Stem Leaf
1 1
0 0,0,0.0 0 0,0,0,1,1
-0 0,1,2,5,5,7,8 -0 1,2,4,6
-1 -1 3
Fine motor control (3 studies) Visuo-spatial ability (3 studies)
Stem Leaf Stem Leaf
1 1
0 0
-0 2,2,2 -0 4,4,5
-1 -1
Figure 4.4 Stem and leaf displays of the effect size data for the cognitive domains which produced
the largest effect sizes (Mackenzie Ross et al study removed).
4.4 Discussion
The literature review described in Chapters 3 and 4 was carried out to investigate the
functional consequences of long term low level exposure to OPs. Whilst evidence
exists to support the view that high level/ acute exposure to OPs is detrimental to human
health, the possibility that long-term low-level exposure to OPs causes ill health is
controversial. Previous research has produced inconsistent findings, possibly because a
large body of literature exists concerning the neurotoxicity of OPs incorporating
different methodologies, populations examined and outcome measures. Meta-analysis is
a useful method of quantifying the results of different studies to establish if an
association exists between specified variables in a group of studies. However, the
results are only meaningful if the studies included and aggregated deal with similar
constructs and relationships and utilise similar statistical analyses. Therefore strict
inclusion and exclusion criteria were applied to the literature review to limit it to
relevant, high quality studies of human adult populations which utilise similar
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methodologies. This was done to ensure studies included in the review were comparable
(homogeneous).
Although more than 500 published papers were identified concerning the impact on
health of exposure to OPs, 483 were excluded as they did not address low level
exposure to OPs and neurobehavioural functioning in adult populations. After removing
articles that had been duplicated by different search strategies, failed to meet exclusion
and inclusion criteria or failed to provide relevant statistical information required for
meta-analysis, a final sample of 13 studies were identified as suitable for inclusion in
this review. The majority of studies were of individuals who had been exposed to a
mixture of pesticides, OPs being just one of the chemicals involved. All studies
involved comparisons of exposed and unexposed individuals and provided quantitative
measures of exposure and neurobehavioural outcomes.
Meta-analysis assimilated the data from these studies in order to determine the extent
and nature of any association between exposure to OPs and cognitive impairment. Data
from more than 1,400 participants was aggregated in order to produce a more reliable
estimate of the association between exposure to OPs and neuropsychological
impairment. The analyses show that overall a significant association exists between
exposure to low levels of OPs and decrements in cognitive function which is small in
magnitude. Working memory, psychomotor speed, fine motor control and visuo-spatial
ability were affected to a greater degree than other cognitive domains such as language
and general knowledge.
Methodological differences between studies make it difficult to comment further on the
precise nature of the relationship between exposure to OPs and neurobehavioural
functioning. A number of important questions remain unanswered, for example, the
critical exposure variable remains unclear; is it dose, intensity, frequency or duration of
exposure? Is there a simple, continuous, linear dose-response relationship or a stepwise
or curvilinear relationship. If the latter, can a threshold be identified which if reached
trigger symptoms of ill health? Is the dose-response relationship mediated by other
factors such as genetic differences between people in their capacity to detoxify
chemicals or the synergistic effects of chemical combinations? What is the time course
of development of neurobehavioural problems and can they be ameliorated? Have the
human health risks of exposure been underestimated by previous studies, the majority of
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which have been of individuals fit enough to be in employment and have not included
individuals who have left the profession because of disabling disease. Have the human
health risks of exposure been overestimated by previous studies because inappropriate
or unmatched comparison groups have been used; or the potentially confounding effects
of prior medical and psychiatric history have not been considered? Might the apparent
association between exposure to OPs and diminished neurobehavioural function be due
to factors other than exposure such as stressful life events, beliefs, attributions or
personality characteristics?
4.4.1 What are the critical exposure variables?
Although the current review utilised strict inclusion and exclusion criteria to limit the
analyses to studies incorporating similar methodologies, there remained a degree of
heterogeneity amongst studies, most notably in terms of the populations examined.
Different occupational groups were evaluated including chemical plant manufacturers,
pest control operatives, greenhouse workers, fruit and crop sprayers and sheep dippers.
These populations differ considerably in terms of intensity and frequency of exposure
which can range from a couple of days a year to several months or even daily exposure
in the case of manufacturers. Indeed, Srivastava et al (2000) and Amr et al (1997) who
examined chemical plant manufacturers and Farahat et al (2003) who examined
Egyptian pesticide applicators describe their study participants as having fairly
prolonged, continuous, daily exposure to OPs as opposed to brief seasonal exposures
reported in other occupational groups. Formulators work 40 hour days, every day and
Egyptian Applicators work 120 days per year. This contrasts with sheep dippers who
may only be exposed to OPs on as little as two to four occasions a year (Mackenzie
Ross et al, 2007; Stephens et al 1995). The populations included in this review also
differ in terms of their country of origin, some of the largest effect sizes being produced
by studies from developing nations (Amr et al 1997; Farahat et al 2000; Srivastava et al
2000) where daily exposure is not only more frequent and intense; but heat and
humidity may alter the characteristics and toxicity of chemical products and influence
decisions regarding the use of personnel protective clothing. Linguistic differences and
possible illiteracy may mean instructions for use, storage and other health and safety
advice is not followed and economic factors may mean products that have been banned
from other countries due to health and safety concerns may still be in use.
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Lifetime cumulative exposure may also be an important variable underlying the
development of neurobehavioural problems and this also ranged considerably between
studies from as little as 2 years to over twenty years. Srivastava et al (2000), Amr et al
(1997) and Farahat et al (2003) all found evidence of significant neurobehavioural
problems following long-term exposure to OPs. Studies by Roldan Tapia et al (2005
and 2006) and Bazylewicz-Walczak et al (1999) of greenhouse workers found an
association between cumulative exposure and neurobehavioural problems, particularly
in those exposed for more than 10 years. The importance of ‘prolonged exposure’ was
echoed by Mackenzie Ross et al (2007) who found an association between duration of
exposure and impaired memory and motor function in a group of sheep dippers with an
average of 14 years of exposure to OPs. All of these studies suggest neurobehavioural
problems develop over many years and not after a single episode or season of exposure.
It is important that future researchers group and analyse studies by occupation and
country of origin because exposure history varies greatly between different occupational
groups and even between nations. A variety of factors influence the amount of exposure
an individual worker might have including the nature of the work (spraying, dipping,
ground application), hours, days, years spent working with pesticides; whether the
worker is exposed to a single chemical or a mixture of chemicals, use of protective
measures (whether machinery was used to apply the pesticides, whether workers were
protected by being in sealed cabs or using respirators or other protective clothing)
environmental differences in temperature, humidity etc. It is also important to note that
important differences may exist even within occupational groups for example the
exposure histories of farm workers/pesticide applicators in different regions of the USA
vary considerably. Some regions employ migrant workers who live in camps adjacent to
fields where chemicals have been sprayed. This is not the case in California which has
strict regulations for the protection of farm workers and a surveillance programme for
reporting pesticide related illness.
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4.4.2 Have the human health risks of exposure to OPs been underestimated?
Another issue raised by this analysis is the possibility that the human health risks of
exposure to OPs may have been underestimated by previous studies, because the
majority have recruited individuals who are fit enough to be in employment and have
not included individuals who have left the profession because of disabling disease. The
largest effect size noted in this review was produced by the Mackenzie Ross et al (2007)
study, in which two thirds of study participants had retired or reduced their workload on
ill health grounds. This is the only study to have included individuals who are no longer
fit enough to be in employment and this may explain why this study produced the
largest effect sizes. Individuals who have retired on ill health grounds may constitute a
sub-group of persons who are particularly vulnerable to the effects of OPs either
because of their exposure history or genetic factors which may influence their capacity
to detoxify chemicals. It is therefore important that future researchers take account of
the ‘healthy worker’ effect and examine individuals who have retired on ill health
grounds in addition to those who are still fit enough to be in employment. Measures of
susceptibility or vulnerability to the neurotoxic effects of OPs should also be included in
future studies. For example human serum paraoxonase (PON1) hydrolyzes and
detoxifies a variety of OPs and previous research suggests PON1 status differs amongst
individuals (Richter & Furlong, 1999; Richter, Jarvik & Furlong 2008; 2009; Roest et
al, 2007). PON1 polymorphisms may render some people at greater risk of developing
ill health following exposure to OPs than others (Cherry et al, 2002; Mackness et al,
2003) and this should be explored by future researchers.
4.4.3 Have the human health risks of exposure to OPs been overestimated?
It is also possible that the human health risks of exposure been overestimated by
previous studies because study participants were unrepresentative or high risk groups
were recruited (Mackenzie Ross et al, 2007) or inappropriate or unmatched comparison
groups may have been used. Steenland et al (2000), Fiedler et al (1997) and Srivastava
et al (2000) utilised comparison groups who were more educated than the exposed
cohort and would therefore be expected to obtain higher scores on neuropsychological
tests because of pre-existing differences in premorbid ability. Unless further analyses
are undertaken to take account of this issue it is difficult to determine the degree to
which exposure predicts performance.
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4.4.4 Do other factors account for inferior performance on
neuropsychological tests in OP exposed populations?
A final issue raised by this analysis is whether any other factor, apart from exposure to
OPs, can account for the inferior performance on neuropsychological tests observed in
individuals with a history of low level exposure to OPs. Earlier reviews have referred to
inconsistencies in neurobehavioural outcomes between studies which undermine the
link between exposure and effect and suggest other factors may account for
neurobehavioural symptoms such as health beliefs and attributional error, somatising
tendencies (Solomon et al, 2007), stress and mood disorder or confounding factors like
medical and psychiatric history. However, this review found considerable agreement
between studies in terms of the neurobehavioural domains affected. For example,
slowing of reaction times and impaired fine motor skills are almost universally found in
all studies. Individuals who are more severely affected may show additional deficits in
short-term memory and executive function (Bazylewicz-Walczak et al, 1999; Farahat et
al, 2003; Mackenzie Ross et al, 2007; Roldan-Tapia et al 2005 and 2006; Stephens et al,
1995; Srivastava et al, 2000). None of the studies reviewed report deficits in general
intellectual functioning, semantic or autobiographical memory, perception or aphasias,
agnosias or apraxias; and none report a positive association between cognitive function
and exposure to OPs. Consistency of findings across many studies argues against the
alternative explanations listed above as the latter would produce more variable symptom
profiles.
4.4.5 Conclusion
In summary, the majority of well designed studies find a significant association between
long term, low level exposure to OPs and impaired neurobehavioural function, which is
consistent, small to moderate in magnitude and concerned primarily with
neurobehavioural functions such as working memory, psychomotor speed, fine motor
control and visuo-spatial ability. One potential bias in meta-analysis arises from the
fact that significant findings are more likely to be published than non significant
findings. This is likely to be less of a problem when it comes to research on pesticides
as organophosphate pesticides are the most widely used insecticides in the world and
prevent millions of people from starving to death and from disease. Studies which
produce negative findings are of great interest and are likely to be published as they
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imply that continued use of these pesticide is safe. Nevertheless, further analyses were
undertaken during this review to explore the issue of publication bias and revealed that
the number of unpublished studies reporting null results that would need to exist to
make the results of the current meta-analysis non significant would be forty five. It is
therefore unlikely that the association between exposure to OPs and decrements in
neurobehavioural function is entirely due to publication bias.
However, a number of unresolved issues remain in the literature concerning the precise
nature of the relationship between exposure to OPs and neurobehavioural function and
the strength of the association (has it been under or over estimated). This should be the
focus of future studies. The next three chapters of this thesis present the findings of a
four year empirical study of neuropsychological functioning and mood state in UK
sheep farmers, in which methodological weaknesses of earlier studies identified in this
review were addressed in the study design. For example study participants who had
retired on ill health grounds were included to take account of the ‘healthy worker
effect’; study participants with a history of acute poisoning and those with a psychiatric
or medical history that might otherwise account for ill health were excluded; exposure
history was examined in detail and objective, reliable, valid, neuropsychological tests
were used which are known to be sensitive to neurotoxic effects; and genetic factors that
may render some individuals more vulnerable to the effects of OPs than others were
explored.
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PART 3
Neuropsychological and psychiatric functioning
in UK sheep farmers exposed to low levels of
organophosphate pesticides.
An empirical study.
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Chapter 5 : Empirical study methodology
5.1 Background to the study
Organophosphate pesticides (OPs) are being increasingly used around the world for a
variety of agricultural, industrial and domestic purposes. Concerns have been expressed
about the effects of these chemicals on human health, but there is a lack of reliable data
on the scale of the problem. The immediate effects of high-level exposure to OPs have
been well documented and involve inhibition of the enzyme acetylcholinesterase,
causing changes in peripheral, autonomic and central nervous system function
(cholinergic crisis). However, the possibility that long-term low-level exposure to OPs
in doses below that causing acute toxicity may cause ill health is controversial (COT
Report, 1999). In 2000 the UK Government agreed to fund a programme of research to
address this issue and the author was successful in securing funding to undertake a 4
year study to determine whether low level exposure to OPs is associated with impaired
neuropsychological and psychiatric functioning. The occupational group examined in
this study were sheep farmers, as organophosphate pesticides were used extensively in
the dipping of sheep in the UK and farmers are generally considered to have relatively
low-level exposure to OPs. Methodological weaknesses of earlier studies were
addressed in the study design such as; detailed exposure assessment and exclusion of
study participants with a history of acute poisoning that might otherwise account for ill
health; inclusion of study participants who had retired on ill health grounds to take
account of the ‘healthy worker effect’; exclusion of study participants with a psychiatric
or medical history that might otherwise account for ill health; use of objective, validated
psychometric outcome measures; and exploration of factors that may render some
individuals more vulnerable to the effects of OPs than others such as the capacity to
metabolise OPs.
5.1.1 Study objectives
Objective 1: To establish whether farm workers with a history of low level exposure to
OPs (insufficient to cause acute intoxication) show evidence of physical disease,
cognitive impairment and / or mood disorder.
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Objective 2: To determine the nature and severity of physical symptoms,
neuropsychological abnormalities and psychiatric disorder in farm workers with a
history of low level exposure to OPs.
Objective 3: To determine whether individuals who have retired on ill health grounds
constitute a particular subgroup of individuals who are more susceptible to the effects of
OPs than others.
Objective 4: To investigate whether background factors (e.g. exposure history or
capacity to metabolise OPs) render some individuals more vulnerable to the effects of
OPs than others.
5.1.2 Study hypotheses
1. Farm workers with a history of low level exposure to OPs (insufficient to cause acute
intoxication) will show evidence of cognitive impairment, mood disorder and physical
ill health.
2. Farm workers will show a similar pattern of cognitive and emotional deficits as that
reported in earlier studies by Stephens et al, 1995 and Mackenzie Ross et al, 2007, such
as impaired response speed, working and general memory, mental flexibility and higher
rates of emotional distress. Deficits in perceptual, intellectual reasoning and general
verbal abilities are not expected.
5.2 Method
5.2.1 Ethical approval
Ethical Approval for this study was granted by the joint University College London /
University College London Hospital committee and written informed consent was
obtained from all study participants (see Appendix 3).
5.2.2 Study design
This is a cross sectional, case control study in which performance on
neuropsychological tests of working and retired farmers, exposed to OPs in the course
of their work, was compared with non exposed, working and retired healthy controls.
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5.2.3 Statistical power
Using prior research to establish the sample size needed to detect a relationship between
neuropsychological functioning and exposure history is challenging, as previous studies
have utilized an array of different methodological designs, populations, psychometric
tests and control groups (see previous chapter for further discussion of this). As such, it
might be prudent to consider previously established effect sizes for studies which have
investigated comparable exposed populations and/or cognitive domains which have
consistently been found to show impairment.
The meta-analysis in Chapter 4 found that response speed, working memory, visual-
spatial abilities and fine motor control showed significant impairment in the exposed
cohorts. Using the effect sizes established by the meta-analysis for these domains
(range = 0.2 - 0.5), a power analysis was conducted to determine the necessary sample
size to detect relationships of similar magnitudes. Calculations revealed that an n of
between 64 and 394 per group would be needed to obtain statistical power at the
recommended .80 level (Erdfelder, Faul & Buchner, 1996) for 2-tailed tests. More
specifically, studies which have investigated performance on psychometric tests using
the same occupational group as the current study (UK sheep farmers), have found
moderate to large effect sizes (0 .6 -0 .9) between cognitive function and exposure
history (Mackenzie Ross et al, 2007; Stephens, 1995). Using this information, power
analyses indicates that a sample size of between 21 and 45 individuals per group would
be required to have 80% power to detect a relationship of this magnitude between
neuropsychological functioning and exposure history using 2-tailed tests.
5.2.4 Participants
5.2.4.1 Exposed cohort
Two groups of sheep farmers were recruited: 67 working sheep farmers and 60 sheep
farmers who had retired on ill health grounds. Both groups had a history of low level
exposure to OPs, insufficient to cause acute intoxication resulting in medical
intervention. Prior acute exposure was assessed by interview at the recruitment stage
and again during the clinical study. Participants were asked whether they had ever felt
so unwell immediately after dipping that they sought medical advice/intervention within
48 hours. If they had, they were excluded from the study. Remaining participants were
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asked if they had ever suffered symptoms of ‘dippers flu’ after dipping for which they
had not sought medical intervention. Since the main aim of this study was to determine
whether there is a relationship between low level exposure to OPs and cognitive
impairment, it was important to exclude any participants with a medical or psychiatric
condition which might otherwise account for any deficits identified during assessment
(see Table 5.1 for inclusion/exclusion criteria).
Table 5.1 Inclusion and Exclusion Criteria.
Exposed cohort Unexposed cohort
Inclusion Aged between 18-70 years old
Living in the South West or North of
England.
For the retired cohort, they must
have retired on ill health grounds
NOT age or economic reasons.
Exposure to organophosphate
pesticides for a minimum of 5 years
prior to 1991 (safety regulations
were implemented in 1992).
NO history of acute intoxication
requiring medical intervention.
Aged between 18-70 years old
Has worked in a rural area in the South
West or North of England
For the retired cohort, they must have
retired on ill health grounds NOT age
or economic reasons.
No known exposure to
organophosphate pesticides.
Exclusion History of psychiatric problems
prior to exposure, neurological or
serious medical problems which
might otherwise account for any
cognitive or emotional problems
identified in this study.
Substance abuse (including alcohol).
Those with a history of acute
organophosphate intoxication.
History of psychiatric problems,
neurological or serious medical
problems which might otherwise
account for any cognitive or emotional
problems identified in this study.
Substance abuse (including alcohol).
Exposure to organophosphates.
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5.2.4.2 Healthy controls
It is extremely difficult to find a group of farmers in the UK who do not have a history
of exposure to OPs and so it was necessary to identify a different occupational group to
act as controls. A number of occupational groups were considered, but a primary
concern was to find an occupational group with sufficient numbers of individuals who
have retired on ill health grounds, that could be easily identified and accessed. Other
important criteria included:
 The control group should be matched to farmers in terms of characteristics
which have been shown by previous research to affect cognitive function (the
main outcome variable of this study), for example: age, gender, education level,
premorbid IQ.
 The control group should not have a history of exposure to organophosphates.
Variables such as the exact nature of the work undertaken, location, lifestyle, attitudes,
life experiences were considered to be less important since these variables have not
been shown by research to significantly affect performance on psychometric tests.
Rural police workers who have never worked in the farming industry were recruited as
controls. Rural police workers undertake both administration and outdoor work as do
farmers and a major advantage of using the police as a control group is that an
organisation exists which holds a database of 80,000 retired members of the police
force. Furthermore, the police force is divided into local constabularies making it
possible to recruit police workers from the same geographical regions as sheep farmers.
None of the police workers included in the study had a history of exposure to OPs. 38
rural police workers who were fit enough to be in employment and 40 rural police
workers who had retired on ill health grounds were examined.
5.3 Recruitment
5.3.1 Identification of study participants: Sheep farmers.
For practical reasons, the focus of the project was restricted to two geographical areas of
England with the highest number of sheep, according to the UK Department of
Environment, Food and Rural Affairs (DEFRA) ‘Distribution of Sheep in UK on 02
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June 2005’. These two areas were the North and South West of England.
Three methods of sampling were used to identify the target population:
 Purposive sampling – written correspondence
 Purposive sampling – telephone contact
 Advertising
5.3.1.1 Purposive sampling – written correspondence
Contact details of farm owners in the south west and north of England were purchased
from databases held by (1) a company called Experian which owns the right to sell data
from the UK National Business Directory (2) a company called Tri-Direct which owns
the right to sell the membership lists of the National Farmers Union (NFU) (3) The
Royal Agricultural Benevolent Institution (RABI) which provides welfare advice to
working and retired farmers in need, especially those who are elderly or disabled. These
companies restricted the amount of contact with their members. Members could be
contacted on only one occasion, by letter. It was not possible to telephone members.
Letters were sent to all of the farm owners on these databases asking them to provide us
with the contact details of any sheep farmers who had retired on ill health grounds that
were known to them. They were offered a small financial incentive for any contacts that
subsequently met our inclusion / exclusion criteria. Eight thousand, two hundred and
sixty two farm owners were contacted. The response rate was poor and less than 2% for
business directories and 4.5% for RABI. Nominees identified from this method of
sampling were subsequently contacted by telephone and interviewed to establish some
basic facts about them including their reasons for retirement and exposure history.
5.3.1.2 Purposive sampling – telephone contact
The contact details of sheep farmers in the south west and north of England were
obtained from the Wool Marketing Board (WMB). The WMB gave us this information
free of charge as they were keen to assist us with this study. Over fifteen thousand
farmers were listed on this database, twelve thousand of whom were new to us in the
sense that they were not included on the other databases mentioned in this report. We
contacted every fifth person on the WMB database, up to a total of three hundred and
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ninety three farmers, by telephone and explained the purpose of this study, asked them
if they had retired on ill health grounds or could suggest any other farmers who might
have retired on ill health grounds. The response rate from this method of sampling was
much greater than written correspondence at 59%.
5.3.1.3 Advertising
Details about this study were published in farming newspapers and publications, in
organisations’ newsletters such as union newsletters (NFU and Transport and General
Workers Union (TGWU)) and support organisation newsletters (Organophosphate
Information Network (OPIN), Pesticide Action Network (PAN) and RABI).
Information about the study was also distributed at agricultural shows and sent to a
number of rural GP surgeries. The study was also described in several regional radio
broadcasts (circa 17) and on the Farming Today programme (twice) between 2005 and
2007.
5.3.2 Identification of study participants: Police workers.
The police force is divided into local constabularies and the Human Resources and
Occupational Health Departments for each of the 12 regions we had recruited
agricultural workers from were contacted and their assistance was sought in recruiting
working and retired police workers into the study.
The National Association of Retired Police Officers (NARPO), which holds a database
of 80,000 retired members of the police force, assisted us in recruiting rural police
workers who had retired on ill health grounds. Two police convalescence and treatment
centres in the UK, the Northern Police Convalescent and Treatment Centre in Harrogate
and the Police Convalescent Home in Berkshire, also assisted us in recruiting rural
police workers who had retired on ill health grounds.
Details of the study were emailed by police constabularies and NARPO to police
workers on their database and the study was advertised in Police Press and associated
websites (local police magazines and newsletters and national publications such as
Police Life, Police Oracle, Police Review). Posters advertising the study were also
placed in a few local police stations.
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5.4 Procedures and measures
Study participants were visited at home or at their workplace and underwent an
extensive neuropsychological assessment and completed a number of questionnaires to
establish demographic, mood, health and exposure information.
5.4.1 Exposure history
Accurate estimation of exposure is critical for the validity of studies investigating the
adverse effects of exposure to pesticides and researchers have used a range of
techniques to estimate exposure in the past. Biological monitoring, such as
measurement of OP metabolites in urine, of cholinesterase activity in plasma, of AChE
activity in red blood cells and of neuropathy target esterase in lymphocytes, has been
used to measure recent exposure but can’t be used to measure cumulative long-term
exposures. Epidemiological studies investigating the effects of long term exposure to
pesticides often use surrogates for exposure such as ever/never worked as a farm worker
or number of years spent working as a farm worker. However, these measures suffer
from a number of limitations as they do not provide information about the type of
pesticide a subject was exposed to, in what amount, frequency, intensity or duration,
and can result in misclassification of exposure status. At the very least information in
required about job title, the type of chemicals a worker was exposed to, how often and
for how long.
In the present study, farm workers were asked to provide detailed information about
work practices. Each sheep farmer underwent a semi-structured interview about their
work and exposure history (see Appendix 2). Individuals were asked to specify when
they began working with OPs, in what capacity, their level of exposure in terms of
frequency and duration (i.e. number of times per year, number of days per year spent
dipping sheep, flock size), the use of protective clothing, their involvement in high risk
activities such as diluting concentrate, their use of other agricultural chemicals, the
onset of their physical/psychological problems and the temporal relationship with
exposure to OPs, and whether or not they had a history of acute poisoning (i.e. ‘dippers
flu’), and whether or not they had felt so unwell after dipping that they sought medical
help.
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In addition to obtaining information about specific aspects of exposure, two exposure
indices were calculated for each participant. Exposure metrics are often considered to be
an improvement over conventional dichotomous exposed/non exposed categories as
they attempt to consider multiple aspects of exposure history which may be relevant. A
number of different exposure metrics have been proposed by researchers in the past and
range from simple methods whereby different measures of frequency and duration of
exposure are multiplied together to provide an overall rating; to complex formula which
attempt to estimate intensity of exposure in addition to duration by incorporating
weightings for variables such as job activity, use of protective clothing and so on.
Exposure metrics do not reflect absolute exposure but provide a ranking within a
population under study. The validity of such measures is dependent on the assumptions
underlying the metric, the variables considered, the accuracy of information provided by
respondents and the weighting assigned to variables.
Two metrics were calculated in this study: (1) a relatively simple estimate of ‘lifetime
exposure’ based on the number of days per year spent using OPs multiplied by the
number of years spent using OPs; (2) and a more complex formula which took account
of intensity in addition to duration of exposure. The latter is referred to as the ‘ESK
Metric’ and was devised by Cherrie and Robertson (1995) for use in a previous study of
UK sheep farmers. The Esk metric takes account of the concentration of the sheep dip in
the skin contamination layer (Csk) and the area of skin contaminated (Ssk), both
estimated from job title, and duration of exposure (t). It involves the following formula:
Esk = Csk x t x Ssk
Rural police workers were only included in the study if they did not have a history of
exposure to potentially toxic chemicals. This was established by telephone interview at
the recruitment stage of the study. They were asked if at any time in their lives they had
been exposed to or worked with potentially toxic chemicals and if they had ever felt
unwell after being exposed to chemicals. Thirty three police workers had to be excluded
because they had assisted farmers with sheep dipping in the past.
5.4.2 Cognitive assessment
All participants (exposed and control cohorts) underwent neuropsychological
assessment. Well known, standardized and clinically sensitive tests which are
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commonly used in routine clinical practice within the National Health Service were
selected. All tests had adequate published reliability, validity and normative data. The
Researchers who evaluated study participants were aware of which group they came
from (e.g. farmer or police worker) but were blind to the participants’ exposure history
whilst assessing their cognitive function and mood state.
Intellectual ability - the Wechsler Adult Intelligence Scale-III was administered to
assess current intellectual functioning (Wechsler, 1998). This test is composed of
fourteen subtests which measure a range of cognitive functions such as general
knowledge, vocabulary, arithmetic, verbal and visual reasoning, working memory,
response speed and visuo-spatial ability. Two of the subtests are optional. These were
not administered. In addition, the Wechsler Test of Adult Reading (WTAR) was
administered to estimate premorbid intellectual ability. It estimates WAIS-III IQ index
scores.
Memory - The Wechsler Memory Scale – III (short version) was used to assess
working, visual and verbal memory (Wechsler, 1998). The following subtests were
administered, logical memory (story recall), verbal paired associates, letter/number
sequencing, digit span, spatial span, face recognition and family pictures.
Response speed and mental flexibility were assessed by a number of means (1) Trail
Making Tests A and B (Spreen & Strauss, 1991) (2) The California Computer
Assessment Package (CALCAP) which measures simple and choice reaction time
(Miller, 2002). The Stroop test was included as a measure of mental flexibility
(Trenerry, Crosson, DeBoe & Leber, 1988).
Language - the Graded Naming Test was administered to assess naming ability
(McKenna & Warrington, 1983). A verbal fluency test (FAS) was used to assess
expressive language (Borkowski, Benton & Spreen, 1967).
Fine Motor Skill – the Grooved Pegboard was used to assess motor dexterity (Trites,
1977). This test is very sensitive to general slowing due to medication, toxic effects and
diffuse brain injury.
Effort / Malingering – The Medical Symptom Validity Test was used as a measure of
cognitive effort (Green, 2004). It is a brief computerised verbal memory screening test
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which measures a person’s effort on testing and was included in the battery to ensure
psychometric test results were valid. It is insensitive to all but the most extreme forms
of cognitive impairment whilst being very sensitive to poor effort and exaggeration of
cognitive difficulties.
Ten key areas of cognitive function were identified and tests were grouped in a way that
would reflect participants’ abilities in these areas (Table 5.2).
Table 5.2 Key cognitive domains and associated neuropsychological tests.
Cognitive Domain Tests Cognitive Domain Tests
Working Memory WAIS-III Digit Span Response Speed WAIS-III Digit Symbol
WAIS-III Digit Span Trails A
Backwards CALCAP Simple
WAIS-III Arithmetic
WMS-III LNS Verbal ability WAIS-III Vocabulary
WAIS-III Comprehension
Visual Memory WMS-III Visual Graded Naming
Immediate memory
WMS-III Visual Verbal & visual
WAIS-III Picture
arrangement
Delayed memory reasoning WAIS-III Comprehension
WAIS-III Similarities
Auditory Memory WMS-III Auditory
Immediate memory Mental flexibility Trails B
WMS-III Auditory Stroop
Delayed memory CALCAP Choice
WMS-III Auditory
Recognition delayed Strategy making Verbal Fluency
Visuo-spatial skills WAIS-III Block design Fine Motor Control Grooved Pegboard
WMS-III Spatial span
5.4.3 Mood state
Mood State and Life Events – Mood state was assessed by two means: (1) A structured
clinical interview (SCID; First Spitzer, Gibbon & Williams, 1997) and (2)
Questionnaire measures: The Hospital Anxiety and Depression Scale (Snaith &
Zigmund, 1983) and the Beck Anxiety (Beck & Steer, 1990) and Depression
Inventories (Beck, Steer & Brown, 1996). The Hospital Anxiety and Depression Scale
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was included to screen for clinically significant levels of anxiety and depression. Mood
disorder has been shown to have a negative effect on performance on psychometric tests
and so levels of anxiety and depression need to be taken account of in any analyses
concerning the impact of exposure on cognitive functioning, The Beck anxiety and
depression inventories were included as measures of symptom severity. However, self-
assessment scales are only valid for screening purposes and definitive diagnosis requires
a comprehensive clinical examination, which is why a structured clinical interview
(SCID) was included in the assessment process.
Structured interviews provide an important method of standardising evaluations and
improving diagnostic reliability and validity. Structured interviews standardise the
coverage of specific issues (thus reducing the possibility of missed diagnoses) and
require the systematic appraisal of relevant symptoms, to reduce misdiagnosis. The
basic rationale for standardised interviews is the minimization of needless variability in
interviewer-based evaluations. Many structured interviews have been developed over
the years which vary in terms of focus and depth of coverage. The structured clinical
interview (SCID; First et al, 1997) was chosen for the current study because it was
developed to standardise DSM-IV evaluations of mental disorders. DSM-IV is a manual
published by the American Psychiatric Association to assist clinicians in evaluating
mental health disorders in both children and adults. The SCID aims to improve the
reliability of DSM diagnoses and has been extensively validated over the last decade.
Study participants were evaluated for the following: Past major depressive episode,
current major depressive episode, dysthymic disorder; generalised anxiety disorder,
panic disorder, anxiety disorder or depression due to a general medical condition. With
regard to the latter, DSM-IV requires the symptoms of anxiety or depression to be a
direct physiological consequence of the general medical disorder. Anxiety and
depression which has arisen as an emotional reaction to having a general medical
disorder is not encompassed under this diagnostic heading.
A life events checklist (Holmes and Rahe, 1967) was included in an attempt to tease
apart the relative contribution of recent stressful life events and exposure to pesticides in
triggering mood disorder. This scale consists of 43 positive and negative life events
such as divorce, marriage, retirement, change in financial state, which are capable of
inducing stress and ill health. Each life event is assigned a value according to how
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stressful they were considered to be by a standardisation sample of 394 individuals.
Study participants were asked to state whether they had experienced any of these events
over the last 12 months. Scores above 150 are associated with an increased risk of
illness and a score above 300 is associated with a high risk of developing a stress related
illness.
5.4.4 Physical health
A questionnaire concerning physical symptoms was constructed (see Appendix 2). It
was based on a number of existing questionnaires with known reliability and validity:
(1) the SF36 Health Survey, a multi-purpose, generic measure of disease burden (Hays,
Sherbourne & Mazel, 1995) (2) the Q16 questionnaire on neurotoxic symptoms
(Lundberg, Hogberg, Michelsen, Nise & Hogstedt, 1997) was examined to ensure
symptoms, identified by previous research as being associated with exposure to
neurotoxic agents, were included in the current questionnaire. Additional symptoms
which are not associated with exposure to neurotoxic agents were added to the list such
as hearing loss, toothache, tinnitus, hay fever. This was to determine whether
participants who suffer from ill health show a specific pattern of disease and complain
of symptoms associated with neurotoxic exposure as opposed to an array of symptoms
with different underlying causes. The questionnaire was not subject to any form of
further validation during this study.
Participants were asked to give an overall rating of their health and to state the degree to
which their work and social life had been affected by poor health. The questionnaire
then provides a list of 39 symptoms and participants were asked to state whether they
suffered from these symptoms, if so, when the symptom first appeared, the frequency
with which the symptom is experienced, symptom severity, level of distress caused and
the degree to which the symptom interferes with daily activities.
5.4.5 Possible genetic vulnerability factors - Blood analyses (determination of PON1
status)
Genetic differences between individuals render some people more susceptible to the
toxic effects of certain chemicals than others. For example, the human paraoxonase
1/arylesterase enzyme (PON1) plays an important role in the detoxification of
organophosphates and helps protect against the potentially harmful effects of OPs.
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Each study participant was asked to provide a sample of blood which was collected
from all study participants via venipuncture following informed consent. Heparinized
whole blood was centrifuged and divided into plasma, buffy coats and red blood cells
and stored at -80C before being shipped in dry ice to the University of Washington,
Seattle, where it was also stored at -80C until analyses of enzyme activity could take
place.
PON1 status was determined under conditions that allow for determination of in vivo
rates of diazoxon detoxification. An individual’s PON1 status can be determined by
measuring rates of paraoxon and diazoxon hydrolysis as this correlates with the amount
of enzyme activity and protein levels. This method was developed and validated in
adult populations by Richter & Furlong (1999 and 2009). The two-substrate enzyme
analyses is carried out using molecular devices SPECTRAmax PLUS Microplate
Spectrophotometer. Initial rates of substrate hydrolysis are determined with rates of
diazoxon hydrolysis (y-axis) plotted against rates of paraoxon hydrolysis (x-axis). This
method separates individuals into the three phenotypes, individuals homozygous for
PON1 Q192, heterozygotes for PON1192 (QR) and individuals homozygous for PON1
R192. It also reveals PON1 plasma levels reported as arylesterase levels in subsequent
tables and analyses.
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Chapter 6 : Empirical study results
Overview
Section 1, presents the number of participants identified by different sampling methods
followed by demographic information regarding the participants’ who were included in
the study. In Section 2 the nature and extent of cognitive impairment, mood disorder
and physical health is analysed. Differences in performance between the exposed and
control cohorts on psychometric testing are presented. In Section 3 the relationships
between cognitive impairment and indices of exposure are described.
6.1 Section one: Recruitment rates
Initially 434 farmers came forward (222 retired, 212 working) and 252 police (170
retired, 82 working), however 67% of the farmers and 63% of the controls had to be
excluded based on the inclusion/exclusion criteria or they declined to take part in the
study (see Tables 6.7 and 6.8). Twelve police identified as being eligible, were not
examined due to time constraints. A further 12 farmers and 3 controls were excluded to
in order to establish similar demographic profiles between the groups as farmers and
controls had to be matched on a number of demographic factors thought to influence
cognitive performance in order to eliminate any potential confounds: age, years in
education and premorbid intelligence; 5 farmers’ and 1 policeman’s data were excluded
because they showed evidence of poor effort/malingering on a psychometric test which
is insensitive to severe brain injury but which is greatly affected by effort (Green, 2004).
This left a final sample of 127 exposed sheep farmers (67 working and 60 retired) and
78 unexposed controls (38 working and 40 retired).
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434
(222R & 212W)
290
Excluded
144
Eligible
Examined
17 Excluded
12 matching
5 poor effort
127
(60R & 67W)
PS Ad
R 92 130
W 179 33
PS Ad
R 21 44
W 64 15
PS Ad
R 19 43
W 55 10
----------
----------
-----------
R = Retired
W = Working
Figure 6.1 Flow diagram illustrating recruitment numbers and sources for farmers.
252
(170R & 82W)
94 Eligible
82 Examined
78
(40R & 38W)
158
Excluded
12 not
examined
4 Excluded
3 matching
1 poor effort
R = Retired
W = Working
Figure 6.2 Flow diagram illustrating recruitment numbers and sources for police workers.
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6.1.1 Sources of recruitment and reasons for retirement
All working and retired controls (rural police workers) were recruited by advertising.
The primary reason for retirement given by police workers was musculo-skeletal injury
(78%). A small number (7%) retired due to stress which had fully resolved by the time
they took part in this study; and 15% retired on other ill health grounds such as
breathing difficulties, gout, benign tumour, chronic fatigue and arthritis (see Table 6.6).
Working and retired farmers were recruited by a combination of purposive sampling
(written correspondence and phone calls) and advertising. The majority of working
farmers (81%) were recruited by purposive sampling and 19% responded to adverts.
The majority of retired farmers (68%) were recruited by advert as many were no longer
listed on union/business membership lists. Having said that, over a third (32%) of
retired farmers were recruited by purposive sampling. Around half of the retired cohort
had retired from farming completely (51%) whilst the remainder had semi- retired.
None used sheep dip after retiring, the average number of years having elapsed since the
last time they dipped sheep being 9 years for working farmers and 11 years for retired
farmers. The primary reasons for retirement given by farmers (77%) was a constellation
of non-specific symptoms including chronic fatigue, headaches, cognitive impairment,
muscular and joint pain, numbness and chemical sensitivity. A quarter of these farmers
attributed their symptoms to pesticide (sheep dip) poisoning. The remainder of the
retired sample (23%) had retired on other ill health grounds such as musculo-skeletal
injury, breathing difficulties and prostate problems (see Table 6.3).
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Table 6.1 Number of farmers identified from different sampling methods.
Written Telephone Support
Groups
Advertising Word
of
mouth
Other Totals
Retired 25 21 27 41 10 124
Semi-retired 23 21 13 19 3 2 81
Changed
occupation
1 1 2 9 3 1 17
Sub-total
Retired/CO
49 43 42 69 16 3 222
Working 57 122 4 14 13 2 212
Table 6.2 Examined farmers and their source.
Written Telephone Support
Groups
Advertising Word
of
mouth
Other Totals
Retired 5 1 9 12 6 0 33
Semi-retired 11 4 4 10 2 1 32
Changed
occupation
0 0 1 0 0 0 1
Sub-total
Retired/CO
16 5 14 21 8 1 65
Working 27 37 0 6 8 1 79
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Table 6.3 Primary reasons for retirement given by farmers included in the analysis.
Reason for Retirement Included sample
Non-specific symptoms*, no attribution
made
34
Non-specific symptoms attributed to
OPs
16
Other ill health grounds+ 15
Total 65
*Non-specific symptoms: Participants reported suffering a range of symptoms including chronic fatigue,
headaches, memory loss, lack of concentration, chemical hypersensitivity, numbness, balance problems,
aches and pains and symptoms of mood disorder. The majority reported a combination of several of these
symptoms.
+Other ill health grounds: These included breathing difficulties, skeletal problems (back pain, arthritis),
chest pain, prostate problems and poor circulation.
12 farmers were subsequently removed from the statistical analyses for age matching
purposes and 5 were removed because they failed a test of effort, leaving a final sample
of 127 farmers included in the analysis of cognitive function, mood state and exposure
history.
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Table 6.4 Number of police workers identified from different sampling methods.
NARPO Convalescent
Homes
Advertising Word
of
mouth
Totals
Retired 123 1 6 2 132
Semi-retired 4 5 1 0 10
Changed
occupation
22 0 6 0 28
Sub-total
Retired/CO
149 6 13 2 170
Working 7 2 65 8 82
Table 6.5 Examined police workers and their source.
NARPO Convalescent
Homes
Advertising Word
of
mouth
Totals
Retired 27 0 4 0 31
Semi-retired 1 1 0 0 2
Changed
occupation
4 0 5 0 9
Sub-total
Retired/CO
32 1 9 0 42
Working 6 1 29 4 40
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Table 6.6 Primary reasons for retirement given by police workers included in the analysis
Reason for Retirement Included sample
Spinal, neck, knee, shoulder, limb
injury or condition
33
Reactive depression now fully resolved 3
Other ill health grounds+ 6
Total 42
+Other ill health grounds include breathing difficulties, arthritis, Gout, benign tumour, Meniere’s disease,
chronic fatigue.
3 police workers were subsequently removed from the statistical analyses for age
matching purposes and 1 was removed because he failed a test of effort, leaving a final
sample of 78 police workers included in the analysis of cognitive function, mood state
and exposure history.
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Table 6.7 Primary reasons for exclusion - exposed cohort.
Reason for
Exclusion Retired Semi-retired
Changed
Occupation Working TOTAL
Acute OP
poisoning 4 5 4 13
Refusal 7 5 19 31
Psychiatric 2 3 5
TBI 2 5 10 17
Neurological 15 2 1 18
CV 4 2 1 7
Epilepsy 1 1
Heart 5 6 1 2 14
Lung 2 3 3 8
Liver
Kidney 1 1 2
IDDM 1 1 1 3
Endocrine 1 1
Cancer 4 1 5
Alcohol 5 1 3 9
Deceased 1 1
Age 21 11 16 48
Inadequate
exposure
history
12 9 5 35 61
Other 11 3 1 31 46
TOTAL 97 54 9 130 290
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Table 6.8 Primary reason for exclusion - control cohort.
Reason for exclusion Retired Semi retired Changed
Occupation
Working TOTAL
Urban 8 2 9 19
Not RIHG 17 1 1 1 20
OP exposure 25 1 7 33
Other Chemical
exposure
3 1 1 5
Refusal 4 2 1 7
Age 5 10 15
Current Psychiatric 11 1 12
Retired on psychiatric 2 1 3
TBI 1 1 2
Neurological 6 1 2 1 10
CV 0
Epilepsy 1 1
Heart 2 1 3
Lung 0
Liver 1 1
Kidney 1 1
IDDM 3 2 5
Endocrine 0
Cancer 0
Alcohol 1 1 2
Area 4 1 1 7 13
Other 3 1 2 6
TOTAL: 97 4 16 41 158
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6.1.2 Demographic information
Demographic characteristics of farmers and controls appear in Table 6.9. The WTAR
test under estimated premorbid intelligence in both groups and was not used as a
measure of premorbid ability in the analyses. Farmers and controls obtained similar
scores on a test of vocabulary (which is sometimes used as a measure of premorbid
ability (Lezak, 2004)), but since previous research suggests organophosphate exposed
individuals may have impaired verbal ability (Mackenzie Ross et al, 2007) premorbid
ability was estimated using a measure that is unlikely to have been affected by cognitive
damage (matrix reasoning). Farmers and controls were successfully matched for gender,
education and premorbid IQ, but not age. As the majority of psychometric test data
used in the analysis were age-corrected, it is unnecessary to match the groups on age.
Table 6.9 Demographic information for the control and exposed participants.
Exposed group Control Group
Mean (SD) Mean (SD)
Age* 54.73 (9.42) 51.73 (7.36)
Years in Education 11.57 (2.08) 11.95 (1.59)
Matrix Reasoning† 2.33 (.55) 2.34 (.47)
Vocabulary 10.39 (2.43) 10.99 (1.90)
Gender 102M, 25F 68M, 10F
*significant difference between groups using an independent t-test, p<.05
† transformed scores reported and analysed
Farmers and controls were successfully matched for gender (χ2=1.61, p=.21), education
(t(203)=-1.39, p=.17) and premorbid IQ (t<1), but not age (t(191.41)=2.54, p<.05). As
the majority of the tests used within the test battery were age-scaled (i.e. the effects of
age were removed), the fact that the groups were not matched on age is not a problem.
The potential confounding effects of age on the non-age-scaled scores will be discussed
at various points in the results section.
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6.2 Section 2: Exposed versus unexposed cohort comparisons; the nature and
extent of cognitive impairment, mood disorder and physical ill health following
exposure to OPs
This section summaries the effect of Exposure Group on neuropsychological
functioning and health. To minimize any potential Type I errors Multivariate Tests of
Analysis (MANOVA) were used wherever possible. When Univariate or Multivariate
Analysis of Variance was used, the variables of interest were Exposure Group (which
had two levels: exposed and control) and Working Status (which also had two levels:
farmers and controls). When MANOVA was not appropriate1 differences in mean
scores were analysed using unrelated t -tests or the non-parametric equivalent (Mann
Whitney U). Unless otherwise stated, all statistical tests were two-tailed.
Before analysis took place the distribution of all variables was checked to determine
whether normality could be assumed. In order to do this, skewness (S) and kurtosis (K)
values were converted into z-scores using the following equations:
zskewness= (S-0)/SEskewness zkurtosis= (S-0)/SEkurtosis
The resultant z-scores were then compared against known values for the normal
distribution (see Field, 2010). In this case, as the sample size was over n=200, a value
greater than 2.58 was used to signify a significantly skewed or kurtotic sample (p<.01)2.
Simple tests of normality (Kolmogorov-Smirnov and Shapiro-Wilk) were not used to
determine non-normality due to the liberal nature of these tests (Field, 2010).
It was found that some variables exhibited unacceptable skewness and/or kurtosis for
parametric statistical analyses. Positively skewed variables were first subjected to a
square root transformation, as the action of square-rooting has a greater impact on larger
numbers than smaller (which serves to bring in the right tail of the distribution towards
the centre), thus reducing a positive skew. If this correction did not work, the original
variables were then put through a logarithm transformation, which also brings the larger
1 i.e. when the initial assumptions of the test were not met or when non-aged-scaled scores were being
analysed
2 Using 1.96 as the cut off criterion (p<.05) may be deemed too liberal in this case, as even small
deviations from normality may present as significant (e.g. Field, 2010).
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numbers towards the centre of the distribution. Table 6.10 shows the variables that
were corrected in this way.
The same procedure was used for negatively distributed data, however in this case raw
scores were reversed first by adding 1 to the highest data value in the data set and then
subtracting the individual’s original raw score. The addition of 1 to the highest score
was to avoid producing any values of 0 (as zero has no logarithm value). To avoid
confusion over the direction of the scores corrected in this way, they were then reversed
back to reflect the original pattern of data (with higher numbers equating to a higher
score) using the same method described above (see Table 6.10).
Table 6.10 Abnormally distributed variables.
Square Root
Transformation
Natural
Logarithm
Transformation
Reflected and
Square Root
Transformation
Digit Span x
Digit Span Backwards x
Digit-Symbol Substitution x
Similarites x
Matrix Reasoning3 x
Semantic fluency (animals) x
While it was possible to correct some of these distributions by transforming the data,
transformations were not successful for all measures. The following variables were not
able to be transformed into a normal distribution using the above method, and so
abnormally distributed raw scores were used in the analyses:
 Trails A and B
 Grooved Pegboard (Dominant and Non-dominant hand)
 Stroop
 CALCAP (simple and choice)
3 When the groups were matched on matrix reasoning scores, this was done using the transformed scores.
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Tables 6.11-6.16 summarise the effect of Exposure Group on broad cognitive domains
and the results of univariate analyses examining the effect of Exposure Group on the
individual psychological tests that comprise these domains. There were no effects of
Working Status (and no significant interactions), so descriptive statistics were collapsed
across this variable.
6.2.1 Impaired cognitive domains
6.2.1.1 General intellectual function
While participants were matched on pre-morbid intellectual ability using matrix
reasoning, an independent two-way ANOVA revealed that there was a significant main
effect of Group on current IQ, as measured by the full-scale WAIS (F(1,192)=10.21,
p<.01, ηp
2=.05), with the exposed group exhibiting a significantly lower IQ
(mean=104.79, 11.76) than the controls (mean=110.03, 10.83). No effect of Working
Status was found (F<1), nor was there a significant interaction between these variables
(F(1,192)=2.86, p=.09, ηp
2=.02). Subsequent analyses reveal the exposed cohort exhibit
reduced performance on specific cognitive tests (not all intellectual tests) which are
associated with exposure to OPs (see following chapters) and is unlikely to reflect pre-
existing differences in overall premorbid IQ between the control and exposed cohorts.
6.2.1.2 Memory
6.2.1.2.1 Working memory
Differences in working memory were analysed using Digit Span, Digit Span
Backwards, Letter-Number Sequencing and Arithmetic subtests. A two way
independent MANOVA revealed a significant main effect of Exposure Group on
working memory (V=.20, F(4,189)=12.05, p<.001, ηp
2=.20), but no effect of Working
Status (V=.03, F(4,189)=1.54, p=.19, ηp
2=.03) and no significant interaction between
these variables (F<1). These results suggest that the exposed cohort were significantly
impaired on measures of working memory and this pattern was similar for both the
working and retired groups.
Follow-up univariate tests (summarized in Table 6.11) revealed that this main effect of
group on working memory was driven by group differences in Digit Span, Digit Span
Backwards and Letter-Number Sequencing performance.
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6.2.1.2.2 Visual memory
Differences in visual memory were analysed using Visual Immediate Memory and
Visual Delayed Memory. A two way independent MANOVA revealed the difference
between the exposed and control participants to be a significant one (V=.07,
F(2,197)=7.54, p=.001, ηp
2=.07). No effect of Working Status was found and there was
no significant interaction between these variables (F<1 for both). To summarise, these
results suggest that the exposed cohort were significantly impaired on measures of
visual memory and this pattern was similar for both the working and retired groups.
Follow-up univariate tests (summarized in Table 6.11) revealed that this main effect of
group on visual memory was the product of group differences in both immediate and
delayed visual memory.
6.2.1.2.3 Verbal memory
Differences in auditory memory and information processing were analysed using
Auditory Immediate Memory, Auditory Delayed Memory and Auditory Recognition
Delayed Index Scores. A two way independent MANOVA revealed a significant
multivariate effect of Exposure Group on auditory memory scores (V=.07,
F(3,197)=5.10, p=.002, ηp
2=.07) which the exposed cohort performed worse than the
controls. No effect of Working Status was found and there was no significant
interaction between these variables (largest V=.02; largest F=1.36).
Follow-up univariate tests (summarized in Table 6.11) revealed that this main effect of
group on auditory memory was the result of group differences in immediate, delayed
and recognition aspects of auditory memory.
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Table 6.11 IMPAIRED domains - Main effects of group on performance on memory tests and
descriptive statistics and univariate effects of exposure group on cognitive performance.
Exposed Control
Cognitive Area N Mean SD N Mean SD Tests FValue
Working Memory M 12.05***
Digit Span† 121 3.04 0.38 75 3.33 0.41 A 25.12***
Digit Span Backward† 121 2.14 0.26 75 2.29 0.29 A 15.70***
Letter-Number (LNS) 121 9.55 2.62 75 11.73 2.39 A 34.53***
Arithmetic 121 11.42 2.79 75 11.48 2.89 A 0.03
Visual Memory M 7.54***
Visual immediate 125 91.00 15.96 77 98.84 16.71 A 11.06***
Visual delayed 125 93.04 14.78 77 101.34 14.45 A 15.00***
Auditory memory M 5.11**
Auditory immediate 125 98.86 15.89 78 107.32 13.69 A 15.35***
Auditory delayed 125 99.87 14.86 78 107.23 13.98 A 13.09***
Auditory recognition 125 101.08 15.69 78 106.03 13.30 A 5.74**
*** p<.001; ** p<.01; * p<.05; † transformed scores reported
A=ANOVA, M=MANOVA
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6.2.1.3 Cognitive processing speed, control and mental flexibility
6.2.1.3.1 Response speed
Differences in response speed were analysed using Digit Symbol Substitution,
CALCAP (simple) and Trails A tests. The 3 variables were analysed separately, as
different statistical tests were appropriate for each one.
An independent two-way ANOVA revealed that there was a significant main effect of
Group on Digit Symbol scores (F(1,197)=32.81, p<.001, ηp
2=.14), but no effect of
Working Status and no significant interaction between these variables (F<1 for both).
This suggests that the exposed cohort were significantly impaired on response speed
and this pattern was similar for both the working and retired groups.
A similar deficit was found for Trails A performance, with the exposed participants
performing significantly worse than the controls overall (U=2726, p<.001), and when
broken down into working and retired cohorts (U=860, p<.01; U=503, p<.001
respectively).
In addition to these tests the CALCAP (simple) results were analyzed overall, and for
both the working and retired cohorts. For this test participants were scored nominally
by categorizing their performance as either normal or abnormal. Performance was
defined as abnormal when scores lay more than 2 standard deviations away from the
mean (see Table 6.12 for a breakdown of this).
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Table 6.12 Breakdown of the Expected vs Observed instances of Normal and Abnormal
performance on CALCAP (simple).
Normal Abnormal Total
Total Participants
Exposed
Observed 103 17 120
Expected 107.7 12.3
Control
Observed 63 2 65
Expected 58.3 6.7
Total 166 19 185
Working Participants
Exposed
Observed 56 6 62
Expected 57.4 4.6
Control
Observed 32 1 33
Expected 30.6 2.4
Total 88 7 95
Retired Participants
Exposed
Observed 47 11 58
Expected 50.3 7.7
Control
Observed 31 1 32
Expected 27.7 4.3
Total 78 12 90
Overall, 14.2% of the exposed participants performed abnormally on this test, compared
to 3.1% of the controls, which was found to be significant (χ²(1)= 5.63, p<.05).  
However, when broken down for the two working status groups, this difference was
only found to be significant for the retired cohort (working: χ²(1)=1.39, ns; retired:
χ²(1)= 4.48, p<.05). 
To summarise, the exposed cohort appear to be impaired on measures of response
speed.
6.2.1.3.2 Fine motor control
As organophosphates can damage the peripheral nerves, a measure of fine motor control
was included into the test battery in the form of the grooved peg board. Mann Whitney
U tests were used to investigate whether there was a significant deficit in the exposed
cohort.
Overall, the exposed participants were found to perform significantly worse than the
controls on the Grooved Peg Board for both the dominant (U=2235, p<.001) and non-
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dominant hand (U=2554.50, p<.001).
When broken down into working status the same pattern was found for the working
(dominant hand: U=468, p<.001; non-dominant hand: U=610.50, p<.001) and retired
cohort (dominant hand: U=562.50, p<.001; non-dominant hand: U=606., p=.001).
6.2.1.3.3 Executive function
Participants’ performance on measures of executive function were examined in three
ways: 1.) tests of mental flexibility and participant’s ability to switch between tasks by
successfully inhibiting responses to certain stimuli were measured using CALCAP-
choice, Trails B and Stroop. 2.) Participants’ ability to use successful strategies to
complete tasks was examined using Verbal Fluency. 3.) Participants’ Verbal and Visual
Reasoning Skills were examined using Picture Arrangement, Comprehension and
Similarities.
6.2.1.3.3.1 Mental flexibility & inhibition
Mann Whitney U tests revealed that the exposed participants were significantly
impaired on Trails B compared to matched controls overall (U=2835.5, p<.001), and
when broken down into working and retired cohorts (U=769.5, p=.001; U=643.5,
p<.001 respectively).
On CALCAP (choice) 24.2% of the exposed participants exhibited abnormal
performance, compared to 9.2% of the controls, which was a significant difference
(χ²(1)=6.13, p<.05).   However, when this was broken down for the two working status 
groups, it was only found to be significant for the retired cohort (working: χ²(1)=.90, ns;
retired: χ²(1)= 6.11, p<.05). 
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Table 6.13 Breakdown of the Expected vs Observed instances of Normal and Abnormal
performance on CALCAP (choice).
Normal Abnormal Total
Total Participants
Exposed
Observed 91 29 120
Expected 97.3 22.7
Control
Observed 59 6 65
Expected 52.7 12.3
Total 150 35 185
Working Participants
Exposed
Observed 52 10 62
Expected 53.5 8.5
Control
Observed 30 3 33
Expected 28.5 4.5
Total 82 13 95
Retired Participants
Exposed
Observed 39 19 58
Expected 43.8 14.2
Control
Observed 29 3 32
Expected 24.2 7.8
Total 68 22 90
In addition to this the Stroop test was examined. The Stroop test is a measure of mental
flexibility, in particular, the ability to switch between competing response modes. The
manual that accompanies the Stroop neuropsychological screening test provides
normative data for healthy and brain damaged populations and cutoff scores for
abnormality, stratified by age.
The analysis revealed that 14.2% of the exposed participants failed the Stroop test,
compared to only 1.5% of the controls, which was a significant difference (χ²(1)=15.84, 
p<.001). However, when this was broken down for the two working status groups, it
was only found to be significant for the retired cohort (working: χ²(1)=5.65, p<.06; 
retired: χ²(1)= 11.77, p<.01). 
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Table 6.14 Breakdown of the Expected vs Observed instances of passes and fails on the Stroop.
Pass Fail Total
Total Participants
Exposed
Observed 94 29 123
Expected 104.7 19.8
Control
Observed 75 3 78
Expected 64.3 12.2
Total 169 32 201
Working Participants
Exposed
Observed 49 16 65
Expected 53.6 12.1
Control
Observed 35 3 38
Expected 30.4 6.9
Total 84 19 103
Retired Participants
Exposed
Observed 45 13 58
Expected 51 7.8
Control
Observed 40 0 40
Expected 34 5.2
Total 85 13 98
To summarise, the above results suggest that the exposed cohort were significantly
impaired on measures of mental flexibility and that this pattern was more pronounced in
the retired group.
6.2.1.3.3.2 Strategy making
An independent two-way ANOVA revealed that there was a significant main effect of
Group on verbal fluency scores (F(1,200)=50.21, p<.001, ηp
2=.20), but no effect of
Working Status (F<1) and no significant interaction between these variables
(F(1,200)=3.61, p=.06, ηp
2=.02). This suggests a deficit in strategy making ability in the
exposed cohort, with a similar pattern for both the working and retired groups.
However, it is of note that Levene’s test of homogeneity of variance was significant in
this case (F(3,200)=4.02, p<.01), thus these findings should be interpreted with caution.
Mann Whitney U tests (which do not assume equality of variance) confirmed this
pattern, with the exposed group performing significantly worse that the controls on
verbal fluency overall (U=2244, p<.001), and when broken down into the working and
retired cohorts (U=655.5, p<.001; U=479, p<.001 respectively).
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Table 6.15 IMPAIRED domains - Main effects of group on performance on tests of response speed
and mental flexibility and descriptive statistics and univariate effects of exposure group on
cognitive performance.
Exposed Control
Cognitive Area N Mean SD N Mean SD Tests FValue
Response speed
Digit Symbol 126 2.94 0.42 75 3.27 0.33 A 32.81***
Trails A 127 41.03 15.30 74 32.27 13.05 U 2726***
CALCAP simple X2 see text
Fine Motor Control
Grooved Pegboard
Dominant Hand (RT) 124 92.65 24.51 74 75.08 11.89 U 2235***
Grooved Pegboard
Non-Dominant Hand
(RT) 123 96.49 22.47 73 81.12 13.92 U 2554.5***
Mental Flexibility
Trails B 124 96.26 44.74 77 71.03 30.79 U 2835.5***
Stroop X2 see text
CALCAP choice X2 see text
Strategy Making
Verbal fluency 127 32.88 11.51 77 44.21 10.47 A 50.21***
*** p<.001; ** p<.01; * p<.05
A=ANOVA, U=Mann-Whitney, X2=Chi Square
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6.2.2 Intact cognitive domains
6.2.2.1 Verbal and visuo-spatial ability and reasoning skills
6.2.2.1.1 Verbal ability
Participants’ performance on verbal ability was assessed using Vocab, Graded Naming
and Comprehension. A two way independent MANOVA revealed no significant main
effects or interactions (largest V=.03, largest F=1.81). These results suggest that verbal
abilities are largely intact.
6.2.2.1.2 Visuo-spatial abilities
Differences in visuo-spatial abilities were analysed using Block Design and Spatial
Span. A two way independent MANOVA revealed no significant main effects or
interactions (largest V=.02, largest F=1.65). These results suggest that visuo-spatial
abilities are largely intact.
6.2.2.1.3 Verbal & visual reasoning
In order to investigate whether there was a significant effect of Exposure Group or
Working Status on Verbal and Visual Reasoning Skills, scores on Similarities,
Comprehension and Picture Arrangement were entered into a two way independent
multivariate analysis of variance (MANOVA). Pillai’s trace revealed no significant
main effects or interactions (highest V =.04; highest F=2.27).
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Table 6.16 INTACT domains - Main effects of group on performance on tests of verbal and visuo-
spatial ability, reasoning and general intellectual function and descriptive statistics and univariate
effects of exposure group on cognitive performance.
Exposed Control
Cognitive Area N Mean SD N Mean SD Tests FValue
Verbal Ability M 1.81
Vocabulary 119 10.39 2.43 73 10.99 1.90 A 3.45
Comprehension 119 10.84 2.64 73 11.41 2.05 A 2.75
Graded Naming 119 12.41 1.28 73 12.78 1.12 A 4.41*
Visuo-spatial ability M 1.65
Block Design 125 11.98 2.84 76 12.17 3.19 A 0.22
Spatial Span 125 10.10 2.64 76 10.83 3.14 A 3.21
Verbal/Visual
Reasoning M 2.45
Picture Arrangement 119 9.92 2.70 69 10.96 2.78 A 6.58*
Similarities 119 2.32 0.25 69 2.37 0.17 A 2.75
Comprehension 119 10.84 2.64 69 11.28 2.13 A 1.66
*** p<.001; ** p<.01; * p<.05
A=ANOVA, M=MANOVA
6.2.3 Summary
Overall, the results seen in this chapter illustrate a pattern of patchy under functioning in
some, but not all areas of cognitive performance in the exposed cohort. These findings
are summarised in Table 6.17.
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Table 6.17 Areas of cognitive deficit in the exposed cohort
Cognitive Domain Function Status
General Intellectual Ability Impaired
Working Memory Impaired
Visual Memory Impaired
Auditory Memory Impaired
Response Speed Impaired
Fine Motor Control Impaired
Mental Flexibility & Inhibition Impaired
Strategy Making Impaired
Verbal Ability Intact
Visio-Spatial Abilities Intact
Verbal & Visual Reasoning Ability Intact
While the results suggest a that long-term, low-level exposure to OPs may cause a
significant pattern of cognitive deficit, it does not take into account possibility that the
observed finding may have been due to other, extraneous variables inherent in the
exposed cohort (but not the control group). Indeed, it may be that the pattern of results
could be explained by other variables intrinsic to the exposed cohort that have not been
considered in this analysis. As such, the next chapter will address a specific set of
possible covariates known to influence cognitive function, in order to assess the validity
of the above findings. Specifically, the next chapter will seek to address the following
questions:
(1) Could the pattern of deficit be due to mood disorder rather than exposure to OPs?
(2) Could the pattern of deficit observed above have been driven by inclusion of study
participants with undiagnosed acute exposure?
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Chapter 7 Further analyses: Exploring the exposed cohort
7.1 Could the pattern of deficit observed be due to mood disorder rather than
exposure to OPs? Re-analysis of the data controlling for the effects of mood.
Previous research has shown that depression and anxiety can significantly alter
cognitive performance (Baddeley, Wilson & Watts, 1995). Opinions differ as to the
nature, extent and aetiology of cognitive impairment in anxious and depressed patients.
This may reflect the different methodologies used by investigators, the populations
studied and failure to control for potentially confounding variables such as medication
and differences in intellectual ability between control subjects and study participants.
Depressed patients often perceive their memory functioning to be worse than it actually
is with complaints about memory outstripping actual performance on psychometric
tests. Although some investigators have found differences between control subjects and
depressed patients on some information-processing speed and memory tests (prose
recall, list learning, design learning, but working memory is usually intact; Watts, 1996;
Zakzanisi, Leach and Kaplan, 1998), mood disorder is associated with a lesser degree of
impairment than organic brain damage (Coughlan and Hollows, 1984; Watts, 1996).
Differences in task performance between control subjects and those who are depressed
are either non-existent or frequently small (less than one standard deviation) and this
has led some researchers to suggest that poor performance may be secondary to lack of
motivation. Indeed, depressed patients frequently show errors of omission or give ‘don’t
know’ responses, suggesting a lack of effort (Lezak, 1995). Impaired functioning is
more common in patients with moderate to severe depression, in older patients (mean
age more than 50 years) and those who take antidepressant medication (Austin, et al,
1999; Paradisio, Lamberty, Garvey & Robinson, 1997; Zakzanisi et al, 1998). Studies
on younger, unmedicated patients (mean age 32-39 years) with mild to moderate levels
of depression find few differences in task performance between control subjects and
those who are depressed (Grant, Thase and Sweeney, 2001; Porter, Gallagher,
Thompson & Young, 2003).
Trait anxiety seems to have little effect on performance but state anxiety has opposing
effects on high and low ability subjects. Anxiety often enhances the performance of
high ability subjects, but has a deleterious effect on low ability subjects. Working
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memory span is frequently affected by anxiety, whilst performance on other memory
tests is often within normal limits, though subjects may have to expend more effort to
succeed. Performance deteriorates when task demands are increased and if subjects
experience failure (Watts, 1996).
This chapter intends to address the question of whether the observed cognitive deficit
seen in the farming cohort in the previous chapter is due to mood disorder rather than
exposure to OPs. Study participants were asked to complete the Hospital Anxiety and
Depression Scale (HAD), a screening tool for anxiety and depression which was
designed for use with patients who may suffer concurrent physical illness. Figure 7.1
shows the proportion of participants in each group with clinically significant depression
and anxiety scores on the HAD. 45.9% of farmers had scores above clinical cut-offs for
depression compared to only 6.6% controls; and 41 % of farmers scored in the clinical
range for anxiety compared to only 22.4% of controls. The incidence of depression and
anxiety was particularly high amongst retired farmers.
Figure 7.1 Proportion of participants in each group with clinically significant depression and
anxiety scores on the Hospital Anxiety and Depression Scale.
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Table 7.1 Mean scores on the Hospital Anxiety and Depression Scale for the controls and exposed
participants in both the working and retired groups.
HADS Anxiety Score HADS Depression Score
N Range Mean SD Range Mean SD
Exposed Working 64 0-16 6.19 4.15 0-15 4.61 3.76
Retired 58 3-17 8.98 4.09 0-17 9.40 4.15
Control Working 37 0-10 3.76 3.09 0-8 2.41 2.34
Retired 39 0-14 5.03 3.41 0-9 3.28 2.74
Table 7.1 shows the mean HAD scores for the different groups. As all anxiety and
depression scores were distributed abnormally, as series of Mann Whitney U tests were
carried out to investigate group differences for the working and retired cohorts.
Exposed participants obtained significantly higher scores on the depression subscale of
the HAD than the controls for both the working and retired cohorts (U=762.5, p<.01;
U=267, p<.001 respectively) and the same was true for anxiety scores (HADS working:
U=759.5, p<.01; HADS retired: U=536.5, p<.001).
As previous research has shown that depression and anxiety may be related to poor
performance on certain psychometric tests (Baddeley, Wilson & Watts, 1995) and as
there are differences in mood scores between the different exposure and employment
groups, it is therefore standard practice to take account of participants’ mood scores
when analysing their performance on neuropsychological tests.
In order to do this the original analyses on cognitive performance were re-run with the
effects of mood partialled out. This was done by re-running the above ANOVAs and
MANOVAs with age scaled variables, but by including depression and anxiety scores
as covariates. While all depression and anxiety scores were extremely skewed and
kurtotic, the HADS anxiety and depression scores were able to be normalised using a
simple squareroot transformation (a constant of 1 was added to all raw scores as the
lowest score was 0, prior to transformation). As such, these transformed variables were
used to control for mood and anxiety in the parametric tests.
Re-analysis of the non-parametric tests are described separately as a different method to
control for depression and anxiety was used. In this case, participants with any signs of
depression and/or anxiety according to the HAD scale were removed from the analysis
entirely.
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7.1.1 Originally impaired cognitive domains
7.1.1.1 Intellectual function
An independent two-way ANCOVA (with depression and anxiety scores on the HADS
as covariates) revealed that there was a significant main effect of Group on current IQ,
as measured by the full-scale WAIS (F(1,184)=7.57, p<.01, ηp
2=.04), with the exposed
group exhibiting a significantly lower IQ than the controls even after controlling for
mood and anxiety levels. No relationship was found between the covariates and IQ
(F<1 for both) and no effect of Working Status was found (F<1). There was also no
significant interaction between these variables (F(1,192)=2.33, p=.13, ηp
2=.01).
Subsequent analyses reveal the exposed cohort exhibit reduced performance on specific
cognitive tests (not all intellectual tests) which is associated with exposure to OPs (see
following chapters) and is unlikely to reflect pre-existing differences in overall
premorbid IQ between the control and exposed cohorts.
7.1.1.2 Working memory
Differences in working memory were re-analysed using Digit Span, Digit Span
Backwards, Letter-Number Sequencing and Arithmetic subtests and with HADS
depression and anxiety scores as covariates. A two way independent MANCOVA,
revealed that neither HADSA (V=.02, F<1) nor HADSD scores (V=.03, F(4,181)=1.45,
p=.22, ηp
2=.03) were significantly related to working memory; and after controlling for
the effect of these variables, a significant main effect of Exposure Group on working
memory was found (V=.16, F(4,181)=8.48, p<.001, ηp
2=.16). Again, no effect of
Working Status (V=.02, F(4,181)=1.08, p=.37, ηp
2=.02) and no significant interaction
between the independent variables (V=.02, F(4,181)=1.08, p=.37, ηp
2=.02) were found.
These results suggest that the exposed cohort were significantly impaired on measures
of working memory, even after the effects of mood and anxiety had been partialled out;
and this pattern was similar for both the working and retired groups.
Follow-up univariate tests, also controlling for HADSA and HADSD scores
(summarized in Table 7.2) revealed that this main effect of group on working memory
was driven by group differences in Digit Span, Digit Span Backwards and Letter-
Number Sequencing performance.
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7.1.1.3 Visual memory
As with working memory, the effect of exposure and working status on visual memory
was re-analysed with HADS depression and anxiety scores as covariates. Using Visual
Immediate Memory and Visual Delayed Memory as dependent variables, a two way
independent MANCOVA revealed no significant relationship between either depression
or anxiety and visual memory (largest V=.002, F<1 for both). Again, the difference
between the exposed and control participants was found to be significant (V=.07,
F(2,189)=6.97, p=.001, ηp
2=.07), even after removing the potential effect of mood and
anxiety. No effect of Working Status was found (V=.01, F(2,189)=1.07, p=.34,
ηp
2=.01) and there was no significant interaction between these variables (F<1). To
summarise, these results suggest that after controlling for mood and anxiety, the
exposed cohort were significantly impaired on measures of visual memory and this
pattern was similar for both the working and retired groups.
Follow-up univariate tests (summarized in Table 7.2) revealed that this main effect of
group on visual memory was the product of group differences in both immediate and
delayed visual memory (again, after partialling out HADS anxiety and depression
scores).
7.1.1.4 Auditory verbal memory
Differences in auditory memory and information processing were re-analysed using
Auditory Immediate Memory, Auditory Delayed Memory and Auditory Recognition
Delayed Index Scores as dependent variables, and HADSA and HADSD scores as
covariates. A two way independent MANCOVA revealed no significant relationship
between auditory memory and depression (F<1) or anxiety (V=.02, F(3,189)=1.28,
p=.28, ηp
2=.02). After controlling for these effects, a significant multivariate effect of
Exposure Group on auditory memory was found (V=.06, F(3,189)=4.05, p<.01,
ηp
2=.06), in which the exposed cohort performed worse than the controls. No effect of
Working Status was found and there was no significant interaction between these
variables (largest V=.02; largest F=1.12).
Follow-up univariate tests controlling for the effect of depression and anxiety
(summarized in Table 7.2) revealed that this main effect of group on auditory memory
was the result of group differences in immediate, delayed and recognition aspects of
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auditory memory.
7.1.1.5 Response speed
Differences in response speed were analysed parametrically using Digit Symbol
Substitution. An independent two-way ANCOVA using HADSA and HADSD scores
as covariates revealed that there was no significant relationship between Digit Symbol
scores and either anxiety (F(1,188)=1.44, p=.23, ηp
2<.01) or depression (F(1,188)=2.92,
p>.05, ηp
2=.01) scores. The significant main effect of Group on Digit Symbol scores
held true (F(1,188)=19.87, p<.001, ηp
2=.10) even after the influence of mood was
partialled out. No effect of Working Status and no significant interaction between these
variables was found (F<1 for both). This suggests that even after controlling for the
possible influence of depression and anxiety, the exposed cohort were significantly
impaired on response speed and this pattern was similar for both the working and retired
groups.
7.1.1.5.1 Response speed: Non-parametric analyses
As response speed measures Trails A and CALCAP (simple) cannot be analysed
parametrically (see Section 6.2) mood and anxiety needed to be controlled for in a
different manner for these variables. To try and remove the possible influence of mood
on cognitive ability, the participants were split into groups according to their scores on
the Hospital Anxiety and Depression Scales. The HAD is a diagnostic screening tool
and the standard cutoff score of 8 was used to determine clinical caseness. Score below
8 are considered normal and participants who obtained scores greater than 8 on either
the depression or anxiety subscale were removed from the analyses. Non-parametric
analyses were then rerun, having removed the influence of mood, with the following
outcomes:
Mann-Whitney U tests on Trails A performance found that the exposed participants
performed significantly worse than the controls for the working group (U=423.5,
p<.05), however this did not reach significance in the retired cohort (U=79, p=.06).
With regard to simple reaction time, 9.6% of exposed participants performed
abnormally on the CALCAP (simple) test, compared to 0% of controls, which was
found to be significant (χ²(1)= 5.06, p<.05).  However, when broken down for the two 
working status groups, this difference was only found to be significant for the retired
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cohort (working: χ²(1)=2.02, ns; retired: (χ²(1)= 4.39, p<.05).
The above results indicate that response speed deficits were evident in the exposed
cohort, even after controlling for the potentially confounding effects of depression and
anxiety.
7.1.1.6 Fine motor control
As Grooved Peg Board scores could not be analysed parametrically, analysis controlled
for mood and anxiety using the same method outlined in the previous section.
Mann-Whitney U tests on Grooved Peg Board scores for the dominant hand revealed
that the exposed participants were found to perform significantly worse than the
controls in both the working and retired cohorts (U=246, p<.001; U=67, p<.05
respectively). This pattern was replicated for non-dominant hand scores (working:
U=315.5, p=.001; retired: U=71, p<.05). Overall, this suggests an impairment in fine
motor control for the exposed cohort after controlling for mood and anxiety issues.
7.1.1.7 Executive function: Strategy making
An independent two-way ANCOVA with anxiety and depression scores as covariates
revealed that there was no relationship between verbal fluency and HAD depression
scores (F<1), but there was a significant relationship with anxiety (F(1,191)=4.68,
p<.05, ηp
2=.02). Nevertheless, a significant main effect of Group on verbal fluency
scores was still found (F(1,191)=46.93, p<.001, ηp
2=.20) even after the effects of mood
were partialled out. Again, no effect of Working Status (F<1) was found. However in
this case there was a significant interaction between these variables was found
(F(1,191)=4.01, p>.05, ηp
2=.02), with working farmers performing better than retired
farmers (means=33.52 and 30.84 respectively), while the opposite pattern was observed
in the control group (working control mean = 42.97; retired control mean = 46.97).
This suggests a deficit in strategy making ability in the exposed cohort even after
controlling for anxiety and depression, however the reason behind the interaction with
working status is unclear.
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7.1.1.8 Executive function: Mental flexibility & inhibition
Non-parametric analyses were carried out controlling for mood in the way outlined in
section 7.1.2.5.1. Mann-Whitney U tests on Trails B performance found that the
exposed participants performed significantly worse than the controls for both the
working and retired cohorts (U=385.5, p<.01; U=67, p<.05 respectively).
With regard to choice reaction time, 15.4% of exposed participants performed
abnormally on CALCAP (choice), compared to 12% of controls and no significant
difference was found for between exposed and control subjects or working status groups
(χ²(1)= 0.25, ns; working: χ²(1)<1, ns;  retired: χ²(1)= 1.35, ns).
With regard to mental flexibility, 22.2% of the exposed participants failed the Stroop
test, compared to only 1.8% of the controls, which was a significant difference
(χ²(1)=11.24, p<.001), for the two working status groups (working: χ²(1)=5.08, p<.05; 
retired: χ²(1)= 5.91, p<.05). 
While differences in CALCAP (choice) scores did not differ according to exposure,
significant deficits were evident for mental flexibility and inhibition in terms of Trails B
and Stroop, indicating that the exposed cohort are impaired on this dimension, even
after controlling for depression and anxiety.
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Table 7.2 Impaired domains after including depression and anxiety scores and covariates in
parametric analyses.
Exposed Control
Cognitive Area N Mean SE N Mean SE Tests FValue
Working Memory Mc 8.48***
Digit Span† 117 3.04 0.04 73 3.34 0.05 Ac 20.15***
Digit Span Backward† 117 2.14 0.03 73 2.28 0.03 Ac 8.58**
Letter-Number (LNS) 117 9.54 0.25 73 11.70 0.32 Ac 24.83***
Arithmetic 117 11.31 0.27 73 11.74 0.35 Ac 0.80
Visual Memory Mc 6.97***
Visual immediate 121 90.79 1.59 75 99.79 2.06 Ac 10.55***
Visual delayed 121 93.15 1.42 75 102.34 1.84 Ac 13.81***
Auditory memory Mc 4.05**
Auditory immediate 121 99.05 1.44 76 107.01 1.86 Ac 10.05***
Auditory delayed 121 99.44 1.37 76 107.75 1.77 Ac 12.08***
Auditory recognition 121 100.99 1.45 76 105.88 1.87 Ac 3.75*
Response speed
Digit Symbol † 121 2.96 0.04 73 3.25 0.05 Ac 19.87***
Strategy Making
Verbal fluency 122 32.18 1.06 75 44.97 1.39 Ac 46.93***
*** p<.001; ** p<.01; * p=.05; † transformed scores reported
Ac=ANCOVA, Mc=MANCOVA
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7.1.2 Summary
To examine whether the patterns of deficit observed in the initial analysis could have
been driven by the potentially confounding effects of anxiety and depression on
cognitive performance, the data was re-analysed after controlling the effects of mood
statistically or removing all farmers who scored in the clinical range for anxiety and/or
depression on the HAD scale. The same areas of deficit remained after the effects of
anxiety and depression were removed, with only three minor changes, involving the
influence of working status, but not exposure group, on tests of executive function and
motor speed (stroop, verbal fluency and Trails A); and one significant exception which
involved choice reaction time results. In the initial analyses a significant difference was
found between exposed and control subjects on CALCAP choice results, but this
difference was lost during follow-up analyses which controlled for mood.
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7.2 Could the pattern of deficit observed above have been driven by inclusion
of study participants with undiagnosed acute exposure? Re-analysis of the data
after removal of participants who report a history of ‘dippers flu’.
The previous section sought to address the question of whether cognitive deficits
evident in the farming cohort were secondary to mood disorder. The findings illustrated
that, generally, the original deficit pattern seen in Chapter 6 remained, even after
controlling for mood. While this suggests the cognitive deficits may be a product of
long-term low level exposure to organophosphates, another fundamental question needs
to be addressed before this explanation can be accepted: whether the observed deficits
are due to accidental inclusion of study participants with a history of acute exposure.
The aim of the current study is to determine whether repeated low level exposure to OPs
is harmful to human health, so individuals with a history of high level exposure and
acute poisoning were excluded. However, the definition of acute poisoning is that which
results in symptoms of acute toxicity of such severity that people seek medical help.
However, research has shown that variables other then severity of illness determine
whether individuals consult physicians (Pitts & Phillips, 1991) and the incidence of GP
visits per capita are notoriously low in the country (British Medical Association, 2005).
It may be a mistake to rely on measures of acute exposure which are defined by medical
help-seeking behaviour as a definition of this kind may under-estimate instances of
acute poisoning. Instead, it may be prudent to consider symptom-based diagnostic
criteria for acute exposure. A number of participants (33.8% of the working cohort and
50.9% of the retired group) reported that throughout their working life they suffered
repeated episodes of flu-like symptoms following exposure to OPs. The farming
community refers to this phenomenon as ‘dippers flu’. The cause and nature of ‘dippers
flu’ has not been established scientifically, but the symptoms have much in common
with those associated with mild exposure to organophosphate compounds and appear to
share a temporal relationship with exposure to sheep dip. Hence, ‘dippers flu’ may
reflect undiagnosed, untreated acute toxicity (Cherry, Mackness, Mackness, Dippnall &
Povey, 2011).
The aim of this section is to determine whether the observed pattern of cognitive
deficits seen in Chapter 6 could be explained by inclusion of participants with
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undiagnosed acute exposure. To examine whether the patterns of deficit observed in the
initial analysis could have been driven by participants with undiagnosed acute exposure,
the data was re-analysed after removing all farmers who had experienced ‘dippers flu’
(and those for which this information was not available, n=5). This left a total of 43
working and 28 retired farmers. A chi-square test revealed no significant difference
between working and retired farmers in terms of how many reported ‘dippers flu’
(χ² (1)= 3.62, ns).
The results are described below.
7.2.1 Originally impaired cognitive domains
7.2.1.1 General intellectual function
While participants were matched on pre-morbid intellectual ability using matrix
reasoning, an independent two-way ANOVA revealed that there was a significant main
effect of Group on current IQ, as measured by the full-scale WAIS (F(1,139)=8.66,
p<.01, ηp
2=.06), with the exposed group exhibiting a significantly lower IQ than the
controls. No effect of Working Status was found (F<1), however the interaction
between these variables reached marginal significance (F(1,139)=3.92, p=.05, ηp
2=.03).
This suggests that the exposed cohort were significantly impaired on general intellectual
functioning. While the working cohort had a higher IQ score than the retired
participants in the exposed group (means = 106.69; 101.74 respectively), the opposite
was true for the controls (working mean = 108.61; retired mean = 111.53).
7.2.1.2 Working memory
Differences in working memory were analysed using Digit Span, Digit Span
Backwards, Letter-Number Sequencing and Arithmetic subtests. A two way
independent MANOVA revealed a significant main effect of Exposure Group on
working memory (V=.19, F(4,136)=8.07, p<.001, ηp
2=.19), but no effect of Working
Status (V=.03, F(4,136)=1.06, p=.38, ηp
2=.03) and no significant interaction between
these variables (F<1). These results suggest that the exposed cohort were significantly
impaired on measures of working memory and this pattern was similar for both the
working and retired groups.
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Follow-up univariate tests (summarized in Table 7.3) revealed that this main effect of
group on working memory was driven by group differences in Digit Span, Digit Span
Backwards and Letter-Number Sequencing performance.
7.2.1.3 Visual memory
Differences in visual memory were analysed using Visual Immediate Memory and
Visual Delayed Memory. A two way independent MANOVA revealed the difference
between the exposed and control participants to be a significant one (V=.08,
F(2,142)=6.41, p=.002, ηp
2=.08). No effect of Working Status was found and there was
no significant interaction between these variables (F<1 for both). To summarise, these
results suggest that the exposed cohort were significantly impaired on measures of
visual memory and this pattern was similar for both the working and retired groups.
Follow-up univariate tests (summarized in Table 7.3) revealed that this main effect of
group on visual memory was the product of group differences in both immediate and
delayed visual memory.
7.2.1.4 Auditory memory and information processing
Differences in auditory memory and information processing were analysed using
Auditory Immediate Memory, Auditory Delayed Memory and Auditory Recognition
Delayed Index Scores. A two way independent MANOVA revealed a significant
multivariate effect of Exposure Group on auditory memory and information processing
scores (V=.07, F(3,142)=3.56, p<.05, ηp
2=.07) which the exposed cohort performed
worse than the controls. No effect of Working Status was found and there was no
significant interaction between these variables (largest V=.04; largest F=2.14).
Follow-up univariate tests (summarized in Table 7.3) revealed that this main effect of
group on auditory memory was the result of group differences in immediate, delayed
and recognition aspects of auditory memory.
7.2.1.5 Response speed
Differences in response speed were analysed using Digit Symbol Substitution,
CALCAP (simple) and Trails A tests. The 3 variables were analysed separately, as
different statistical tests were appropriate for each one.
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An independent two-way ANOVA revealed that there was a significant main effect of
Group on Digit Symbol scores (F(1,142)=29.82, p<.001, ηp
2=.17), but no effect of
Working Status and no significant interaction between these variables (largest F=1.10).
This suggests that the exposed cohort were significantly impaired on response speed
and this pattern was similar for both the working and retired groups.
A similar deficit was found for Trails A performance, with the exposed participants
performing significantly worse than the controls in both the working and retired cohorts
(U=583.5, p<.05; U=208, p<.001 respectively).
With regard to simple reaction time, 6.8% of exposed participants performed
abnormally on the CALCAP (simple) test, compared to 1.5% of controls, which was
found to be significant (χ²(1)= 4.63, p<.05).  However, when broken down for the two 
working status groups, this difference was only found to be significant for the retired
cohort (working: χ²(1)=1.38, ns; retired: χ²(1)= 3.80, p=.05). 
To summarise, the exposed cohort appear to be impaired on measures of response
speed.
7.2.1.6. Fine motor control
As before, scores on the Grooved Peg Board task were analysed for both the dominant
and non-dominant hand).
When broken down into working status the exposed participants were found to perform
significantly worse than the controls for both hands, in both the working (dominant
hand: U=345, p<.001; non-dominant hand: U=383.5, p<.001) and retired cohorts
(dominant hand: U=228.5, p<.001; non-dominant hand: U=218, p<.001).
7.2.1.7 Executive function: Mental flexibility & inhibition
Mann Whitney U tests revealed that the exposed participants were significantly
impaired on Trails B in both the working and retired cohorts (U=515, p<.01; U=294,
p<.01 respectively).
With regard to choice reaction time, 11.4% of exposed participants performed
abnormally on CALCAP (choice), compared to 4.5% of controls which was found to be
significant (χ²(1)=4.27, p<.05). However, when broken down for the two working status 
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groups, this difference was only found to be significant for the retired cohort (working:
χ²<1 ns; retired: χ²(1)= 7.96, p=.01). 
With regard to mental flexibility, 11.4% of the exposed participants failed the Stroop
test, compared to only 2% of the controls, which was a significant difference
(χ²(1)=14.28,  which occurred in both of the working status groups (working: 
χ²(1)=6.50, p<.05; retired: χ²(1)=7.71, p<.01). 
To summarise, the above results suggest that the exposed cohort were significantly
impaired on measures of mental flexibility and that this pattern was more pronounced in
the retired group (based on CALCAP analyses).
7.2.1.8 Executive function: Strategy making
An independent two-way ANOVA revealed that there was a significant main effect of
Group on verbal fluency scores (F(1,144)=30.23, p<.001, ηp
2=.17), but no effect of
Working Status (F(1,144)=2.38, p=.13, ηp
2=.02) and no significant interaction between
these variables (F<1). This suggests a deficit in strategy making ability in the exposed
cohort, with a similar pattern for both the working and retired groups. However, it is of
note that Levene’s test of homogeneity of variance was significant in this case
(F(3,144)=4.48, p<.01), thus these findings should be interpreted with caution.
7.2.2 Summary
To examine whether the patterns of deficit observed in the initial analysis could have
been driven by unintentional inclusion of participants with a history of undiagnosed
acute exposure, the data was re-analysed after removing all farmers who had
experienced ‘dippers flu’. The same areas of deficit remained even after removal of
these subjects with only two minor changes, one involving the influence of working
status, but not exposure group, on a test of executive function (Stroop); and one
involving an interaction between working status and exposure group in relation to
overall, full scale IQ. These findings indicate that the pattern of deficit observed in the
initial analyses was not driven by inclusion of participants with undiagnosed acute
toxicity.
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Table 7.3 Main effects of group on parametric tests of cognitive performance that were originally
impaired, once possible acute exposure had been removed.
Exposed Control
Cognitive Area N Mean SD N Mean SD Tests FValue
Working Memory M 8.07***
Digit Span† 68 3.12 0.37 75 3.33 0.41 A 9.92**
Digit Span Backward† 68 2.18 0.26 75 2.29 0.29 A 5.82*
Letter-Number (LNS) 68 9.57 2.74 75 11.73 2.39 A 26.57***
Arithmetic 68 11.59 2.83 75 11.48 2.89 A 0.006
Visual Memory M 6.41***
Visual immediate 70 91.70 16.09 77 98.84 16.71 A 7.00**
Visual delayed 70 92.49 15.19 77 101.34 14.45 A 12.84***
Auditory memory M 3.56**
Auditory immediate 70 100.13 15.81 78 107.32 13.69 A 9.66**
Auditory delayed 70 100.69 14.54 78 107.23 13.98 A 9.85***
Auditory recognition 70 102.64 15.94 78 106.03 13.30 A 2.41
Response speed
Digit Symbol † 71 2.92 0.45 75 3.27 0.33 A 29.82***
Strategy Making
Verbal fluency 71 33.77 12.01 77 44.21 10.47 A 30.23***
*** p<.001; ** p<.01; * p<.05; † transformed scores reported
A=ANOVA, M=MANOVA
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Chapter 8 Further analyses: Exploring the control group cohort
8.1 Could the pattern of deficit observed in the initial analyses be due to
selection of an inappropriate control group (i.e. rural police workers) who differ
from farmers in some important way other than exposure history?
The previous chapters sought to establish whether the cognitive deficits observed in the
farming cohort in Chapter 6 may have been due to an intrinsic problem with the
exposed participants. Specifically, (1) whether they had mood disorder which could
explain the pattern, or (2) whether the pattern was due to the accidental inclusion of
acutely exposed participants. The results from both indicated that this was not the case.
There is, however, another issue that needs consideration when evaluating the outcome
of Chapter 6. Is it possible that the observed pattern was due to the use of an
inappropriate control group who differ from farmers in some important way other than
exposure history, resulting in exaggerated group differences?
A potential weakness of this study design which could limit the conclusions that can be
drawn from the above analyses was the recruitment of rural police workers as an
unexposed control group. Although matched to the farmers as far as possible in terms of
characteristics which may affect cognitive function (i.e. age, gender, education level,
premorbid IQ), police workers differ from farmers in terms of the exact nature of the
work they undertake, lifestyle and life experiences. Differences in performance on
neuropsychological testing between exposed farmers and unexposed rural police
workers could be due to an unidentified confounder that was not controlled for in this
study and may not reflect exposure history. Therefore, the above analyses were
repeated using normative comparison standards.
8.2 Exposed cohort versus normative comparison standards: Re-analysis of the
data using an alternative comparison group.
The neuropsychological test battery used in Chapter 6 consisted of well known, reliable
and clinically sensitive measures for which population test norms are available. For
example, the Wechsler Adult Intelligence scale and the Wechsler Memory Scale
(Wechsler scales) have been developed over many years and the current editions are the
result of extensive empirical studies in the US and UK involving a standardisation
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sample of over 2000 adults aged 16-90 years. The sample was divided into 13 age
groups and stratified on key demographic variables including age, sex, years in
education, race/ethnicity, geographic region. Extensive testing of reliability and validity
were undertaken, including validation studies on clinical populations (learning
disability, cortical and subcortical dementias, traumatic brain injury, multiple sclerosis,
epilepsy, alcohol abuse, schizophrenia). The Wechsler scales provide contemporary
normative information and interpretive tables allowing an individual’s performance on
these scales to be compared to national norms. Test norms were also available for all
other measures included in our battery.
To determine whether organophosphates have a negative effect on cognitive function,
the pattern of performance of the exposed group was compared to what one would
expect to see in the normal population.
8.2.1 Wechsler Memory Scale – III
The Wechsler Memory Scale – III (WMS-III) was used to assess working, visual and
auditory memory. Discrepancies between Intelligence (IQ) and memory are sometimes
used to evaluate memory functioning. IQ score can be used as an index of probable,
premorbid level of memory ability. Discrepancy scores between the IQ estimated
memory performance and actual memory performance were calculated to indicate
whether the exposed participants ability to learn and recall information was consistent
with what would be expected given their intellectual functioning. The WMS-III manual
provides tables which show whether a given discrepancy is statistically significant and
what percentage of the standardisation sample had a discrepancy of that magnitude.
Figure 8.1 shows the percentage of people performing on the WMS-III sub-tests at a
level seen in less than 10% of the standardisation sample. As can be seen in the graph
below, the exposed cohort were more than twice as likely to perform poorly on tests of
visual, working and general memory than the standardization sample. Retired farmers
were more likely to likely to perform poorly on tests of auditory memory, in addition to
the above.
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AI = auditory immediate memory; VI = visual immediate memory; IM = immediate memory score
(aggregate of previous variables); AD = auditory delayed memory; VD = visual delayed memory; ARD =
auditory delayed recognition memory; GM = general memory (aggregate of all scores); WM = working
memory.
Figure 8.1 Percentage of people performing on the WMS-III sub-tests at a level seen in less than
10% of the standardisation sample.
A series of binomial tests with .1 set as the proportion of expected impairment revealed
that significantly more working farmers were impaired than one would have expected
on measures of visual, immediate and general memory (VI, VD, IM, GM; p<.001 for
all) and working memory (WM; p<.01). Retired farmers were shown to be
significantly impaired on all measures (ARD and WM; p=.01, all other measures
p<.001).
8.2.2 Wechsler Adult Intelligence Scale-III
The Wechsler Adult Intelligence Scale-III (WAIS-III) was administered to assess
participants’ current intellectual functioning. The test is comprised of 11 subtests which
measure a range of cognitive functions such as working memory, response speed, verbal
ability, verbal and visual reasoning and visuo-spatial ability. Figure 8.2 depicts the
pattern of performance of study participants on the different WAIS-III subtests and
Figure 8.3 shows the percentage of people in each group with significant impairment on
WAIS sub-tests according to published test norms.
Expected
Frequency
Double
Expected
Frequency
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Vocab = vocabulary subtest; sim = similarities; arith = arithmetic; dspan = digit span; info =
information; comp = comprehension; pc = picture completion; dsymb = digit symbol; bd = block design;
mr = matrix reasoning; pa = picture arrangement.
Figure 8.2 Performance profiles on WAIS-III sub-tests (error bars represent ±2 S.E.), UK data
taken from Wycherley, Lavender, Holttum, Crawford and Mockler (2005).
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Vocab = vocabulary subtest; sim = similarities; arith = arithmetic; dspan = digit span; info =
information; comp = comprehension; pc = picture completion; dsymb = digit symbol; bd = block design;
mr = matrix reasoning; pa = picture arrangement.
Figure 8.3 Percentage of people significantly underperforming on the WAIS-III sub-tests.
From looking at Figures 8.2 and 8.3 it appears that overall the exposed cohort
performed relatively similarly to that seen in the UK population. However, they
appeared to show weaker performance on Digit Span (working memory) and Digit
Symbol (response speed) subtests. This was true for both working and retired farmers.
These findings were further investigated in terms of what one would expect to see in the
standardization sample. Again, looking at impairment levels one would only expect to
see in 10% of the standardization sample, a series of binomial tests with .1 set as the
proportion of expected impairment were carried out. Results revealed that the only
measure on which significantly more participants performed below that seen in the
general population was on Digit Symbol; and this was true for both the working and
retired cohort (p<.001 for both).
8.2.3 Additional tests
In addition to the abovementioned tests, further measures of response speed and
executive function were collected (Trails A & B, verbal fluency, Stroop). Figure 8.4
shows the proportion of people in this study who performed with levels of impairment
Expected
Frequency
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one would only expect to see in 20% of the general population. A cut-off of 20% was
selected because the norms for one of the tests (Trail Making A&B) indicated if
individuals performed below the 20th percentile but did not provide any further
information.
Figure 8.4 Percentage of people performing at a level seen in less than 20% of the standardisation
sample on measures of executive function.
A series of binomial tests with .2 set as the proportion of expected impairment were
carried out and revealed that both the working and retired farmers were significantly
overrepresented at this level of impairment on all four measures (highest p=.01). This
indicates that the OP exposed cohort performed more poorly on measures of executive
function in comparison to the general population.
In addition, participants’ performance of CALCAP simple & choice were analysed in
terms of the frequency of participants who performed less than two standard deviations
below normal. In a normal population we know that approximately 95% of the
population falls between ±2 standard deviations from the mean. As such, we would
expect to see about 2.5% of the population performing at a level of 2 standard
deviations below the mean. Figure 8.5 shows the proportion of people in this study that
performed at this level of impairment.
Expected
Frequency
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Figure 8.5 Percentage of people performing at an impairment level only expected in 2.5% of the
population, on reaction time measures.
A series of binomial tests with .025 set as the proportion of expected impairment were
carried out and revealed that both the working and retired farmers were significantly
overrepresented at this level of impairment on both CALCAP measures (highest
p=.003). This indicates that the OP exposed cohort showed significant impairments on
measures of response speed and mental flexibility in comparison to the general
population.
8.3 Summary & conclusions
In summary the findings above demonstrate that the exposed farmers showed significant
underfunctioning in some cognitive domains, summarised in Table 8.1. The overall
findings suggest that exposed participants have a consistent pattern of deficit, whether
compared to a control group (in this case, rural police workers) or in comparison to
published test norms derived from a cross section of healthy adults in the general
population. Furthermore, the findings are consistent with the study hypotheses and show
deficits on tests of working and general memory, response speed and mental flexibility,
but preserved verbal, visuo-spatial, reasoning and general intellectual functioning.
Expected
Frequency
147
Table 8.1 Areas of cognitive deficit in the exposed cohort.
Working Retired
General Intellectual Ability
Response Speed x x
Working Memory* x x
Visual Memory x x
Auditory Memory x
Verbal Abilities
Mental Flexibility & Inhibition x x
Strategy Making x x
Verbal & Visual Reasoning
Ability
Visio-Spatial Abilities
x = cognitive deficit present
* – Working memory is impaired according to performance on the WMS-III
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Chapter 9 : The issue of exposure history; descriptive information and
the relationship between cognitive function and indices of exposure.
9.1 Exposure history
9.1.1 Frequency and duration of exposure
Participants in this study had been exposed to OPs over a number of years as a result of
sheep dipping and were asked to report retrospectively on their exposure history.
Unsurprisingly, some individuals had difficulty giving precise details about the duration
and frequency of exposure (estimates were given instead) or the names of the chemical
products used. Participants used a variety of OP products of differing compositions,
most individuals using more than one product during their lifetime. Exposure history
varied considerably despite participants appearing to have similar jobs (see Table and
Figure 9.1.).
The average number of years farmers spent dipping sheep was 24.46 years (SD= 13)
and farmers typically dipped twice a year for one day and for an average of about 7
hours per day. The mean time since farmers were last involved in dipping sheep was
10.31 years ago. No significant overall differences were observed between working and
retired farmers in terms of these exposure variables.
9.1.2 Variability in the data
It is important to note that although no gross differences were found between the
working and retired farming cohorts, there is a degree of variability amongst individuals
in terms of their exposure history and this is apparent from looking at the large standard
deviations relative to means, broad ranges and differences between the mean and modes
and medians for some of the variables. Further exploration of the raw data was
undertaken to determine whether there were outliers who may be biasing the mean and
inflating the standard deviations.
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Table 9.1 Duration and frequency of exposure to sheep dip and flock size (sometimes used as a
proxy measure of exposure intensity).
Exposure variable Mean Standard
deviation
Range Median Mode Mann
Whitney U
Years spent working with OPs
Working Group
Retired Group
Total
23.05
26.11
24.46
10.72
15.17
13.01
8-49
5-66
5-66
20
24
22
10
7
10
U=1737.5
p<.466
How many times per year
Working Group
Retired Group
Total
2.14
2.03
2.09
1.78
1.38
1.58
1-15
1-10
1-15
2
2
2
2
2
2
U=1825
p<.708
No. days per year
Working Group
Retired Group
Total
3.77
2.84
3.34
6.89
3.54
5.61
0.50-30
1-21
0.50-30
1
2
1.75
1
1
1
U=1674
p<.523
Hours per day
Working Group
Retired Group
Total
6.46
6.69
6.57
2.44
2.47
2.45
1.5-13
2-12
1.5-13
6
7
7
6
8
8
U=1568
p<.381
Years since last dipped
Working Group
Retired Group
Total
9.48
11.25
10.31
8.78
7.65
8.2
0-37
0-42
0-42
7.5
10.5
9.5
2
6
2
U=1568
p<.083
Flock Size
Working Group
Retired Group
Total
791.46
1426.86
734.96
3065.35
5-3,500
3-20,000
500
500
500
300
400
300
U=1882
P<.988
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Figure 9.1 Exposure history: time spent dipping sheep.
No data entry errors were detected, but boxplots revealed a number of individuals
whose exposure history deviated from the normal pattern, though not necessarily on all
of the exposure variables simultaneously. For example, there were six individuals who
dipped sheep for between 15-30 days per year as opposed to the more usual 1-2 days
per year, yet in terms of frequency per year, they were not unusual in that five of them
dipped twice a year. Had data only been collected on the number of times per year they
dipped sheep, their increased intensity of exposure (relative to the majority of the
cohort) would not have been detected. Three individuals dipped sheep between 7-15
times per year, rather than the more typical twice a year; and six individuals had very
large flock sizes (between 2000 and 20,000). Flock size is sometimes considered a
proxy measure of exposure intensity, since it takes longer to dip large flocks of sheep.
These findings illustrate the importance of measuring many different aspects of
exposure since variables such as duration, frequency and intensity of exposure may not
always correlate. An individual may have a low frequency of exposure, but a high
intensity of exposure or vice versa, according to these findings.
9.1.3 Other exposure variables – intensity of exposure
Measures such as years spent dipping, frequency, days per year, etcetera, give an
indication of duration of exposure, but they do not necessarily provide a valid
assessment of intensity of exposure. Therefore more detailed information about work
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practices such as the primary task being performed, were collected as these variables
can affect the intensity of exposure. Farmers were asked to specify the primary role
they undertook whilst dipping and the results were as follows; 44% were responsible for
‘dunking’ sheep, which meant they stood by the dip bath and plunged each sheep under
the surface with an implement or with their feet/hands. Dunkers are frequently splashed
and soaked by sheep dip during the course of their work. 26% of farmers were
‘chuckers’ which meant they herded sheep in and out of the dipping facilities; and a tiny
minority (3%) were ‘helpers’ who rounded up sheep prior to dipping.
Previous hygiene studies of sheep dipping in the UK have shown that the principle
source of exposure to OPs is via the handling of concentrate dip and exposure to dilute
dip wash through splashing (Buchanan et al, 2001). Hence, farmers were asked if they
worked with concentrate and how often they were soaked with sheep dip during the
dipping process. The majority of working and retired farmers worked with concentrate
sheep dip (78% and 68% farmers respectively) and about half the cohort were regularly
soaked by sheep dip during the dipping process (47% working and 58% retired
farmers).
9.1.4 Dippers flu
Farmers were also asked whether they had experienced symptoms of ‘dippers flu’, a
general malaise (headaches, aching limbs, runny nose, nausea, diarrhoea) that may
occur after dipping, which may be indicative of undiagnosed acute toxicity (as
discussed in Chapter 7). A total of 40% of farmers reported a history of ‘dippers flu’
(48% retired and 33% of working).
9.1.5 Exposure metrics
Accurate estimation of exposure is critical for the validity of studies investigating the
adverse effects of exposure to pesticides and a number of different exposure metrics
have been proposed by researchers in an attempt to consider all of the different aspects
of exposure history which may be relevant. Exposure metrics vary greatly in terms of
which variables they consider important and range from simple methods whereby
different measures of frequency and duration of exposure are multiplied together to
provide an overall rating; to complex formulae which attempt to estimate intensity of
exposure, in addition to duration, by incorporating weightings for variables such as job
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activity, use of protective clothing and so on. Exposure metrics do not reflect absolute
exposure but provide a ranking within a population under study.
Two metrics were calculated in this study: a relatively simple estimate of ‘lifetime
exposure’ based on the number of days per year spent using OPs multiplied by the
number of years spent using OPs; and a more complex formula which took account of
intensity in addition to duration of exposure (‘ESK Metric’). This metric was originally
constructed by Cherrie and Robertson (1995) and involves estimating the concentration
of exposure through the skin (Csk) and area of skin contaminated (Ssk) according to job
title and multiplying this information together with the cumulative amount of time the
participants were involved in the dipping activity measured in terms of 8 hour days (t)
in other words Esk = Csk x t x Ssk. Farmers exposure history profiles, estimated by
these two metrics appear in Table 9.2.
Table 9.2 Exposure metrics - descriptive information.
EXPOSURE
METRICS
Mean Standard
deviation
Range Median Mode Mann
Whitney
Lifetime index
Working Group
Retired Group
Total
87.92
72.18
80.78
177.39
86.29
143.09
8-1020
5-504
5-1020
35
46.5
36
10
52
10
U = 1581
p=.35
ESK index
Working Group
Retired Group
Total
136.08
68.63
105.85
477.26
85.72
359.41
0.38-
2906.25
0.33-405
0.33-
2906.25
25.32
36.45
29.03
2.81
16.20
6.75
U=1534
p=.47
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Figure 9.2 Exposure history: exposure metrics.
Again, working and retired cohorts do not appear to differ significantly in terms of these
exposure metrics, but it is important to note the large standard deviations associated
with these indices. The standard deviation indicates how well the mean represents the
data and large standard deviations, relative to the mean, indicate that the data points are
distant from the mean (Field, 2000). In other words there is a considerable amount of
variability in this data. Furthermore, Figure 9.2 shows that the different metrics
produce very different means for the working cohort, while producing similar indices
for the retired, raising questions about the validity of these metrics.
9.2 Relationship between cognitive tests and exposure indices
In Chapter 6, the OP exposed cohort were found to perform significantly worse than
healthy controls on a range of psychometric tests. Thus, operationalising exposure into
“exposed” and “unexposed” groups yielded significant results. However, in this chapter
analyses are undertaken, using Spearman correlations, to determine whether there is a
linear relationship between indices of exposure and cognitive function within the
exposed cohort.
To avoid Type I error the number of variables entered into the correlation matrix were
limited. Instead of entering scores from all of the individual subtests included in the test
battery, composite z-scores were calculated so that participant’s performance in the 10
cognitive domains described in Chapter 6 could be examined in relation to exposure
history. To do this, z-scores were created for each test score so that higher scores were
interpreted as better performance (z-scores = (raw score – mean score)/stdev). To do
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this reaction time date was reversed (Trails A and B, Grooved Pegboard and Stroop).
Average z-score performance was then calculated for each domain. To avoid bias and
determine the false discovery rate, all 10 cognitive domains were entered into the
analyses and not just the domains shown to be impaired in the group analyses.
Table 9.3 Non parametric correlations between indices of exposure and measures of cognitive
function.
Yrs_dip Lifetime_Exp ESK Age
n=123 n=119 n=116 n=127
Working Memory 0.00 -0.07 0.00 0.11
Visual Memory -0.24** -0.14 -0.09 -0.07
Auditory Memory -0.15 -0.12 -0.06 0.09
Response Speed -0.21* -0.14 -0.12 -0.08
Verbal Ability -0.25** -0.15 -0.07 -0.01
Mental Flexibility
Inhibition -0.23
** -0.17 -0.12 -0.34**
Strategy Making -0.18* -0.09 -0.06 -0.04
Verbal Visual Reasoning -0.19* -0.11 0.02 -0.07
Visio-Spatial Ability -0.17 -0.15 -0.09 -0.13
Fine Motor Control 0.14 0.11 0.14 0.38**
Asterisks denote 2-tailed significance: ** - p<.01; * - p<.05
Spearman’s correlations revealed significant, negative correlations between duration of
exposure and Visual Memory (rs = -.24, p<.01), Response Speed (rs = -.21, p<.05),
Verbal Ability (rs = -.25, p<.01), Mental flexibility (rs = -.23, p<.01), Strategy Making
(rs = -.18, p=.05) and Verbal-Visual Reasoning (rs = -.19, p<.05) indicating an
association between duration of exposure and impairments in these areas. No
significant correlations were found between the cognitive domains and other exposure
metrics.
However it is of note that while these correlations were nominally significant, none of
them survived a Larzelere and Mulaik correction (Howell, 1992). This correction is a
stepped procedure designed to control for Type I errors in correlations. Stage one of
this correction is identical to a standard Bonferroni correction (.05/k), where k
represents the total number of comparisons that were carried out. The number of tests
that are significant at this stage (s1) are noted, and the procedure moves to the next step.
At the second stage the alpha level (.05) is divided by a new denominator: k-s1 (i.e. the
total number of comparisons minus the number of those recorded as significant at stage
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1). Again, the number of tests reaching significance are counted (s2), and the procedure
moves on. Next, alpha is divided by k-(s1+s2). In summary, the total number of
comparisons minus those recorded as significant at any previous stage. The procedure
stops at the stage where no significant outcomes are recorded.
However a debate exists in the literature concerning the need to make p-value
adjustments when multiple outcome measures have been used (Feise, 2002; Moran,
2003). Some researchers recommend adjusting the p-values when multiple measures
have been used to reduce the risk of finding spurious, false positive results which have
occurred by chance. Other authors argue that adjustments such as Bonferroni are overly
conservative and in reducing the chance of making a Type I error, the risk of Type II
error is increased. These authors suggest study findings are interpreted within the
context of study design, methodology and sample size rather than relying on overly
conservative statistical methods (Feise, 2002; Moran, 2003). Austin Bradford-Hill, a
medical statistician, devised criteria to assist researchers in determining whether
significant results are due to real biological effects rather than random chance. The main
principles set forward by Bradford-Hill which he deemed necessary to provide adequate
evidence of causation are that (1) findings are consistent with previous research (2)
results can be reproduced (3) any associations found are plausible in terms of being
compatible with existing theories and understanding of underlying processes (4) there is
a temporal and specific relationship between a putative cause and effect (Bradford-Hill,
1965). The issues surrounding statistical correction and the conditions needed to
establish causal relationships will be addressed in more detail in Chapter 14, the
discussion section of this thesis.
9.2.1 Partial correlations with age
Age correlates significantly with duration of exposure (rs = 0.38, p<.01), but
interestingly, not with either of the exposure metrics. Age is also known to correlate
with cognitive function and in this cohort it correlated with mental flexibility and fine
motor control (see Table 9.3). Therefore, the above analyses were repeated, utilising
partial correlation, to control for the potentially confounding effects of age, but all
nominally significant correlations were lost following this process.
However, it may not be appropriate to partial out the effects of age in this circumstance.
Age is inextricably linked with duration of exposure; and scores on most psychometric
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tests have been age corrected, the exceptions being tests of response speed. Returning to
the above table, age only correlates significantly with cognitive domains that
incorporate response speed tests. It does not correlate with memory and verbal and
visuo-spatial ability and reasoning tests which correlated significantly with duration of
exposure in the initial analyses. Attempting to remove the effect of age in the above
correlational analyses may be tantamount to removing the effect of exposure.
9.2.2 Possible contribution of undiagnosed acute toxicity
To examine the possible contribution of undiagnosed acute toxicity on the relationship
between duration of exposure and cognitive function, farmers with dippers flu were
examined as a separate group (N=51). It was possible to classify the frequency with
which they suffered from dippers flu as follows: every time they dipped sheep, most
times, sometimes, not often, once or twice after dipping sheep.
Correlations were run between frequency of dippers flu and the 10 cognitive domains.
The following table depicts the 2-tailed Spearman correlation coefficients. Lower
performance on tests of Strategy Making were associated with increased instances of
dippers flu. However, while nominally significant, this finding did not survive a
Larzelere and Mulaik correction.
Table 9.4 Correlations between instances of dippers flu and the 10 cognitive domains.
Cognitive Domain r
Working Memory -0.17
Visual Memory 0.26
Auditory Memory 0.15
Response Speed -0.11
Verbal Ability -0.13
Mental Flexibility -0.27
Strategy Making -0.38*
Verbal Visual Reasoning -0.16
Visio-Spatial Ability -0.08
Fine Motor Control 0.25
Asterisks denote 2-tailed significance: * - p<.05
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9.3 Summary
Participants in this study had been exposed to OPs through sheep dipping for an average
of 24 years and farmers typically dipped once or twice a year for one to two days.
However, there was a degree of variability amongst individuals in terms of their
exposure history with some participants deviating from the normal pattern on one or
more variables such as duration, frequency or intensity of exposure. Measures such as
years spent dipping, frequency, days per year, give an indication of duration of
exposure, but they do not necessarily provide a valid assessment of intensity of
exposure, so more detailed information was collected about work practices (e.g.
handling concentrate, role performed, instances of ‘dippers flu’) and metrics constructed
in an attempt to consider all of the different aspects of exposure history which may be
relevant. However, the exposure indexes produced variable results raising questions
about their validity.
Statistical analyses were undertaken to determine whether a linear relationship exists
between indices of exposure and cognitive function. A number of significant, negative
correlations were found between duration of exposure (but not the exposure metrics)
and visual memory, response speed, verbal ability, mental flexibility, strategy making
and verbal-visual reasoning. However these were lost following statistical correction for
Type I error and when the possible confounding effects of age and undiagnosed acute
toxicity were controlled for. This can be interpreted in two ways (1) the cognitive
deficits identified in study participants were not caused by exposure to OPs but by some
other confounding factor; (2) the cognitive deficits identified in study participants were
caused by exposure to OPs, but may have been lost for one (or more) of the following
reasons:
 The association was small and eradicated following the application of overly
conservative statistical methods. As mentioned previously, a debate exists in the
literature concerning the need to make p-value adjustments when multiple
outcome measures have been used, as this increases the risk of Type II error,
particularly when subtle or rare effects are being investigated.
 The study did not include a sufficient number of participants to reliably detect
small effect sizes (i.e. the study was under-powered). For example, power
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analysis indicates a sample size of 193 would be necessary to detect a small
(r=0.2) relationship between exposure and cognitive function (alpha=.05; power
=.80).
 Accurate estimation of exposure was impossible and critical exposure data was
not captured, rendering exposure measures invalid. As mentioned earlier, it can
be hard to obtain accurate estimates of exposure history in some occupational
settings.
 The relationship between exposure to OPs and neurobehavioural functioning is
not linear. A number of researchers have questioned the assumption that dose-
response relationships are always linear. ‘U’ shaped and inverted ‘U’ shaped
curves have been identified and threshold effects below which health effects are
not apparent, but above which symptoms develop have also been noted
(Hartman, 1995; Peterson Myers, Zoeller, vom Saal, 2009). Furthermore,
genetic differences between individuals in their capacity to detoxify and
metabolise xenobiotics may render some individuals more susceptible to the
effects of certain chemicals than others, thereby compounding any dose-
response relationships which may exist.
Interpretation of the findings in this chapter and the issues raised above will be re-
visited in Chapter 14; the discussion section of the thesis.
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Chapter 10 : Psychiatric functioning and OP exposure
10.1 Introduction
A principle aim of this thesis is to investigate whether farm workers with a history of
low level exposure to OPs (insufficient to cause acute intoxication) will show evidence
of mood disorder, above that seen in a control population. Several measures of
emotional well being were included in this study for different purposes. Self-rating
scales such as the Hospital Anxiety and Depression Scale and the Beck anxiety and
depression inventories were included to screen for clinically significant levels of anxiety
and depression and measure severity of anxiety symptoms and depression. However,
self-assessment scales are only valid for screening purposes and definitive diagnosis
requires a comprehensive clinical examination, therefore, we also included a structured
clinical interview (SCID; First et al, 1997) in our assessment process.
Structured interviews provide an important method of standardising evaluations and
improving diagnostic reliability and validity. The SCID was chosen for the current
study because it was developed to standardise DSM-IV evaluations of mental disorders.
DSM-IV is a manual published by the American Psychiatric Association to assist
clinicians in evaluating mental health disorders in both children and adults. The SCID
aims to improve the reliability of DSM diagnoses and has been extensively validated
over the last decade (Rogers, 2001). Study participants were evaluated for the
following: Past major depressive episode, current major depressive episode, dysthymic
disorder; generalised anxiety disorder, panic disorder, anxiety disorder or depression
due to a general medical condition. With regard to the latter, DSM-IV requires the
symptoms of anxiety or depression to be a direct physiological consequence of the
general medical disorder. Anxiety and depression which has arisen as an emotional
reaction to having a general medical disorder is not encompassed under this diagnostic
heading. Findings are outlined in the following section.
10.2 Prevalence of mood disorder in the exposed vs control cohort
10.2.1 Current major depressive episode
Overall, 10.7% of farmers met DSM-IV criteria for a diagnosis of current major
depressive episode compared to only 2.6% of controls and this difference was
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significant (χ²(1)=4.31, p<.05).   However, when this was broken down for the two 
working status groups, it was only found to be significant for the retired cohort
(working: χ²(1)=0.58, ns; retired: χ²(1)= 4.58, p<.05). 
10.2.2 Past major depressive episode
Overall, 39.7% of farmers met DSM-IV criteria for a diagnosis of past major depressive
episode compared to only 17.1% of controls and this difference was significant
(χ²(1)=11.12, p<.001).   However, when this was broken down for the two working 
status groups, it was only found to be significant for the retired cohort (working:
χ²(1)=0.51, ns; retired: χ²(1)= 16.25, p<.0001). 
10.2.3 Dysthymic disorder
Only a small proportion of farmers and controls met DSM-IV criteria for a diagnosis of
dysthymic disorder (4.9% and 2.6% respectively) and no significant difference was
found between these two groups (χ²(1)=0.63, ns).
10.2.4 Depression due to a general medical condition
Only a small proportion of farmers and controls met DSM-IV criteria for a diagnosis of
depression due to a general medical disorder (4.3% and 2.7% respectively) and no
significant difference was found between these two groups (χ²(1)=0.30, ns).
10.2.5 Panic disorder
Overall, 9.1% of farmers met DSM-IV criteria for a diagnosis of panic disorder
compared to only 1.3% of controls and this difference was significant (χ²(1)=4.93, 
p<.05). However, when this was broken down for the two working status groups, it
was only found to be significant for the retired cohort (working: χ²(1)=1.13, ns; retired:
χ²(1)= 4.3, p<.05). 
10.2.6 Generalized anxiety disorder
Overall, 14.2% of farmers met DSM-IV criteria for a diagnosis of generalized anxiety
disorder compared to only 1.3% of controls and this difference was significant
(χ²(1)=9.07, p<.005).   However, when this was broken down for the two working status 
groups, it was only found to be significant for the retired cohort (working: χ²(1)=1.85, 
ns; retired: χ²(1)= 8.06, p<.005). 
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10.2.7 Anxiety due to a general medical condition
Only a small proportion of farmers and controls met DSM-IV criteria for a diagnosis of
anxiety due to a general medical disorder (0.9% and 1.4% respectively) and no
significant difference was found between these two groups (χ²(1)=0.094, ns).
Figure 10.1 Percentage of farmers and controls who meet DSM-IV criteria for a diagnosis of
anxiety and depression.
In summary, rates of depression and anxiety disorder were much higher amongst
farmers than controls (see Figure 10.1). Few participants met criteria for anxiety or
depression due to a general medical disorder, or suffered from dysthymia, so these
diagnostic categories do not appear in subsequent tables and graphs.
Overall, these results concur with earlier findings using the Hospital Anxiety and
Depression screening measure. However, it is important to note that a much smaller
number of farmers and controls meet DSM-IV criteria for a diagnosis of anxiety or
depression than the numbers found to be reporting significant levels of anxiety and
depression on the self-report screening tool (see Table 10.1).
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Table 10.1 Rates of anxiety and depression according to different methods of assessment; a self-
report screening tool (HAD) and a structured clinical interview for DSM-IV disorders.
Disorder HAD* DSM-IV
Depression
Farmers
Controls
45.9%
6.6%
10%
2.6%
Anxiety (GAD)
Farmers
Controls
41%
22.4%
21.7%
2.7%
*Please note, the HAD does not split anxiety into generalised anxiety and panic disorder, so diagnoses
were collapsed on the SCID to match.
Analyses concerning the rates of mood disorder and anxiety in the different working
status groups reveals much higher rates of these conditions in retired participants,
particularly in the farming cohort (see Figure 10.2).
Figure 10.2 Percentage of farmers and controls who meet DSM-IV criteria for a diagnosis of
anxiety and depression, split by working group.
In terms of symptom severity, more farmers than controls describe their symptoms of
anxiety and depression as being of moderate to severe severity (see Table 10.2).
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Table 10.2 Percentage of participants with mood or anxiety-related disorders by severity.
Anxiety Depression
Exposed
Group
Control
Group
Exposed
Group
Control
Group
Normal 58.7 83.1 53.7 87.0
Mild 16.5 14.3 15.7 9.1
Moderate 19.0 1.3 17.4 3.9
Severe 5.8 1.3 9.9 0
10.2.8 Possible causation
An important issue is the extent to which the anxiety and depression seen in farmers is
related to exposure to OPs (either directly as a result of damage to the central nervous
system, or indirectly as an emotional reaction to more general ill health); or has arisen
as a consequence of some other factor such as stressful life events or a reaction to
retirement.
Given rates of anxiety and depression are higher amongst farmers who have retired on
ill health grounds compared to controls who have retired on ill health grounds, it seems
likely that an additional factor, other than retirement per se accounts for the levels of
distress noted in farmers.
A life events checklist (Holmes and Rahe, 1967) was included in an attempt to tease
apart the relative contribution of recent stressful life events and exposure to pesticides in
triggering mood disorder. This scale consists of 43 positive and negative life events
(such as divorce, marriage, retirement, change in financial state) capable of inducing
stress and ill health. Each life event is assigned a value according to how stressful they
were considered to be by a standardisation sample of 394 individuals. Participants in the
current study were asked to state whether they had experienced any of these events over
the last 12 months. Scores above 150 are associated with an increased risk of illness and
a score above 300 is associated with a high risk of developing a stress related illness.
Descriptive information is provided in Table 10.3 but it is important to note that the life
event data was not normally distributed.
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Table 10.3 Descriptive statistics for stressful live events scores for the exposure and non-exposed
cohorts.
Mean Standard deviation Range
Farmer
Working
Retired
49.89
106.07
58.16
78.68
0-199
0-311
Control
Working
Retired
73
96.21
69.37
69.60
0-254
0-286
Review of the descriptive data reveals that only a small proportion of working farmers
and controls obtained a total score of over 149 on this measure (9.2% and 8.6%
respectively) but around a fifth of retired farmers scored above this cut off (20.3%
retired farmers vs 15.4% retired controls). No controls scored above the cut off of 300
on this measure, but 2% of retired farmers obtained high scores. However, statistical
analysis indicated that the differences noted between farmers and controls in terms of
the scores they obtained on the life events scale, were not significantly different (U=
4.157, ns). In other words, the rate of recent stressful life events is equivalent in the
exposed farmers and unexposed controls.
Not surprisingly high scores on the life events scale are associated with increased
severity of anxiety symptoms and mood disorder (see Table 10.4), but given that the
rate of recent stressful life events is equivalent in the exposed farmers and unexposed
controls, life stress per se cannot be the sole factor underlying the increased rates of
psychiatric disturbance observed in the farming cohort.
Table 10.4 Correlations between self-report measures of anxiety and depression and stressful life
events experienced over the last year.
HAD
Anxiety
HAD
depression
Beck
Anxiety
Beck
Depression
Farmer
Life events score .280** .250** .310** .320**
Control
Life events score .430** .322** .375** .433**
**Significant at p<0.01 (2-tailed)
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As the exposed cohort show a significantly higher incidence of mood disorder than
controls, and given that the two groups do not differ in terms of stressful life events, it
seems that OP exposure may indeed have a part to play in the depression and anxiety
seen in the farming cohort.
In order to see whether exposure has a linear relationship with anxiety and depression,
exposure variables (lifetime exposure index, Esk, duration of exposure (in years), years
since last dip) were entered into partial correlations with HAD, BDI and BAI scores,
while controlling for recent stressful life events. No significant results were found.
10.2.8 Summary
A principle aim of this study is to investigate whether farm workers with a history of
low level exposure to OPs show evidence of mood disorder. Several measures of
emotional well being were included in this study. Rates of depression and anxiety were
much higher amongst farmers than controls, especially amongst retired farmers. Rates
differ according to the method used to evaluate mood and a smaller percentage of
farmers meet DSM-IV criteria for a diagnosis of anxiety or depression than the numbers
who complain of significant levels of distress on self-report screening tools.
An important issue is the extent to which the mood disorder observed in farmers is due
to exposure to OPs as opposed to lifestyle factors. Findings indicate that retirement per
se is unlikely to be solely responsible for the mood disorder observed in retired farmers
as controls who had also retired on ill health grounds had lower rates of mood disorder
than farmers. Stressful life events, although associated with increased severity of mood
disorder, are unlikely to be solely responsible for elevated rates of anxiety and
depression in farmers as the rate of recent stressful life events is equivalent in the
exposed farmers and unexposed controls.
However, no significant correlations were observed between indices of exposure to OPs
and mood, possibly the study did not include a sufficient number of participants to
reliably detect small effect sizes; or because exposure measures invalid; or the
relationship between exposure to OPs and neurobehavioural functioning is not linear.
Alternatively, the mood disorder observed in farmers may not have been caused by
exposure to OPs and could be due to some other factor. Individuals with a history of
exposure to OPs often complain of chronic ill health and a constellation of physical
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symptoms which can be severe and disabling (Mackenzie Ross et al 2007). The elevated
rates of anxiety and depression observed in farmers who took part in this study, may
have arisen as a reaction to deteriorating physical health and well being. In the next
chapter, the physical health of farmers is examined and compared to that of unexposed
controls and the possible relationship between symptoms of ill health and exposure to
OPs is explored.
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Chapter 11 : Physical Symptoms and OP exposure
11.1 Introduction
In Chapter 2, the toxicology of OPs and associated health effects were described in
some detail. To summarise, organophosphates are readily absorbed by the body through
the skin, lungs, gastrointestinal tract and conjunctiva. Exposure to OPs can result in
acute and chronic health effects. The immediate effects of OP poisoning which occur
within hours of exposure have been well documented (Baxter et al, 2000; COT Report,
1999; ECETOC Report, 1998; Royal Colleges’ Report, 1998; WHO Report, 1990) and
involve inhibition of the enzyme acetylcholinesterase, causing changes in peripheral,
autonomic and central nervous system function (cholinergic crisis). Recovery from
mild poisoning occurs rapidly (circa 24-48 hours) and it is widely believed that if an
individual survives the initial life threatening crisis they will make a complete recovery.
However, patients have been presenting to clinicians with symptoms that have persisted
long after resolution of the cholinergic crisis (COT Report; Royal Colleges Reports).
OPs are capable of producing several delayed physical and neurological syndromes
which are not well known or understood and may be unrelated to the cholinergic effects.
These include The Intermediate Syndrome which involves proximal flaccid limb
paralysis typically starting 1-4 days after poisoning and lasting 5-18 days;
organophosphate induced delayed polyneuropathy (OPIDN), a delayed sensory and
motor polyneuropathy affecting predominantly the lower limbs, but in severe cases the
upper limbs as well. OPIDN onsets around 2-4 weeks after exposure and recovery is
slow and often incomplete; and a neurobehavioural syndrome involving subtle
cognitive impairment, greater psychiatric morbidity, chronic fatigue and minor sensory
changes.
How OPs might cause such effects is unknown, but several mechanisms have been
proposed; such as changes in receptor sensitivity, non-cholinergic effects (e.g. on
dopaminergic or adrenergic sites), inhibition of other enzymes and proteins (Jamal,
1997), hypoxic brain damage (Baze, 1993) and apopotic neuronal cell death (Abou-
Donia, 2005; Kapur et al, 2007). IS and OPIDN usually follow an episode of acute
poisoning but neurobehavioural deficits have been associated with both high and low-
level exposure (Brown & Brix, 1998; Davies, Ahmed and Freer, 2000; Kamel and
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Hoppin, 2004).
Previous studies of sheep farmers, regularly exposed to OPs, have found a high
incidence of symptoms consistent with chronic fatigue syndrome such as extreme
fatigue, impaired memory and concentration, aching joints, aching muscles, muscle
weakness, headaches, sleep disturbance, irritability, word-finding difficulties,
depression, anxiety, parasthesia, gastro-intestinal disturbance and respiratory disorders
(Ahmed & Davies 1997; Beach et al, 1996; Davies et al, 1999; Dunn, 2002; Fletcher, et
al, 2005; Jamal et al, 2002; Mackenzie Ross et al, 2007; Pilkington et al, 2001; Solomon
et al, 2007; Tahmaz, Soutar and Cherrie, 2003).
Ahmed and Davies published several reports concerning neuropsychiatric abnormalities
seen in individuals with a history of exposure to OPs. In 1997 they described a
neuropsychiatric syndrome (referred to as COPIDN) which they observed in 26 out of
33 clinical cases referred to them for an opinion about the possible relationship between
ill health and exposure to OPs. COPIND comprises 10 symptoms the cardinal ones
being mood instability, suicidal thinking, cognitive impairment, language disorder,
inability to sustain muscular power, alcohol intolerance and olfactory hypersensitivity.
After taking into account individuals’ medical histories, the authors conclude that the
most likely explanation for these symptoms is OP exposure, although they did not
provide details about the individuals’ exposure histories, other than to state that many
suffered episodes of dippers flu.
In 1999 Davies, Ahmed and Freer described the results of 2 postal surveys in which
they attempted to overcome the methodological difficulties associated with their
previous study. In study 1 they compared 127 exposed and 43 non-exposed farmers
(randomly selected) and found increased reporting of COPIND symptoms in exposed
farmers compared to unexposed farmers. In study 2 they examined the symptom
profiles of 215 individuals with medically unexplained illnesses which they attribute to
OP exposure. Significant similarities in symptom profiles were observed amongst
individuals from different occupational groups whose common factor is OP exposure.
However, they do not report past medical history, making it difficult to determine
whether these individuals have made an attribution error. The response rate in study 1
was low (44.6%) which could indicate a bias in that those individuals who attribute their
difficulties to OP exposure may be more likely to return the questionnaire. Finally,
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detailed exposure history is lacking and it may be that, as above, many of these
individuals have a history of acute OP poisoning.
The UK Veterinary Medicines Directorate (VMD) commissioned an analysis of 646
reports made to their Suspected Adverse Reaction Surveillance Scheme (SARSS) and a
report was published in 2002. The following symptoms were frequently reported by
agricultural workers following exposure to OPs: headache, dizziness, parasthesia,
fatigue, gastro-intestinal disturbance, depression, musculo-skeletal disorders, memory
problems and respiratory disorders. In 2003 Tahmaz, Soutar and Cherie examined 63
respondents to the VMD SARSS scheme and found a high incidence of symptoms
consistent with chronic fatigue syndrome in sheep farmers who use OP pesticides.
Higher fatigue scores were associated with higher exposure to OPs.
An epidemiological survey carried out in the UK of 367 sheep farmers who report ill
health which they attribute to exposure to OPs found a high incidence of memory
problems, headache, fatigue, aching muscles and joints, irritability, word-finding
difficulties, depression, anxiety, sleep difficulties. This was even after excluding
individuals with a medical history which might otherwise account for their symptoms.
On average the health of those with a history of acute poisoning was worse than those
without such a history (Fletcher, MacLehose, Hurley et al, 2005).
In 2006 Solomon et al reported the findings from a postal survey of men born between
1933 and 1977 who were resident in three rural areas of England and Wales.
Neuropsychiatric symptoms were more common in past users of sheep dip than in men
who had never used pesticides; but symptoms were also common in men who had used
pesticides other than sheep dip. Among users of sheep dip, prevalence was higher
amongst men who dipped most often, but the authors suggest non- toxicological factors
may account for these findings as they did not find an elevated risk of ill health in those
individuals who handled sheep dip concentrate and because symptoms were reported by
men who had used other pesticides. The authors suggest public concern about the
adverse effects of pesticides may influence reporting and that individuals who have a
tendency to dwell on somatic complaints are more likely to report ill health.
Mackenzie Ross et al (2007) compared 25 farm workers with a history of apparent low
level exposure to sheep dip with 22 non-exposed healthy volunteers on
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neuropsychological tests. All reported a range of physical symptoms the most
prominent being fatigue, aching muscles and joints, headaches, sleep disturbance and
irritability. Agricultural workers described their symptoms as being severe and disabling
and two thirds of them had retired or reduced their workload on ill health grounds. All
were involved in litigation and so it is unclear how representative they are of the
farming community as a whole.
Although previous studies undertaken in the UK suggest a link between exposure to
sheep dip and the development of neurobehavioral problems, it is unclear whether this
is due to a history of acute poisoning or a result of cumulative low level exposure. In the
present study, farmers and controls were asked to complete a questionnaire regarding
their physical health. This provided two types of information (1) a generic measure of
disease burden which was derived by asking participants to rate their health as being
excellent, very good, good, fair or poor, and (2) more detailed information about health
symptoms, their date of onset, frequency, severity and impact on every day functioning.
The questionnaire was based on a number of existing questionnaires with known
reliability and validity and additional symptoms, not associated with exposure to
neurotoxic agents, were added to the list to determine whether farmers complain of
symptoms associated with neurotoxic exposure or an array of symptoms with different
underlying causes.
11.2 Incidence of physical health problems
Participants were given a list of 39 symptoms (see Appendix 2) and asked if they had
experienced them in the last 4 weeks and if so, to rate their frequency and severity. The
symptoms listed in the questionnaire potentially reflect central, peripheral and
autonomic nervous system damage; but are also relatively non-specific and may have
multiple aetiologies. In addition, participants were asked how much pain they were in
on a scale of 0 (none) to 5 (extremely severe) and how much this impacted on their
social life (this time on a 0-4 point scale from not at all to extremely).
The health symptoms reported by study participants are summarised in Table 11.1.
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Table 11.1 Physical health ratings of study participants according to occupational group and
working status.
Working Retired
Mean StandardDeviation Mean
Standard
Deviation
Overall Health Rating
Exposed Group 2.53 0.78 3.89 .99
Control Group 2.05 0.80 3.08 1.13
Number of Moderate-Severe Symptoms
Exposed Group 2.90 3.34 10.76 7.14
Control Group 1.49 1.42 2.52 2.01
Pain
Exposed Group 1.59 1.15 2.65 1.23
Control Group 1.32 1.12 2.39 0.96
Impact on Social Life
Exposed Group 0.2 0.54 1.74 1.47
Control Group 0.16 0.69 0.69 1.14
As the assumptions of normality and homogeneity of variance were violated for all
variables, a series of Mann Whitney U tests were used to investigate whether there were
any significant differences in the mean overall health rating scores or the amount of
moderate to severe physical symptoms the exposed and control groups reported having.
Overall, and in both the working and retired cohorts, the exposed participants reported
significantly worse general health than the controls (U=3097.5, p<.001; U=829.0,
p<.01; U=606.05, p<.001 respectively). A similar pattern was found in terms of the
number of moderate to severe symptoms that were reported, with the exposed group
reporting more symptoms than the controls in both the working (U=990.0, p<.05) and
retired (U=292.5, p<.001) cohorts, as well as overall (U=1614.5, p<.001).
In contrast, there was no significant difference between the exposure groups in terms of
reported pain for either the working or retired cohorts (U=1059, ns; U=823.5, ns
respectively), nor overall (U=3957, ns). However, the exposed cohort reported their
symptoms had a significantly greater impact on their social life (U=3632, p<.01)
compared to controls, although this only held true for the retired cohort (retired:
U=611.0, p=.001; working group: U=1185.5.00, ns).
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Further Mann Whitney U tests revealed that the retired cohort reported significantly
worse overall health (U=1937, p<.001) than the working group. The retired participants
also reported suffering from a larger number of moderate to severe symptoms
(U=2485.5, p<.001), feeling a greater amount of pain (U=2431.5, p<.001) and
experiencing more interference from these symptoms with their social life (U=1403,
p<.001). This pattern also held true in all cases when working status was looked at
separately for the two exposure groups (U range: 243.5-962.5, largest p=.02).
11.2.1 Incidence of physical health problems and impact on mood
The previous chapter outlined greater problems with mood in the exposed cohort,
compared to the control groups. In order to see whether the health variables described
in the previous section may be related to mood, Spearman’s correlations were carried
out with HAD, BDI and BAI scores. The results in Table 11.2 show a strong
relationship between mood and physical symptoms for both groups.
Table 11.2 Correlations between mood and physical health.
Exposed Cohort Control Group
Health
rating
Pain
rating
Social
impact
Health
rating
Pain
rating
Social
impact
BDI 0.45* 0.36* 0.53* 0.44* 0.32* 0.36*
BAI 0.31* 0.40* 0.43* 0.42* 0.27 0.29
HADSD 0.47* 0.36* 0.51* 0.51* 0.32* 0.40*
HADSA 0.35* 0.36* 0.36* 0.43* 0.35* 0.41*
-Asterisks denote significant correlations after L&M corrections have been applied
11.3 Pattern of physical health problems
In order to establish whether there were any specific symptoms that the exposed cohort
was more likely to complain of compared to controls, symptom profiles were
established for the two groups. To do this, the frequency with which participants
complained of specific physical ailments as being moderate-to-severe was investigated
(see Figure 11.1). Odds ratios were then calculated for each of the 39 physical
symptoms by participants who were exposed to OPs and those who were not (these can
be seen in Table 11.3). An odds ratio greater than 1 indicates that the condition is more
likely to occur in the exposed cohort. In contrast, an odds ratio less than 1 indicates that
the condition is more prevalent in the control group.
173
Figure 11.1 Frequency of moderate-severe physical symptoms.
174
Table 11.3 ODDs ratios for the physical symptoms.
ODDS
Ratio Rank Order New α χ² significant 
Mental Slowing 33.91 1 0.002 *
Memory Problems 16.32 2 0.002 *
Loss of Balance 15.36 3 0.002 *
Temperature 14.51 4 0.002 *
Alcohol Intolerance 14.08 5 0.002 *
Irritability 12.28 6 0.002 *
Muscle Weakness 11.13 7 0.002 *
Dry Mouth 10.06 8 0.002 ns
Dizziness 8.97 9 0.002 ns
Less Sensitivity 8.44 10 0.002 *
Deafness 8.26 11 0.002 ns
Muscle Twitching 7.57 12 0.002 ns
Fatigue 6.01 13 0.002 *
Muscle Tremors 5.34 14 0.003 ns
Burning Sensation 4.98 15 0.003 ns
Skin Complaints 4.59 16 0.003 ns
Urinary Problems 4.23 17 0.003 ns
Cramps 4.12 18 0.003 ns
Pain in Hands/Feet 3.98 19 0.003 ns
Gastro Problems 3.95 20 0.004 ns
Sleep Problems 3.59 21 0.004 *
Loss Sensation in Digits 2.83 22 0.004 ns
Coughing 2.41 23 0.005 ns
Toothache 2.40 24 0.005 ns
Numbness/Tingling 1.88 25 0.006 ns
Nausea 1.82 26 0.006 ns
Ringing in Ears 1.63 27 0.007 ns
Headache 1.50 28 0.008 ns
Blurred Vision 1.41 29 0.010 ns
Weight Gain/Loss 1.37 30 0.013 ns
Feverish 1.23 31 0.017 ns
Hay Fever 1.01 32 0.025 ns
Joint Pain 0.97 33 0.050 ns
Sexual Problems undefined
unable to carry out chi square
due to empty cells
Chest Pains undefined
Disorientation undefined
Short of Breath undefined
Diarrhoea/Constipation undefined
Swollen Glands undefined
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Chi Square tests were also carried out to detect differences in the frequency of these
physical complaints between the two groups and Bonferroni-Holms tests applied to
control for Type I error. This involved deriving revised alpha levels by using the
formula:
α revised = α original / (k-i+1)
where α original =.05; k= number of psychometric tests used; i= the rank order/strength of
the original p value (rank 1 is assigned to the most significant findings).
The results, which can be seen in Table 11.3, highlight 10 physical symptoms which
readily distinguish the exposed and control groups. These can also be seen in Table
11.4, where they are classified by symptom type. From viewing the odds ratios, we can
see that for each of these 10 symptoms farmers are between 3.59 and 33.91 times more
likely to be symptomatic than the controls. It is interesting to note that the majority of
these symptoms can be described as central nervous system (CNS) problems, and half
of them are of a psychological nature. Symptom reporting for musculo-skeletal or
dummy variables did not distinguish the exposed group from the controls. This suggests
the farmers complain of specific symptoms and are not simply endorsing a broad array
of non-specific symptoms.
Table 11.4 Classification of symptom type.
Symptom Problem Type
Mental Slowing CNS
Memory Problems CNS
Loss of Balance CNS
Temperature ANS
Alcohol Intolerance CNS
Irritability CNS
Muscle Weakness PNS
Reduced Sensitivity PNS
Fatigue CNS
Sleep Problems CNS
11.4 Physical health and exposure
When operationalising exposure with the farmers and controls, the exposed cohort show
a specific pattern of physical health problems compared to the controls. In order to see
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whether exposure has a linear relationship with physical health problems, the exposure
indices (lifetime exposure index, Esk, duration of exposure, years since last dip) were
correlated with the frequency (ranging from 0 meaning “never” to 3 representing “all
the time”) with which participants reported experiencing each of the aforementioned 10
symptoms. The number of these 10 symptoms each participant reported was also
entered into these Spearman correlations. No significant results were obtained.
However, while no significant correlations were found between physical health and
exposure, that does not mean that there is no relationship between the variables; just that
it may not be a linear one. To investigate this another way, odds ratios were calculated
for each of the 10 physical symptoms for exposed participants who were in the highest
quintile of the different exposure indices, versus those who fell into the other four
quintiles (these can be seen in Table 11.5). An odds ratio greater than 1 indicates that
the condition is more likely to occur in the highest exposed cohort. In contrast, an odds
ratio less than 1 indicates that the opposite is true.
Table 11.5 ODDs ratios for the difference exposure metrics.
ODDs Ratios
Lifetime Exposure EsK Index Duration of Exposure
Mentally Slower 1.50 1.53 1.01
Memory Problems 0.85 1.43 1.51
Loss of Balance 3.07 1.79 1.81
Temperature 1.37 1.23 2.04
Alcohol
Intolerance 1.17 0.52 0.18
Irritability 1.26 1.73 1.58
Muscle Weakness 1.07 1.14 1.96
Less Sensitivity 3.19 2.16 0.70
Fatigue 1.72 1.65 2.36
Sleep Problems 0.96 1.40 1.09
These findings illustrate that in the majority of cases, the odds of a participant being
symptomatic are higher for those in the highest exposure quintile than those who are
not. This suggests that exposure may indeed have a role to play in physical health,
although the precise relationship between these variables is unclear and warrants further
investigation.
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11.5 Summary
Exposure to OPs can result in acute and chronic health effects and previous studies of
sheep farmers have found a high incidence of symptoms consistent with chronic fatigue
syndrome such as extreme fatigue, impaired memory and concentration, aching joints,
aching muscles, muscle weakness, headaches, sleep disturbance, irritability, word-
finding difficulties, depression, anxiety, parasthesia, gastro-intestinal disturbance and
respiratory disorders.
Farmers who took part in the present study reported significantly worse general health
than controls and an increased number of moderate to severe symptoms. The ten
physical symptoms which readily distinguished the exposed and control groups were
consistent with those reported in earlier studies, but the frequency with which they
suffered from these symptoms did not correlate significantly with indices of exposure.
However, the odds of a participant being symptomatic are higher for those in the highest
exposure quintile than those who are not and this suggests OP exposure may indeed
have a role to play in physical health, although the relationship may not be linear.
Analyses also revealed a strong relationship between depression and health ratings
indicating farmers experience these symptoms as distressing and disabling.
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Chapter 12 : Potential susceptibility to OPs - Genetic data
12.1 Genes and OPs
Paraoxonase (PON1) is a liver and plasma enzyme which may protect against
cardiovascular disease because it metabolises oxidized lipids, thus preventing the
accumulation of lipoprotein on the arterial wall. It also plays a role in the detoxification
of organophosphate pesticides (OPs) and received its name from its capacity to
hydrolyse paraoxon, a toxic metabolite of the insecticide parathion. PON1’s capacity to
metabolise and detoxify OPs makes it an important consideration for any study seeking
to address the health effects of OP exposure, since it may be a useful biomarker of
individual susceptibility to OP toxicity (Costa & Furlong 2002).
12.1.1 Metabolic pathway
Commonly used OPs, parathion, chlorpyrifos and diazinon (a major ingredient of sheep
dip in the UK during the 1980s and 1990s) are manufactured as
organophosphorothioates and are poor inhibitors of acetylcholinesterase (AChE).
However, the thioates are converted to highly toxic oxons by liver cytochrome P450
enzymes and the oxon form is a more potent inhibitor of AChE than the parent
compound. For example, chlorpyrifos oxon inhibits brain cholinesterase at 1000 times
the rate of the parent compound. PON1 hydrolyses the bioactive forms of OPs such as
paraoxon, diazoxon and chlorpyrifos oxon, thus limiting toxicity (Brophy et al, 2000,
Costa & Furlong 2002, Mackness et al, 2003).
12.1.2 Animal studies
Animal studies have demonstrated the importance of PON1 in modulating OP toxicity.
For example studies by Costa & Furlong’s research group in the 1990s found that rats or
mice, injected with exogenous PON1 (purified from rabbit serum) to increase plasma
hydrolytic activity towards OPs, were more resistant than controls to the toxic effects of
chlorpyrifos oxon. Later studies utilising PON1 knockout mice, (which have no
detectable plasma and liver hydrolytic activity towards various OPs) found knockout
mice were killed by dermal exposures to OPs that had no measurable inhibition of brain
AChE in normal mice; and injection of pure human PON1 Q192 or PON1R192 to
restore plasma PON1, provided protection against the toxicity of diazoxon and
chlorpyrifos oxon. These findings have particular clinical relevance to the observation
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that newborn humans have very low levels of PON1 in their sera and are particularly
sensitive to the toxic effects of OPs (Richter & Furlong 1999).
In recent years increasing attention has been given to biomarkers of susceptibility to OP
toxicity and genetic differences in the enzymes involved in the detoxification of OPs
can greatly influence their toxicity, hence some individuals may be more susceptible to
the toxic effects of OPs than others.
12.1.3 Genotype and human polymorphisms
Polymorphisms of PON1 have been found to modulate the toxicity of OPs. In human
populations, two common polymorphisms have been identified in the coding sequence
of PON1: L55M and R192Q. The R192Q polymorphism, but not the L55M, affects the
catalytic efficiency of hydrolysis of some organophosphate pesticides. For example, the
PON1 R192 isoform hydrolyses paraoxon and chlorpyrifos more rapidly than the PON1
Q192 (this is important because up to 50% of the population are homozygous for PON1
Q; Furlong et al 2006); but it metabolises diazoxon more slowly than the Q192 isoform
(Cherry, et al, 2011; Davies et al, 1996). As mentioned previously, diazinon was a
major ingredient of sheep dip in the UK during the 1980s and 1990s and it is possible
that individuals who developed chronic ill health following exposure to OPs carry one
or more R alleles.
12.1.4 PON1 activity levels
Costa and Furlong found that possessing efficient PON1 regulatory regions does not
alone guarantee a high PON1 activity level, because there are large inter-individual
differences in level of PON1 expression. In a given population plasma PON1 activity
can vary up to 40 fold and differences up to 13 fold are present within a single PON1
192 genotype (and levels in newborns are 3-4 times lower than in adults).This means
that individuals with the same genotype have different levels of protection. Therefore, it
is important to measure the level of protein expressed in an individual’s plasma in
addition to determining genotype. Indeed, studies suggest that plasma levels of PON1
are more important in determining sensitivity to diazoxon exposure than the two PON1
192 alloforms Q or R (Li et al 2000). Thus for some exposures it is only the level of
plasma PON1 that is important whereas for others it is both the plasma level of PON1
and the PON1 192 alloform that are important.
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Differences in PON1 status (i.e. genotype and PON1 level) may explain why some
individuals are more sensitive to certain environmental factors (e.g. organophosphate
pesticides), than others and PON1 status may be a better predictor of OP susceptibility
than genotype alone. Although animal and in vivo human studies provide evidence that
PON1 plays an important role in modulating the toxicity of OPs, only a few studies to
date, have looked at the relationship between PON1 status and clinical outcomes in
individuals exposed to OPs (Cherry et al, 2002; Cherry et al, 2011; Furlong et al, 2006;
Holland et al, 2006; Lee, London, Paulauskis,Myers & Christiani, 2003; Mackness et al
2003; Povey et al, 2005).
12.2 UK studies of sheep dippers
The relationship between exposure to sheep dip, PON1 polymorphisms and chronic ill
health has been investigated by Cherry et al (2002 and 2011), Mackness et al (2003) and
Povey et al (2005) using a case-referent study design. They investigated the relationship
between PON1 genetic polymorphisms and activity levels in farmers reporting chronic
ill health attributed to OP exposure in sheep dip (cases) and sheep farmers who carried
out similar activities but remained well (controls). They found that the PON1 192
polymorphism was more common in people reporting ill health and that these
individuals were more likely to have the R PON1 allele than similarly employed
controls who considered themselves to be healthy. Furthermore, cases were more likely
than referents to have low serum hydrolytic activity for diazoxon. Indeed, farmers in
the lowest quintile of diazoxon hydrolysis were 2.5 times more likely to report ill health
(which they attributed to sheep dipping) than farmers in the highest quintile.
12.2.1 The current study
An important objective of the current study was to determine whether background
factors such as the capacity to metabolise OPs, render some individuals more vulnerable
to the effects of OPs than others. Therefore, each study participant was asked to provide
a sample of blood which was shipped to the University of Washington, Seattle for
determination of PON1 status by Professor Clement Furlong’s laboratory. The
methodology for this has been described earlier in Chapter 5. To summarise,
participants PON1 status was determined by measuring rates of paraoxon and diazoxon
hydrolysis as this correlates with the amount of enzyme activity and protein levels.
Their PON1 phenotype (Q/Q; Q/R; R/R) and arylesterase activity levels are summarised
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in Table 12.1.
Table 12.1 PON1 status in study participants according to work status.
Frequency of phenotypes Arylesterase activity
QQ QR RR Mean SD Range
Farmers
Working 26 21 5 150.38 33.67 71-239
Retired 19 26 5 153.85 37.71 88-243
% 44% 46% 10%
Controls
Working 16 15 1 143.33 27.10 92-207
Retired 11 11 3 141.09 29.76 91-207
% 47% 46% 7%
12.2.1.1 Descriptive statistics
The descriptive statistics show that the number of participants in each phenotype group
is consistent with what has been reported in other populations. For example, Brophy et
al (2001) found that around 9-10% of individuals of Northern European origin were
homozygous for the R192 PON1 isoform, 41% were heterozygous for the QR isoform
and 49% were homozygous for the QQ isoform.
Mann Whitney U test was carried out on overall ARElase levels between the exposed
cohort and the controls. No significant difference was found between farmers and
controls in terms of overall ARElase levels (U=2479.5, p=.13), nor when split into
working and retired cohorts (U=743, ns; U=519, ns respectively). This suggests that the
farmers are no more susceptible to the neurotoxic effects of OPs than controls.
12.2.1.2 Phenotype and activity levels
Previous research has found the PON1 R192 isoform hydrolyses diazoxon more slowly
than the Q192 isoform (Cherry et al, 2011; Davies et al, 1996). However, enzyme
activities vary greatly among individuals with the same genotype, so it is important to
measure enzyme activity in addition to genotype.
Table12.2 shows the activity levels for the different phenotypes for the participants who
took part in the current study.
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Table 12.2 PON1 activity and phenotype for all study participants.
N Mean SD
QQ 72 155.78 37.62
QR 73 144.71 29.01
RR 14 131.84 20.56
A one-way ANOVA with Brown-Forsythe correction revealed that there was a
significant effect of phenotype on activity levels (F(2,144.68)=5.42, p<.01) and Games-
Howell post hoc tests showed that this was due to the activity in the QQ group being
significantly greater than the RR group (p<.01). Thus the findings of this study are in
line with those previously reported.
12.2.2 How do our findings compare to other studies that have been undertaken around
the world? Is there a vulnerable subgroup of farmers with low PON1 activity?
Table 12.3 illustrates that arylesterase levels were slightly higher in this cohort than that
reported in other populations (Davies et al 1996; Ekerson, Wyte & La Du 1983; Richter
and Furlong 1999; Richter et al. 2009; van Himbergen et al, 2008). Furthermore, no one
included in this study had arylesterase levels less than 71 units/ml. This is notably
higher than the lowest values reported by several earlier studies which were generally
under 50 units/ml (Davies et al 1996; Furlong 2008, unpublished data; Holland et al,
2006). This indicates that there were no poor metabolisers in the exposed cohort
examined in the current study (see Figure 12.1). This may have occurred because we
inadvertently excluded them from the study.
Participants with a history of acute symptoms following exposure to OPs were excluded
from the study in order to restrict the focus to low level exposure. Low level exposure
was defined as exposures which do not result in symptoms of acute toxicity. However,
it is possible that individuals who experience symptoms of acute toxicity do so because
of low PON1 activity levels and not because the level of OP in the environment was
unduly high. Four percent of potential study participants were excluded because of a
history of acute symptoms following exposure to OPs. In addition, thirteen percent of
potential study participants were excluded because they had a history of heart disease or
pre-existing neurological problems (e.g. cerebrovascular disease and Parkinson’s
disease), but low PON1 activity has been associated with these conditions (Costa &
Furlong, 2002; van Himbergen et al, 2008; Zintzaras & Hadjigeorgiou, 2004). The
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initial reason for excluding these people was to ensure that any cognitive deficits
identified in this study were due to OP exposure rather than pre-existing disease,
however, it is possible that we inadvertently excluded a sub-group of individuals who
are particularly susceptible to the toxic effects of OPs as a result of low PON1 activity.
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Figure 12.1 PON1 status of sheep farmers with a history of
exposure to low levels of OPs in sheep dip.
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Table 12.3 Mean ARElase levels reported by earlier studies. Comparison with the findings from
the current study.
Study Population QQ QR RR Overall
mean
Range
Current
study 2011
Farmers 165.33
(38.82)
(n=45)
143.59
(30.39)
(n=47)
132.37
(20.68)
(n=10)
152.08
(35.58)
(n=102)
71-243
Controls
From UK
139.87
(29.92)
(n=27)
146.74
(26.81)
(n=26)
130.50
(23.34)
(n=4)
142.34
(28.06)
(n=57)
91-207
Furlong
2008*
Navy Seals 136.1
(34.09)
(n=370)
132.9
(30.16)
(n=352)
116
(31.10)
(n=106)
MD <50-275
Davies et al
1996
Hispanics 138
(37)
(n=78)
131
(28)
(n=41)
145
(32)
(n=18)
136
(32)
(n=92)
57-235
Holland et al
2006
Latino mothers
from USA
151.9
(n=39)
144.3
(n=61)
152.2
(n=30)
149.2
(n=130)
19.8-281.4
van
Himbergen
et al 2008
Postmenopausal
women from the
Netherlands
84
(24)
(n=785)
89
(25)
(n=589)
94
(25)
(n=140)
87
(25)
(n=1527)
MD
Ekerson et al
1983
Controls from
USA
116
(33)
(n=159)
115
(30)
(n=144)
121
(29)
(n=45)
MD ~25 -
~245
Wills et al
2010
ALS patients MD
(n=68)
MD
(n=55)
MD
(n=17)
150.3
(38.9)
(n=140)
MD
Controls
From USA
MD
(n=82)
MD
(n=61)
MD
(n=10)
142.1
(35.5)
(n=293)
MD
*unpublished data from Professor Furlong’s laboratory. ALS = Amyotrophic lateral sclerosis; MD some
data is missing as not all studies report all the data listed in the table.
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12.3 Is there a relationship between dippers flu and PON1?
12.3.1 Activity
A number of participants (33.8% of the working cohort and 50.9% of the retired group)
reported that throughout their working life they suffered repeated episodes of ‘dippers
flu’ which may reflect undiagnosed, untreated acute toxicity. To test the hypothesis that
study participants who report dippers flu may represent a vulnerable subgroup of
farmers with low PON1 activity, a comparison of ARElase levels amongst participants
who did an did not report a history of dippers flu was undertaken.
ARElase levels were similar for participants who reported dippers flu, versus those who
did not (overall - U=2162, ns; working - U=499.5, ns; retired - U=541, ns).
Participants who reported a history of dippers flu were also asked to estimate how
frequently they suffered from it during their working lives and the options they could
choose from were: every time they dipped sheep, most times, sometimes, not often, or
once or twice. A Spearman correlation revealed no significant relationship between
frequency of dippers flu and ARElase levels (rS=.05, ns).
12.3.2 Phenotype
To investigate the potential role that PON1 phenotype may play in the incidence of
dipper’s flu, the number of participants who reported such symptoms was investigated
for each of the three subgroups (QQ, QR, RR). While 35.5% of participants with the
QQ phenotype reported a history of dipper’s flu, this was true for 44.4% of QR
participants and 60% of the RR group.
As previous research has suggested that participants with the RR allele may be worse at
metabolising OPs, odds ratios were calculated for the incidence of dipper’s flu for
participants who phenotype RR compared to QQ. It was found that participants with
the RR allele were 2.7 times more likely to report having dipper’s flu than those with
QQ isoforms.
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12.4 Relationship of PON1 status and cognition in the exposed participants
12.4.1 Activity
To investigate the relationship between PON1 activity and cognition, Spearman
correlations were run between ARElase levels and cognitive domain z-scores (see Table
12.4). Only two nominally significant correlations were found. The first was between
ARElase levels and auditory memory, although it was in the opposite direction to what
would be expected in that participants with higher ARElase levels obtained lower scores
on tests of auditory memory. The other significant relationship was in the dippers flu
group. Participants with higher ARElase levels performed better on a test of fine motor
skills than those with lower ARElase levels. However, while these findings were
nominally significant, only the latter survived Larzelere and Mulaik corrections.
Table 12.4 Relationship between PON1 activity and cognitive domain z-scores.
All exposed Dippers Flu
No Dippers
Flu
Working Memory -0.01 -0.05 0.05
Visual Memory -0.05 -0.02 -0.08
Auditory Memory -0.21* -0.08 -0.26
Response Speed 0.11 0.20 0.05
Verbal Ability -0.06 -0.15 0.01
Mental Flexibility
Inhibition 0.08 0.10 0.04
Strategy Making 0.06 0.05 0.05
Verbal Visual Reasoning -0.11 -0.20 -0.07
Visio-Spatial Ability -0.03 -0.11 0.00
Fine Motor Control 0.16 0.52*** 0.06
Asterisks denote 2-tailed significance: *** - p<.001; * - p<.05
Further analyses were undertaken in which the exposed cohort were split into upper and
lower levels of ARElase based on a mean and median split. A series of Mann Whitney
U tests found no significant differences between participants with high and low PON1
levels in any of the cognitive domains in terms of mean, median or quintile split. The
same tests were carried out for exposed participants both with and without dippers flu.
Only one significant result was found: for participants with dippers flu, participants with
high ARElase levels based on a median split had significantly better fine motor skills
(mean z-score = .42, SD = .50) than those with lower PON1 levels (mean z-score = -.14,
SD = .79; U=331.5, p=.005).
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12.4.2 Phenotype
To investigate the difference in cognitive ability for each of the PON1 phenotypes, a
selection of one way ANOVAs for these three subgroups (QQ, QR, RR) were carried
out on each of the 10 cognitive domain z-scores. None of the results were significant
(largest F=1.36). However, given that there were only 10 participants in the RR group
it is not surprising that no effects were found. Therefore, the possible effect of
phenotype on cognitive performance was investigated in a different manner.
The performance of participants on each of the 10 cognitive domains were split into
quintiles, and the proportion of participants falling into the lower quintile were looked
at in relation to their PON1 phenotype. This can be seen in Figure 12.2.
Figure 12.2 Proportion of participants within each phenotype falling into the bottom quintile of
performance for each of the cognitive domains.
As before, the role of phenotype was investigated by calculating odds ratios were for
each of the 10 cognitive domains for participants who phenotype RR compared to QQ
(these can be seen in Table 12.5). An odds ratio greater than 1 indicates that the
participant is more likely to fall into the lowest quartile when they are in the RR group.
In contrast, an odds ratio less than 1 indicates being in the lowest quartile of
performance is more prevalent in the QQ group.
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Results showed that in seven out of ten of the cognitive domains, participants with the
RR isoform were more likely to fall into the bottom quintile than the QQ participants.
In fact, the odds of being in the bottom quintile in the RR group were more than double
that for the QQ group on measures of Working Memory, Visual Memory and Verbal-
Visual Reasoning. However, the opposite was true for Fine Motor Control.
Table 12.5 ODDs ratios for each of the 10 cognitive domains investigating RR versus QQ.
Cognitive Domain ODDS Ratio
Working Memory 2.67
Visual Memory 2.34
Auditory Memory 0.77
Response Speed 0.86
Verbal Ability 1.71
Mental Flexibility 1.71
Strategy Making 1.50
Verbal-Visual Reasoning 3.61
Visuo-Spatial Ability 1.18
Fine Motor Control 0.27
12.5 Relationship of PON1 status and mood in the exposed participants
12.5.1 Activity
To investigate the relationship between PON1 activity and mood, Spearman correlations
were run between ARElase levels and HADS, BDI and BAI scores. No significant
correlations were found.
As before, further analyses were undertaken in which the exposed cohort were split into
upper and lower levels of ARElase based on a mean, median or quintile split. A series
of Mann Whitney U tests found no significant differences between participants with
high and low PON1 levels for any of the measures of mood.
12.5.2 Phenotype
To investigate the potential influence of PON1 phenotypes on mood, a selection of one
way ANOVAs for these three subgroups (QQ, QR, RR) were carried out on each of the
anxiety and depression measures. Again, none of the results were significant.
As before, the role of phenotype was investigated by looking at the number of
participants who score above clinical cut-offs for depression and anxiety for each
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isoform group, and calculating odds ratios (which can be seen in Table 12.6). An odds
ratio greater than 1 indicates that the participant is more likely to score above clinical
cut-offs on mood measures when they are in the RR group. In contrast, an odds ratio
less than 1 indicates the opposite.
Results showed that participants with the QQ isoform were more likely to report
problems with mood than the RR participants. This is the opposite of was expected.
Table 12.6 ODDs ratios for mood in RR versus QQ phenotypes.
Measure Odds Ratio
BDI .36
BAI .40
HADSA .68
HADSD .92
12.6 Relationship of PON1 status and physical symptoms in the exposed
participants
12.6.1 Activity
To investigate the relationship between PON1 activity and physical symptoms,
Spearman correlations were run between ARElase levels and overall health rating,
measure of pain, impact on social life, and reported severity of the 10 symptoms of
interest identified in the previous chapter. No significant correlations were found.
As before, further analyses were undertaken in which the exposed cohort were split into
upper and lower levels of ARElase based on a mean, median or quintile split. A series
of Mann Whitney U tests found no significant differences between participants with
high and low PON1 levels for any of the physical measures.
12.6.2 Phenotype
To investigate the potential influence of PON1 phenotypes on physical symptoms, a
selection of one way ANOVAs for these three subgroups (QQ, QR, RR) were carried
out on each of the physical symptom measures outline in 11.7.1. None of the results
were significant.
As before, the role of phenotype was investigated by looking at the frequency of
symptomatic participants for each of the 10 physical measures for each isoform group.
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This can be seen in Figure 12.3.
Figure 12.3 Proportion of symptomatic participants within each phenotype.
Again, odds ratios were then calculated for each of the 10 domains for participants with
phenotype RR compared to QQ (these can be seen in Table 12.7). An odds ratio greater
than 1 indicates that the participant is more likely to be symptomatic when they are in
the RR group. In contrast, an odds ratio less than 1 indicates the opposite.
Results showed that for seven of the ten physical symptoms participants with the RR
isoform were more likely to report being symptomatic than the QQ participants. In fact,
the odds of being in the bottom quintile in the RR group were more than double that for
the QQ group for Loss of Balance and Sleep Problems.
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Table 12.7 ODDs ratios for each of the 10 key physical symptoms investigating RR versus QQ.
Symptom Odds Ratio
Temperature 1.24
Fatigue 1.57
Loss of Balance 2.27
Sleep Problems 2.78
Memory Problems 1.65
Muscle Weakness 1.50
Decreased Sensitivity n/a
Mental slowing 1.00
Irritability 0.78
Alcohol intolerance 0.75
12.7 Summary
Paraoxonase (PON1) is an enzyme which metabolises oxidized lipids and
organophosphate pesticides such as chlorpyrifos, parathion and diazinon. Genetic
polymorphisms of PON1 have been identified in the coding sequence of PON1
(R192Q) which differ greatly in their activity towards different organophosphate
pesticides and modulate the toxicity of OPs. The R 192 isoform hydrolyses paraoxon
and chlorpyrifos more rapidly than the Q192; but metabolises diazoxon (the toxic
metabolite of diazinon, an OP used in sheep dip in the UK) more slowly than the Q192
isoform. Cherry et al (2002 and 2011) found that the PON1 R192 polymorphism was
more common in sheep farmers reporting ill health than those who are healthy; and ill
farmers were more likely than healthy farmers to have low serum hydrolytic activity for
diazoxon.
An important objective of the current study was to determine whether differences in the
capacity to metabolise OPs render some individuals more vulnerable to the effects of
OPs than others. Results revealed that the number of participants who fell into each
phenotype group is consistent with what has been reported in other populations, but
mean ARElase levels were higher as were the lowest values noted. This indicates that
there were no poor metabolisers in the exposed cohort, something which may have
occurred because our exclusion criteria included diseases associated with low PON1
activity. No relationships were found between PON1 activity levels neurobehavioural
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and/or health outcomes, possibly because our distribution/range of ARElase values was
restricted. However, analysis by phenotype revealed lower PON1 activity in the RR
group and individuals with the RR isoform were more likely to fall into the lowest
quintile of performance on cognitive tests, particularly working and visual memory and
reasoning tasks; and were more likely to complain of physical symptoms associated
with exposure to OPs.
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Chapter 13 : Meta-analysis Revisited
13.1 Overview
In Chapters 3 and 4 a systematic review of the literature was undertaken along with
quantitative evaluation of study findings using meta-analysis. Meta-analysis is a useful
method of quantifying the results of different studies to establish if an association exists
between specified variables in a group of studies. In this section the meta-analysis is
repeated, incorporating the findings from the current study. Figure 13.1 is a forest plot
depicting effect sizes from the initial 12 studies described in Chapters 3 and 4 plus the
findings from the current study.
Figure 13.1 Forest plot depicting effect sizes for each of the studies in date order and 95%
confidence intervals.
The overall effect size for the current study (based on Glass’s delta and the population
mean) is moderate ES = - 0.652. Most of the effect sizes illustrated in Figure 13.1
cluster around-.03 (overall ES -0.3148, p<0.0053) and the findings from the current
study are in keeping with those from earlier studies. Srivastava et al (2000) and
Mackenzie Ross et al (2007) studies remain the ones which produce the largest effect
sizes. Since the earlier study by Mackenzie Ross et al may be biasing the overall
Rodnitzky et al 1975
Ames et al 1995
Stephens et al 1995
Fiedler et al 1997
Bazylewicz-Walczak et al 1999
Srivastava et al 2000
Steenland et al 2000
Farahat et al 2003
Stephens et al 2004
Roldan-Tapia et al 2005
Roldan-Tapia et al 2006
Mackenzie Ross et al 2007
Current Study
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findings, all subsequent analyses and results illustrate the effect of including and
excluding that study on the overall findings.
Table 13.1 Meta-analysis using a random effects model illustrating the effect of including the
findings from the current study and excluding the earlier study by Mackenzie Ross et al (2007).
-Asterisks denote significant effects: * p<.05; ** p<.01
Excluding the study by Mackenzie Ross et al (2007) does not render the overall findings
non significant, but does result in a large reduction in the heterogeneity rating. Removal
of the study alters the overall balance and comparability of remaining studies which
appear more homogeneous once it has been excluded; but the overall effect size
produced by the meta-analysis remains significant. The convention with regard to
interpreting effect sizes is that d=0.2 to 0.5 is ‘small’; 0.5-0.8 is medium and >0.8 is
large; hence the overall effect size found in the current analyses of between -0.2251 and
-0.3148 (depending upon whether the study by Mackenzie Ross et al 2007 is included or
not) can be classified as small. The fail safe N, which estimates the number of studies
with a zero effect needed to make the results of the current meta-analysis non
significant, is 84.
13.2 Effect of cognitive task
Thus far the meta-analysis has incorporated data from all of the psychometric tests
administered in a given study (i.e. multiple effect sizes were calculated) and then a
single mean effect size within each study was computed before undertaking the meta-
analysis. To determine whether task parameters might influence effect sizes the meta-
Glass Delta Mean
Current findings included.
Mackenzie Ross et al 2007
excluded
Glass Delta Mean
All 13 studies included
Overall ES -0.2251 -0.3148
95% CI
lower
-0.402 -0.5361
95% CI
upper
-0.0482 -0.0934
z 2.4939* 2.7867**
t^2 0.0541 0.1168
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analysis was repeated but this time cognitive tests were grouped into cognitive domains
and a single effect size was calculated for each domain by averaging the effect sizes
across all measures within that domain. Table 13.2 summarises the results of meta-
analysis by cognitive domain. For each domain, the first row illustrates the effect sizes
produced by all studies whilst the second row illustrates the findings when the study by
Mackenzie Ross et al (2007) which produces the largest effect sizes, is removed.
Table 13.2 Meta- analyses by cognitive domain (italic illustrate the findings when the study by
Mackenzie Ross et al (2007) is removed).
Cognitive Domain No studies Overall ES Lower CI Upper CI z t^2
Working Memory 12 -0.338 -0.595 -0.080 2.568* 0.156
11 -0.266 -0.511 -0.022 2.134* 0.123
Visual Memory 10 -.0297 -0.532 -0.062 2.475* 0.096
9 -0.217 -0.421 0.014 2.096* 0.054
Verbal Memory 9 -0.152 -0.486 0.182 0.893 0.214
8 -0.007 -0.218 0.233 0.062 0.065
Attention 9 -0.263 -0.511 -0.014 2.078* 0.099
8 -0.142 -0.325 -0.041 1.524 0.031
Speed 13 -0.531 -0.899 -0.163 2.825** 0.407
12 -0.320 -0.541 -0.100 2.848** 0.106
Executive function 10 -0.399 -0.796 -0.002 1.969* 0.361
9 -0.201 -0.504 0.101 1.304 0.171
Visuo-spatial 5 -0.370 -0.616 -0.123 2.938** 0.029
4 -0.295 -0.531 -0.060 2.455* 0.015
Language 7 -0.267 -0.548 0.014 1.864 0.093
6 -0.105 -0.249 0.039 1.433 0.002
FMC 4 -0.462 -1.075 0.150 1.480 0.354
Mood 5 -0.517 -1.044 0.012 1.920 0.310
-Asterisks denote significant effects: * p<.05, ** p<.01 and ***p<.001
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As before, the neuropsychological tests which produced the largest effect sizes included
tests of working memory (digit span), psychomotor speed and visuo-spatial ability.
However, the initial analyses found tests of fine motor control produced significant
effect sizes but the current analysis did not and instead found visual memory tests and
mood measures produced significant effect sizes. Figure 13.2 shows stem and leaf
displays of effect size data for the cognitive domains which produced the largest effect
sizes during the current analysis. Table 13.3 illustrates similarities and differences in
findings between the initial and current meta-analyses.
Psychomotor speed (12 studies) Working memory (11 studies)
Stem Leaf Stem Leaf
1 1
0 0,0,0,1 0 0,0,1,1,1
-0 0,1,1, 2,5,6,7,8,8 -0 1,2,4,6,7
-1 -1 3
Visual memory (9 studies) Visuo-spatial ability (4 studies)
Stem Leaf Stem Leaf
1 1
0 0,0 0
-0 0,1,1,1,4,5,7 -0 1,4,5,5
-1 -1
Mood (5 studies)
Stem Leaf
1
0 1,3
-0 5,9
-1 2
Figure 13.2 Stem and leaf displays of the effect size data for the cognitive domains which produced
the largest effect sizes (Mackenzie Ross et al study removed).
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Table 13.3 Neuropsychological tests producing the largest effect sizes.
Initial meta-analysis
(Chapter 3)
Revised meta-analysis
Working memory Working memory
Speed Speed
Visuo-spatial ability Visuo-spatial ability
Fine motor control Verbal memory
Mood
13.3 Summary
In Chapters 3 and 4 the findings from a systematic review of the literature investigating
the functional consequences of long term low level exposure to OPs were reported. The
majority of well designed studies found a significant association between long term, low
level exposure to OPs and impaired neurobehavioural function, which was small in
magnitude and concerned primarily with neurobehavioural functions such as working
memory, psychomotor speed, fine motor control and visuo-spatial ability. In this
chapter meta-analyses were repeated, incorporating the findings from the current study,
to determine whether the findings are consistent with earlier work.
The overall effect size for the current study was found to be moderate in size and
slightly higher than that found in the majority of previous studies, but lower than studies
by Srivastava et al (2000) and Mackenzie Ross et al (2007) which produced moderate to
large effect sizes.
When the findings from the current study were included into a meta-analysis which
assimilated the results from 13 studies and over 1500 subjects, a significant association
was found between exposure to low levels of OPs and decrements in cognitive function,
which is small in magnitude and consistent with the findings reported in Chapters three
and four.
Earlier research suggests some cognitive functions are affected to a greater degree than
others by exposure to OPs and tests of psychomotor speed, reaction time, fine motor
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control, attention and memory are particularly sensitive to OP exposure; and non verbal
abilities tend to be affected to a greater degree than verbal abilities which do not appear
sensitive to neurotoxic effects (Anger, Otto & Letz, 1996; Anger et al, 1997; Anger et
al, 2000; Hartman 1995; Lucchini et al 2005 ). The finding of the current meta-analysis
were in broad agreement with previous research in terms of the neurobehavioural
domains affected which included slowing of reaction times and reduced performance on
tests of working memory (digit span) and visuo-spatial ability. Consistency of findings
across many studies strongly suggests the association between long term, low level
exposure to OPs and impaired neurobehavioural function is real and unlikely to be due
to alternative explanations. For example, impairment due to psychosomatic disorder,
malingering or stress would be more likely to produce a pattern of global deficit or
variable, inconsistent symptom profiles. It seems reasonable to conclude that low-level
exposure to organophosphates has subtle and specific effects on the central nervous
system, resulting in neurobehavioural problems which may not be apparent to health
care professionals unless patients undergo formal evaluation utilizing sensitive
neuropsychological tests.
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Chapter 14 : Discussion
14.1 Overview
This chapter will provide an overview of the findings of the empirical study described
in this thesis. Results will be discussed with respect to the study objectives described in
Section 5.1.1 and existing literature in this area. Potential limitations of the study
design and sources of bias will then be considered following which the implications of
the study findings and directions for future research will be explored.
The primary objective of this thesis was to determine whether low-level exposure to
OPs (insufficient to cause acute intoxication) is associated with disabling
neuropsychological and psychiatric disease. The initial step taken to address this
question involved carrying out a systematic review of the existing literature concerning
the functional consequences of long-term low-level exposure to OPs, described in
Chapters 3 and 4. Previous research has produced inconsistent findings, possibly
because the large body of literature that exists concerning the neurotoxicity of OPs
incorporates a range of different methodologies, populations examined and outcome
measures. While some studies find evidence of ill health and cognitive impairment
following low level organophosphate exposure (Amr et al, 1997; Bazylewicz-Walczak
et al, 1999; Farahat et al, 2003; Mackenzie Ross et al, 2007; Roldan-Tapia et al 2005
and 2006; Steenland et al, 2000; Srivastava et al, 2000; Stephens & Sreenivasan, 2004;
Stephens et al, 1995), others do not (Ames et al, 1995; Fiedler et al, 1997; Jamal et al,
2001; London et al, 1997; Rodnitzky et al, 1975).
To date, the only published reviews investigating the potential link between low-level
OP exposure and neuropsychological deficits have been qualitative (Alavanja et al,
2004; Arcury & Quandt, 1998; Brown & Brix, 1998; Colosio et al, 2003; COT report,
1999: Davies, 1990; De Silva et al, 2006; ECETOC Report 1998; Jamal et al, 2002;
Kamel & Hoppin, 2004; OCFP Report, 2004; Ray, 1998; Royal Colleges’ Report, 1998;
Soltaninejad & Abdollahi 2009). As such, this thesis sought to extend these findings by
including a quantitative evaluation of previous study findings using meta-analysis.
Meta-analysis is a useful method of quantifying the results of different studies to
establish if an association exists between specified variables in a group of studies. It
does this by representing each study’s findings in the form of effect sizes which are a
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statistical standardisation of study findings based on standard deviation units.
Combining information across studies in this way increases statistical power to detect
small effects that may be missed by individual studies which are too small to yield a
valid conclusion (Zhou et al, 2002).
Data from more than 1,400 participants was aggregated in order to produce a more
reliable estimate of the association between exposure to OPs and neuropsychological
impairment. The analyses described in Chapter 4 showed that the majority of well
designed studies find a significant association between long-term, low-level exposure to
OPs and impaired cognitive function, which is consistent, small to moderate in
magnitude and concerned primarily with neurobehavioural functions such as working
memory, psychomotor speed, fine motor control and visuo-spatial ability. However, a
number of unresolved issues remain in the literature concerning the precise nature of the
relationship between exposure to OPs and neurobehavioural function and whether the
strength of the association has been under- or over-estimated.
In order to address methodological weaknesses of earlier work, an empirical study was
designed and undertaken as part of this thesis. Findings from this four year empirical
study are described in Chapters 5-13. The study involved a comparison of
neuropsychological performance in 127 UK sheep farmers with a history of low-level
exposure to organophosphate pesticides and 78 non-exposed controls (matched for age,
gender, years in education and intellectual ability). Information was also obtained about
physical and mental health. Study participants who had retired on ill health grounds
were included to take account of the ‘healthy worker effect’, something previous studies
had failed to do. Participants with a history of acute poisoning and those with a
psychiatric or medical history that might otherwise account for ill health were excluded;
exposure history was examined in detail and objective, reliable, valid,
neuropsychological tests were used which are known to be sensitive to neurotoxic
effects. Finally genetic factors that may render some individuals more vulnerable to the
effects of OPs than others were explored. The primary aim of this empirical study was
to establish whether farm workers with a history of low-level exposure to OPs show
evidence of physical disease, cognitive impairment and / or mood disorder; and to
determine the nature and severity of any deficits or symptoms identified.
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14.2 Findings in relation to primary objectives
A range of emotional, physical and cognitive problems were identified in sheep farmers
with a history of low level exposure to OPs and are described below:
14.2.1 Cognitive function
In terms of cognitive function, general intellectual ability, reasoning, visuo-spatial and
verbal ability were relatively well preserved, but sheep farmers obtained lower scores
on tests of response speed, working, verbal and visual memory, mental flexibility and
fine motor control, than non-exposed controls. These differences remained after
controlling for Type I errors. Few differences were found between working and retired
farmers in terms of the cognitive deficits identified.
14.2.1.1 Possible confounding factors
While the results described above suggest that long-term, low-level exposure to OPs
causes a significant pattern of cognitive deficit, it is possible that the findings were
caused by extraneous variables. Previous research has shown that depression and
anxiety can significantly alter cognitive performance and so it is standard practice to
take account of participants’ mood scores when analysing their performance on
neuropsychological tests. To examine whether the patterns of deficit observed in the
initial analysis could have been driven by the potentially confounding effects of anxiety
and depression on cognitive performance, the data was re-analysed after controlling the
effects of mood statistically or removing all farmers who scored in the clinical range for
anxiety and/or depression on a self report measure (HAD). The same areas of deficit
remained after the effects of anxiety and depression were removed.
A second possibility is that the pattern of deficit observed in sheep farmers was driven
by accidental inclusion of study participants with a history of undiagnosed acute
exposure. To determine whether this was the case the data was re-analysed after
removing all farmers who had reported a history of ‘dippers flu’. The same areas of
deficit remained even after removal of these subjects.
A third possibility is that the pattern of deficits identified in sheep farmers was due to
the use of an inappropriate control group (i.e. rural police workers) who differ from
farmers in some important way other than exposure history, resulting in exaggerated
group differences. To determine whether this was the case, the performance of sheep
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farmers on neuropsychological tests was compared to test norms derived from a cross
section of healthy adults in the general population. The same pattern of deficit was
evident whether sheep farmers were compared to rural police workers or a cross section
of healthy adults from the general population.
It therefore seems reasonable to conclude that the lower performance observed in
exposed farmers relative to unexposed controls, on neuropsychological tests, is unlikely
to have occurred by chance or to be due to the confounding effects of mood disorder,
undiagnosed acute exposure or selection of an inappropriate control group.
14.2.2 Mood disorder
In terms of emotional well-being, several measures of mood were included in this study.
Rates of depression and anxiety were much higher amongst farmers than controls,
especially amongst retired farmers. Rates differ according to the method used to
evaluate mood in that a smaller percentage of farmers were found to meet DSM-IV
criteria for a diagnosis of anxiety or depression than the numbers who complain of
significant levels of distress on self-report screening tools.
An important issue is the extent to which the mood disorder observed in farmers is due
to exposure to OPs as opposed to lifestyle factors. No significant correlations were
observed between indices of exposure to OPs and mood raising the possibility that OP
exposure is not an important aetiological factor in the development of anxiety and
depression. Retirement per se is unlikely to be solely responsible for the mood disorder
observed in retired farmers as controls who had also retired on ill health grounds had
lower rates of mood disorder than farmers. Stressful life events, although associated
with increased severity of mood disorder, are unlikely to be solely responsible for
elevated rates of anxiety and depression in farmers as the rate of recent stressful life
events is equivalent in the exposed farmers and unexposed controls. Rather, elevated
rates of anxiety and depression reported by sheep farmers appear to be related to
deteriorating physical health and well being.
14.2.3 Physical health
In terms of physical health, farmers who took part in this study reported significantly
worse general health than controls and an increased number of moderate to severe
symptoms. The ten physical symptoms which readily distinguished the exposed and
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control groups were fatigue, mental slowing, memory problems, irritability, sleep
problems, reduced sensitivity (parasthesia), muscle weakness, loss of balance,
temperature dysregulation, and alcohol intolerance. These are consistent with those
reported in earlier studies (Ahmed & Davies 1997; Beach et al, 1996; Davies et al,
1999; Dunn, 2002; Fletcher et al, 2005; Jamal et al, 2002; Mackenzie Ross et al, 2007;
Pilkington et al, 2001; Solomon et al, 2007; Tahmazet al, 2003). However, the
frequency with which they suffered from these symptoms did not correlate significantly
with indices of exposure. Nevertheless, the odds of a participant being symptomatic
were higher for those in the highest exposure quintile than those who were not and this
suggests OP exposure may indeed have a role to play in physical health, but the
relationship may not be linear.
14.2.4 Dose effect relationship
As stated above, the primary aim of the study was to establish whether farm workers
with a history of low-level exposure to OPs (insufficient to cause acute intoxication)
show evidence of physical disease, cognitive impairment and / or mood disorder.
Although differences were noted between exposed and unexposed study participants
these could have been caused by confounding factors which were not measured or
controlled for in the study. Therefore, the relationship between indices of exposure and
measures of cognitive function, mood and physical health was explored.
Unfortunately, there is no biomarker of chronic, long term exposure to organophosphate
pesticides so it was not possible to quantify levels of exposure or analyse precise
dose/response relationships by objective means. Instead, exposure had to be estimated
via self-report. Measuring exposure in this way may be problematic as self report may
be distorted by inaccuracies of memory and response bias (e.g. a tendency to over or
underestimate). Given farmers in this study were being asked to provide details of work
history extending back over the course of their lifetime and given farmers in this study
showed evidence of memory impairment, the accuracy of the exposure information they
provided is open to question, thus reducing the chance of finding significant or reliable
associations.
Farmers were asked to complete a questionnaire regarding their exposure history. This
revealed that study participants had been exposed to OPs through sheep dipping for an
average of 24 years and farmers typically dipped once or twice a year for one to two
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days. However, there was a degree of variability amongst individuals in terms of their
exposure history with some participants deviating from the normal pattern on one or
more variables such as duration, frequency or intensity of exposure. Exposure metrics
were constructed in an attempt to consider these different aspects of exposure history
simultaneously. However, the exposure indexes also produced variable results raising
questions about their validity.
Statistical analyses were undertaken to determine whether a linear relationship exists
between indices of exposure and cognitive function. A number of significant, negative
correlations were found between duration of exposure (but not the exposure metrics)
and visual memory, response speed, verbal ability, mental flexibility, strategy making
and verbal-visual reasoning. However these were lost following statistical correction for
Type I error. This can be interpreted in two ways (1) the cognitive deficits identified in
farmers were not caused by exposure to OPs but by some other confounding factor
which was not measured in this study (2) the cognitive deficits identified in study
participants were caused by exposure to OPs, but may have been lost for one (or more)
of the following reasons:
 The association was small and eradicated following the application of overly
conservative statistical methods.
 The study did not include a sufficient number of participants to reliably detect
small effect sizes.
 Accurate estimation of exposure was impossible and critical exposure data was
not captured, rendering exposure measures invalid.
 The relationship between exposure to OPs and neurobehavioural functioning is
not linear.
14.2.4.1 Statistical correction
As mentioned previously, a debate exists in the literature concerning the need to make
p-value adjustments when multiple outcome measures have been used, as this increases
the risk of Type II error, particularly when subtle or rare effects are being investigated
(Feise, 2002; Moran, 2003). Some researchers recommend adjusting the p-values when
multiple measures have been used to reduce the risk of finding spurious, false positive
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results which have occurred by chance (Bland & Altman, 1995; Ludbrook, 1998; Rice,
1989). Other authors argue that adjustments such as Bonferroni are overly conservative
and in reducing the chance of making a Type I error, the risk of Type II error is
increased (Feise, 2002; Moran, 2003). Moran (2003) points out that the probability of
finding several consistent significant results in a study and for all of them to be due to
chance is low, and although spurious results are likely when multiple measures are used,
Moran asserts that these should not concern researchers as they are unlikely to be
replicated in future studies. He goes on to argue that the application of statistical
correction when multiple outcome measures are used is tantamount to punishing a
researcher for undertaking detailed work as it lowers the probability of finding
significant results; and furthermore, there is no consensus on when to apply statistical
correction. For example there is debate regarding whether corrections should be
restricted to specific sub-sections of results, whether they should be applied to all of the
results from a study in one go, whether they should be applied to all papers published in
a journal, or to all of the research undertaken on a given topic (Feise, 2002; Moran,
2003). Clearly the latter would make it impossible to ever reject the null hypothesis for
a topic under investigation.
Feise (2002) and Moran (2003) suggest study findings should be interpreted within the
context of study design, methodology, sample size and whether the results are replicated
by others, rather than relying on overly conservative statistical methods. Austin
Bradford-Hill, a medical statistician, devised criteria to assist researchers in determining
whether significant results are due to real biological effects rather than random chance
(Bradford-Hill, 1965). The main principles set forward by Bradford-Hill, which he
suggests researchers should consider before concluding there is adequate evidence of
causation, are:
(1) The strength of the association observed between two variables - the stronger the
association between two variables the less likely it is that the relationship is due to
chance or extraneous variables. However, a small association does not mean there is not
a causal relationship.
(2) Consistency of findings – previous research should report similar findings.
(3) Biological gradient – there should be some sort of dose response relationship, in that
greater exposure should be associated with greater risk.
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(4) Temporal sequence – exposure should precede the outcome for it to have a causal
relationship with it.
(5) Biological or theoretical plausibility – there should be a plausible mechanism
between cause and effect, consistent with current understanding of underlying
processes.
(6) Coherence with established knowledge – any association between variables should
be compatible with existing theories, hypotheses and research evidence.
(7) Specificity of the association – the cause should be tightly linked to outcome and
alternative explanations should be ruled out.
Although the correlations reported in this study were weak, they were in the expected
direction and exhibited a dose response relationship in that greater exposure was
associated with lower performance. The findings were consistent with study hypotheses
and group analyses; and the results were consistent with previous research involving
UK sheep farmers (Mackenzie Ross et al, 2007; Solomon et al, 2007; Stephens, 1995).
The possibility that low level exposure to OPs may cause neurobehavioural problems is
also biologically plausible (see Chapter 2) and of particular interest here is the similarity
between the findings of the present study (i.e. working memory and learning deficits)
and those of animal experiments.
Prendergast, Terry and Buccafusco (1997, 1998) examined the effects of low-level
exposure to organophosphates on memory functioning in rats and found that chronic
exposure to OPs, insufficient to elicit symptoms of cholinesterase toxicity, impaired
new learning in rats but not prior learning/knowledge. This impairment persisted even
after withdrawal from OP exposure. AChE activity in the frontal cortex and
hippocampus was suppressed (areas known to be involved in learning and memory) and
hippocampal AChE activity recovered at a much slower rate than other brain regions.
They conclude that extended exposure to OPs in industrial or agricultural settings may
produce selective impairment of working or short term memory, but may not
significantly affect long term, reference memory.
There are a large percentage of cholinergic nerves in the hippocampal complex,
thalamus and amygdala (Mesulam, 1995). Animals given toxic doses of OPs have
neuropathological lesions characterized by axonal degeneration in these regions of the
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brain. Time course studies have found that lesions extend into brain areas that were not
initially affected, for up to 1 year following exposure, as a result of delayed apopotic
neuronal cell death (i.e. programmed cell death involving free radical generation and
oxidative stress; Abou-Donia, 2005). In addition, Baze (1993) reviewed available
published and unpublished technical reports on Soman (a nerve gas) induced
morphological changes in primates. Lesions, characterised by neuronal degeneration
and necrosis were seen in frontal cortex, entorhinal cortex, amygdaloid complex,
caudate nucleus, thalamus, and hippocampus. These brain regions are associated with
new learning and memory, arousal, attention, executive function, response speed and
emotional regulation, the cognitive functions found to be impaired in the current study
of farm workers exposed to low levels of organophosphate pesticides.
The findings from this study meet Bradford-Hill criteria but before concluding that a
relationship exists between low level exposure to OPs and impaired neurobehavioural
functioning; and number of other potential explanations for the weak association noted
between these variables will be considered.
14.2.4.2 Power analyses
Another possible reason why few correlations were observed between indices of
exposure and cognitive function may be because the study did not include a sufficient
number of participants to reliably detect small effect sizes. For example, power analysis
indicates a sample size of between 21- 394 per group would be needed to obtain
statistical power to detect a small (r=0.2) relationship between exposure and cognitive
function (alpha=.05; power =.80). This range is enormous and reflects different effect
sizes reported by studies in the past (see Chapters 3 and 4). Finding a suitable number of
study participants to take part in the current study, who met our strict
exclusion/inclusion criteria and could be assessed within the time frame allowed by the
grant awarding body meant only 127 exposed sheep farmers (67 working and 60 retired)
and 78 unexposed controls (38 working and 40 retired) were included in the analysis.
Clearly subject numbers are at the lower end of the range recommended by power
analysis, thus limiting our ability to detect significant associations; particularly once we
applied statistical correction; and particularly when considered within the context of the
difficulty experienced in obtaining reliable measures of exposure.
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14.2.4.3 Exposure assessment
The weak dose response relationship observed in farmers may have arisen as a result of
exposure misclassification. As mentioned previously, establishing a causal link between
neuropsychological impairment and exposure to neurotoxic substances is not easy as
objective evidence of exposure is seldom available. Often the most that can be achieved
is a rough estimate regarding level and duration of exposure based on an individual’s
testimony / self report regarding their exposure history (Berent & Alber, 2005). Given
the limits of human memory, it is possible that the exposure information collected in
this study was unreliable and that critical exposure data was not captured, thus reducing
the chance of finding significant associations between exposure and psychological
outcome measures.
14.2.4.4 Linear dose/response curves
Another potential explanation for the weak associations observed in this study is the
possibility that the relationship between exposure to OPs and neurobehavioural
functioning is non-linear. A number of researchers have questioned the assumption that
dose-response relationships are always linear. ‘U’ shaped and inverted ‘U’ shaped
curves have been identified and threshold effects below which health effects are not
apparent, but above which symptoms develop have also been noted (Hartman, 1995;
Peterson Myers et al, 2009). For example, Peterson Myers and colleagues describe how
hormone disrupting chemicals can have dose-response curves in which low doses cause
effects opposite to high does. Low dose can stimulate (possibly by receptor up
regulation) and high dose can inhibit disease (possibly by receptor down-regulation).
OPs have been reported to have hormone disrupting effects, particularly on testosterone
but they also disrupt the regulation of other glands in the body (Karalliedde et al, 2001).
Pancetti et al (2007) and Pope (1999) discuss the fact that OPs have a wide range of
effects which go beyond that of disrupting cholinergic transmission and different toxic
and non-toxic responses can follow exposure. For example, drugs derived from OPs
have been used to treat Alzheimer’s patients in low doses (below that which disrupts
cholinergic transmission) as they can potentiate cognitive function via action on other
enzymes such as acylpeptide hydrolase. Peterson Myers et al (2009) argue that
regulatory toxicology ignores non-monotonicity effects and may therefore
underestimate risk in many cases. Hartman (1995) describes another non-linear model
in which injury to the nervous system only becomes apparent when ageing results in
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depletion of neuronal reserves. Furthermore, genetic differences between individuals in
their capacity to detoxify and metabolise xenobiotics may render some individuals more
susceptible to the effects of certain chemicals than others, thereby compounding any
dose-response relationships which may exist. Hence the secondary aims of this study: to
explore the possibility that some individuals are more susceptible to the neurotoxic
effects of OPs than others.
14.3 Findings in relation to secondary objectives
A secondary aim of this study was to determine whether individuals who have retired
on ill health grounds constitute a particular subgroup of individuals who are more
susceptible to the effects of OPs than others; and to investigate whether genetic
differences in the capacity to metabolise OPs, render some individuals more vulnerable
to the effects of OPs than others.
14.3.1 Is there a subgroup of individuals who are more susceptible to the effects of OPs
than others who have retired from the profession?
Almost all of the studies undertaken in the past concerning the neurotoxic effects of
exposure to OPs have examined individuals who are fit enough to be in employment
and have not considered the possibility that those with disabling disease may have left
work or work in a different or reduced capacity. The only exception to this is the study
by Mackenzie Ross et al (2007) in which two thirds of study participants were farmers
who had retired on ill health grounds. It is possible that the large effect sizes produced
by this study were due, at least in part, to the fact that persons with disabling disease
were included in the study.
The current study took account of the ‘healthy worker effect’ by recruiting participants
who had retired on ill health grounds in an attempt to determine whether they constitute
a subgroup of individuals who are more susceptible to the effects of OPs than others.
No significant differences were noted in terms of the exposure history of retired and
working farmers. The primary reasons for retirement given by farmers was a
constellation of non-specific symptoms including chronic fatigue, headaches, cognitive
impairment, muscular and joint pain, numbness and chemical sensitivity; and a quarter
of these farmers attributed their symptoms to OP poisoning. The primary reason for
retirement given by police workers was musculo-skeletal injury.
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Although differences were found between working and retired farmers on subjective,
self report measures of mental and physical health, few differences were found on
objective measures of cognitive function or in terms of PON1 status. The three PON1
phenotypes were equally distributed amongst working and retired farmers and similar
levels of arylesterase activity were found in each group. As such, our study findings
indicate that individuals who have retired on ill health grounds are not at increased risk
of suffering cognitive impairment following exposure to OPs, but they do report more
physical and emotional problems which would be expected.
14.3.2 Is there a subgroup of individuals who are genetically more susceptible to the
effects of OPs than others?
Regarding the question of whether genetic differences in the capacity to metabolise OPs
render some individuals more vulnerable to the effects of OPs than others, analysis of
PON1 status was undertaken. Paraoxonase (PON1) is an enzyme which metabolises a
number of organophosphate pesticides and genetic polymorphisms of PON1 have been
identified in the coding sequence of PON1 (R192Q) which differ greatly in their activity
towards different organophosphate pesticides and modulate the toxicity of OPs. The R
192 isoform metabolises diazoxon (the toxic metabolite of diazinon, an OP used in
sheep dip in the UK) more slowly than the Q192 isoform. Cherry et al (2002 and 2011)
found that the PON1 R192 polymorphism was more common in sheep farmers
reporting ill health than those who are healthy and in those who report ‘dippers flu’; and
ill farmers were more likely than healthy farmers to have low serum hydrolytic activity
for diazoxon.
Findings from the current study indicate that that there were no poor metabolisers in the
exposed cohort and no relationships were found between PON1 activity levels
neurobehavioural and/or health outcomes, possibly because our distribution/range of
ARElase values was restricted. However, analysis by phenotype revealed lower PON1
activity in the RR group and individuals with the RR isoform were more likely to fall
into the lowest quintile of performance on cognitive tests, particularly working and
visual memory and reasoning tasks; and were more likely to complain of physical
symptoms associated with exposure to OPs. The number of individuals identified with
the RR isoform in the farming cohort was small (n=10) and so this finding needs further
exploration. However, it is consistent with findings from previous research and suggests
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individuals with the RR isoform may represent a vulnerable subgroup of farmers at
increased risk of developing ill health following exposure to OPs.
14.4 Limitations of the current study / potential bias
The empirical study contained in this thesis has several potential weaknesses which
should be considered when interpreting the results.
14.4.1 Sample bias
Population characteristics are usually inferred from measures taken from samples. If a
sample is not truly representative of the population from which it is drawn then it is
impossible to make accurate predictions about the population as a whole. Over fifteen
thousand farmers are listed on the UK Wool Marketing Board Database. As with any
epidemiological study, it was only possible to examine a relatively small number of
participants and it is difficult to determine how representative they are of the farming
community as a whole.
A number of different recruitment methods were used in this study, including written
correspondence, telephone contact and advertising, which could have resulted in
selection bias and differences between working and retired cohorts. For example, most
of the retired farmers volunteered to take part in the study after reading about it in an
advertisement and those with neurobehavioural symptoms would be more likely /
motivated to take part in the study than working farmers recruited via purposive
sampling methods. This may mean the findings from this study overestimate the risk
associated with exposure to OPs. Having said that, our study findings indicate that
individuals who have retired on ill health grounds are not at increased risk of suffering
cognitive impairment following exposure to OPs, although they do report more physical
and emotional problems, which one would expect. In contrast, it is also possible that the
study findings underestimate the risk associated with exposure to OPs because over
60% of potential participants had to be excluded from the study. It is therefore possible
that individuals with disabling disease who are particularly vulnerable to the neurotoxic
effects of OPs were inadvertently excluded as a result of the strict inclusion/exclusion
criteria used.
This thesis also considered the possibility that the control group selected introduced bias
by differing from farmers in some important way that exaggerated group differences.
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However, this is unlikely to be the case as re-analysis of the data utilising test norms
derived from a cross section of the population produced similar findings.
14.4.2 Sample size
As mentioned previously, the number of participants in the current study was relatively
small and subject numbers were at the lower end of the range recommended by power
analysis, thus limiting our ability to detect significant associations. Nevertheless weak
associations were found between indices of exposure and predicted cognitive functions
and significant differences were noted between exposed and unexposed study
participants on neurobehavioural measures and physical health ratings which were
consistent with study hypotheses and previous research.
14.4.3 Recall bias
As mentioned on a number of occasions, obtaining a reliable estimate of exposure is
fraught with difficulty but failure to do so may result in exposure misclassification. In
the current study exposure history was estimated via self-report and the accuracy of this
information is open to question because self report may be distorted by inaccuracies of
memory and response bias (e.g. a tendency to over or underestimate). Another
important source of bias is recall bias, where subjects attribute their difficulties to a
publicized risk factor and exhibit better recall for evidence which confirms their bias
than for evidence which contradicts it. Having said that, study participants were
unaware of study hypotheses, yet they showed a specific pattern of cognitive deficit
which they could not possibly have predicted and replicated. In addition, subjects were
unaware of their PON1 status at the time of assessment and were unlikely to be aware
that previous research has shown that individuals with the R isoform are at greater risk
of developing ill health than other isoforms, yet this finding was supported in the
current study.
In an ideal world a prospective cohort study would allow for more precise quantification
of exposure, but would take a long time and be very expensive to complete. For
example, it is difficult to determine how long the study period should be. If we use the
findings of the current study as a guide, they indicate that exposure to OPs may need to
take place on a regular basis for over 10-20 years before symptoms develop. Prospective
research designs can be difficult when studying rare outcomes as it is necessary to study
a very large number of individuals over time to obtain a sufficient sub-sample of
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individuals with the condition of interest. In the absence of reliable epidemiological
information regarding the prevalence of neurobehavioural problems in the agricultural
community it is impossible to determine what sample size would be required for a
prospective study. Other problems include the loss to follow-up of study participants
involved in prospective studies, participants changing their habits over time or changing
their practices as a result of surveillance. With regard to the former, the practice of
sheep dipping has changed considerably over time. During the 1980s farmers were
required to dip sheep twice a year and they used minimal amounts of protective
clothing. Since the early 1990s farmers have been advised to use greater amounts of
protective clothing and are now required to complete a course on the safe handling of
OP formulations. Compulsory dipping is no longer in force and only takes place in
response to an outbreak of sheep scab. If a prospective study were to be commissioned
now and to include individuals who became involved in farming in the 1990s, results
are likely to differ considerably from previous research (c.f. Mackenzie Ross, 2006
thesis).
14.4.4 Association is not causation
Although group and correlation analyses indicate an association exists between
exposure to OPs and impaired neurobehavioural function, this does not constitute
evidence of causation. Differences between exposed and unexposed cohorts may have
been caused by extraneous variables which this study failed to control for; although
further analyses utilising an alternative comparison group (normative data) suggests this
is unlikely to be the case. It is well known in science that correlation does not imply
causation but it does indicate possible causes. Austin Bradford-Hill, a medical
statistician, devised criteria to assist researchers in determining whether significant
results are due to real biological effects rather than random chance and this study fulfils
those criteria. Hill’s work and that of others, gave rise to the ‘precautionary principle’
which states that “when an activity raises threats of harm to human health or the
environment, precautionary measures should be taken even if some cause and effect
relationships are not fully established scientifically” (Klaassen, 2008).
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14.5 Study strengths
The main strengths of this study include:
14.5.1 Neuropsychological assessment
This study involved detailed neuropsychological assessment which is considered by
many researchers to be the most sensitive means of examining the effects of toxic
exposure as they reveal more regarding sub-clinical effects than internal dose indicators
such as levels of toxins in blood or urine (Berent & Albers, 2005; Hartman, 1995;
Lezak, 2004). Indeed, many toxins are metabolised and excreted quickly in the human
body and may not leave biological markers to prove exposure or allow level of exposure
to be determined. Hence, neuropsychological testing is a useful diagnostic tool in the
assessment of exposed persons. This study allowed the nature and extent of
neurobehavioural problems to be explored in considerable depth, using clinically
sensitive measures rather than administering brief screening tests or research tools
which may lack sensitivity and/or specificity. The psychometric test battery was
designed to cover a range of cognitive functions and included tests which are routinely
used in clinical practice for diagnostic purposes. Farmers were found to have deficits in
particular areas whilst other abilities appeared intact. This is an important finding as
some of the discrepancies noted in previous research may be due to limited test batteries
being employed which do not cover all classes of cognitive function
14.5.2 Consideration of the ‘healthy worker effect’
This was one of the few studies undertaken which took account of the ‘healthy worker’
effect by including individuals who had retired from work on ill health grounds.
Previous studies have focused on individuals who are fit enough to work and may have
underestimated risk.
14.5.3 Consideration of potentially confounding variables
This study considered a number of potentially confounding variables which could be
possible causes of the outcome. For example, individuals with a past medical and
psychiatric history that could otherwise account for ill health were excluded; as were
individuals who have a history of acute exposure, but information was obtained about
possible symptoms of undiagnosed acute exposure ‘dippers flu’ so that this could be
considered in the analysis. The potentially confounding effects of mood state on
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cognitive function were explored as was the possibility that an inappropriate control
group had been selected which differed from farmers in some important way, thus
exaggerating group differences. None of these variables were found to account for the
cognitive deficits identified in farmers.
14.5.4 Measurement of possible vulnerability factors
This study considered the possibility that genetic differences in the capacity to
metabolise OPs may render some individuals more sensitive to the neurotoxic effects of
OPs than others. To this end PON1 status of study participants was determined and
results indicate that individuals who carry the R isoform may be at increased risk of
developing ill health following exposure to OPs.
14.6 Summary
A range of cognitive, emotional and physical problems were identified in agricultural
workers with a history of low level exposure to organophosphate sheep dip. Both
correlation and group analyses suggest a relationship exists between low level exposure
to organophosphates and impaired neurobehavioural functioning. Few differences were
found between working and retired farmers on neuropsychological tests which suggest
those that have retired on ill health grounds are not a uniquely vulnerable subgroup.
The cognitive deficits identified in the exposed cohort are specific and limited to
response speed, working, verbal and visual memory, mental flexibility and fine motor
control. They cannot be attributed to the potentially confounding effects of mood
disorder, malingering, or undiagnosed acute exposure; nor have they arisen because an
inappropriate control group was selected. The pattern of cognitive deficits and physical
symptoms reported are consistent with reports from previous neuropsychological
studies of UK sheep farmers; and this study identified a possible subgroup of
individuals at increased risk of developing ill health following exposure to OPs because
of a genetic difference in the capacity to metabolise OPs. The latter finding is also
consistent with previous research. It therefore seems reasonable to conclude that long-
term, low level exposure to OPs is associated with the development of chronic ill health
involving physical symptoms, cognitive impairment and mood disorder.
216
14.7 Implications
The present findings suggest OP pesticides are more harmful than previously thought,
even at low levels of exposure. This has implications for working practice and policies
and guidelines about the use of organophosphate chemicals and for other occupational
groups who are exposed to organophosphate chemicals on a regular basis, such as
military personnel and aviation workers.
Follow-up studies are needed to determine whether symptoms persist, improve or
worsen. At present, there are no treatment protocols for individuals who report chronic
ill health following exposure to OPs and there is a need for prospective treatment trials.
It is also important to consider the possibility that clear cut dose-response relationships
that might be discernable following acute exposure may not be apparent with low level
exposure. Low level exposure may produce subclinical neurological injury that
accumulates over time and only becomes apparent when specialised neuropsychological
or neurological tests are used to evaluate patients or when neuronal reserves are
depleted by processes such as ageing, thus unmasking deficits (Hartman, 1995).
The findings reported in this thesis also have implications for toxicological testing and
risk assessment as they illustrate the importance of considering behavioural outcomes in
addition to more traditional outcomes such as mortality, organ damage, cancers and
reproductive effects. It is also important for future researchers to consider the possibility
that dose-response curves may not be linear in all cases and that a host of factors may
explain this from characteristics of the chemical under investigation to characteristics of
the organism exposed to the chemical, such as genetic differences in the capacity to
metabolise xenobiotics.
“All scientific work is incomplete –whether it be observational or experimental.
All scientific work is liable to be upset or modified by advancing knowledge.
That does not confer upon us a freedom to ignore the knowledge we already
have or postpone the action that it appears to demand at a given time”
(Bradford-Hill, 1965)
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APPENDICES
APPENDIX 1: ARTICLES CONSIDERED IN THE LITERATURE REVIEW
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Database Searches
Relevant studies from the 1960s onwards were identified from MEDLINE, EMBASE
and PsycINFO databases (via Ovid interface) using both subject headings and textword
search strategies on the 27th August 2009.
Subject heading searches were undertaken first to determine appropriate search terms
for the different databases. These varied considerably, for example, in MEDLINE
articles concerning ‘organophosphates’ are indexed under the following subject
headings: ‘phosphoric acid esters’, ‘organophosphate compounds’, ‘pesticides’ and
‘insecticides’. In PsycINFO they are indexed under the term ‘insecticides’ and in
EMBASE as ‘organophosphate’, ‘organophosphate pesticide’ or ‘organophosphate
insecticide’. Relevant psychological search terms also varied considerably between
databases. Terms were exploded during the searches to ensure the maximum number of
potentially relevant articles were retrieved.
Textword searches were undertaken using synonyms identified from the subject heading
searches, alternate spellings and truncation. Search terms were combined using
BOOLEAN operators (and, or) and searches were refined by limiting them to studies of
human, adult populations and studies published in the English language. For
MEDLINE, the following search terms were used: organophosph* or phosphoric acid
ester* or insecticide* or pesticide* and neuropsycholog* or neurobevio* or behavio* or
cognit* or psychiatr* or psycholog* or anx* or depress* or memory*. For PsycINFO
the terms included insecticide* and neuropsychol* or neuropsychiat* or cognit* or
anx* or depress*; and for EMBASE the terms were organophosph* and neuropsychol*
or neuropsychiat* or cognit* or anx* or depress*.
Details of included/excluded studies
The first step of the review process was to determine whether all 43 articles selected
from the initial screening of titles and abstracts, met inclusion criteria for this review.
This was not always apparent from a review of titles and abstracts. Fourteen studies
were excluded following this second stage of the review because they did not meet the
inclusion criteria listed in Table 1. Five studies were excluded because the information
provided on exposure history was so brief, it was difficult to determine one or more of
the following factors; whether the study concerned low level or high level exposure,
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whether individuals with a history of acute poisoning had been included, whether
individuals had been exposed to OPs as opposed to some other pesticides or the type of
OPs’s individuals had been exposed to was unclear (Bosma et al 2000; Dimich-Ward et
al 1996; Korsak & Sato1977; Kurlycheck & Morrow 1989; Ahmed & Davies 1997).
Another two studies were excluded because they involved case studies of patients who
had been referred for medical evaluation and the exposure and occupational histories of
the cases were extremely variable and not comparable (Richter et al 1992; Kilburn,
1999). Another four studies were excluded because they did not concern
neurobehavioural outcomes following low level exposure; three concerned the
association between physical symptoms and cholinesterase levels in farm workers
(Ciesielski et al1994; Smit et al 2003, Ohayo-Mitoko et al 2000); and one concerned
neurophysiological changes following exposure to sheep dip (Beach et al 1996). Two
studies were excluded because they did not include objective measures of
neurobehavioural function (Davies et al 1999; Solomon et al 2007). The study by Cox et
al (2005) was excluded because it involved evaluations of children as well as adults
following domestic exposure to methyl parathion. The findings from adults and children
were not presented separately.
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Number of potentially relevant articles identified during initial literature searches
Database Number of potentially
relevant articles
identified
Initial
exclusions
Number deemed potentially
relevant following Title &
Abstract review
MEDLINE
Subject
Heading search
Textword
search
186
184
169
159
17
25
PsycINFO
Subject
Heading search
Textword
search
27
21
23
17
4
4
EMBASE
Subject
Heading search
Textword
search
49
95
38
77
11
18
Totals 562 483 79
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Articles selected for further review
AUTHOR ML -
KEY
ML -
TXT
PI -
KEY
PI-
TXT
EB-
KEY
EB-
TXT
1 Ahmed & Davies 1997 X X
2 Albers et al, 2004 X X
3 Ames et al, 1995 X X X
4 Bazylewicz-Walczak et al, 1999 X
5 Beach et al, 1996 X X
6 Besseler et al, 2006 X X
7 Bosma et al, 2000 X
8 Ciesielski et al, 1994 X
9 Cole et al, 1997 X X X X X
10 Cox et al, 2005 X
11 Daniel et al, 1992 X X
12 Davies et al, 1999 X X
13 Dimich-Ward et al, 1996 X
14 Farahat et al, 2003 X X
15 Fiedler et al, 1997 X X
16 Jamal et al 2001 X X X X
17 Kamel et al, 2003 X
18 Kamel et al, 2007 X
19 Kilburn 1999 X
20 Korsak & Sato 1977 X
21 London et al, 1997 X
22 Maizlish et al, 1987 X X
23 Misra et al, 1994 X X
24 Parron et al, 1996 X X
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25 Richter et al, 1992 X
26 Rodnitzky et al, 1975 X
27 Rohlman et al, 2007 X X X
28 Roldan-Tapia et al, 2005 X X X
29 Roldan-Tapia et al, 2006 X X X X X X
30 Rothlien et al, 2006 X X
31 Salvi et al, 2003 X X X X
32 Srivastava et al, 2000 X X
33 Steenland et al, 2000 X X
34 Stephens et al, 1995 X X X X
35 Stephens et al, 1996 X X X
36 Stephens & Sreenivasan, 2004 X X X X
Additions
37 Mackenzie Ross et al, 2007
38 Browne et al, 2006
39 Ohayo-Mitoko et al, 2000
40 Smit et al, 2003
41 Solomon et al, 2007
42 Kurlycheck & Morrow 1989
43 Amr et al, 1997
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Neurobehavioural tests used by previous researchers and the cognitive domains
they were assigned to for the purpose of meta-analysis.
Cognitive domain Tests
Working memory & attention Digit Span Tests
Psychomotor speed Digit symbol
Trails A
Reaction Time simple
AMIPB Speed
Hand/eye co-ordination
Tapping
Attention & vigilance Vigilance
Paced Auditory Serial Addition Test
Letter cancellation
AMIPB Task A
Sustained attention
Continuous performance
Verbal – hold tests Vocabulary
Reading
Naming
Token Test
Sentence
WAIS VIQ
Executive function Similarities
Trails B
Syntactic reasoning
Verbal fluency
Reaction time – choice
Stroop
Visuo-spatial Block design
Line orientation
Benton Visual Form Test
WAIS PIQ
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Visual memory Benton Visual Retention Test
Pattern memory
Face recognition
Picture completion
Rey Ostereith [ROC]
AMIPB figure recall
AMIPB design learning
Figure Recall
Location recognition
Verbal memory Story recall or Logical Memory
Auditory Verbal Learning Test
California Verbal Learning Test
List learning
Serial digit
Category learning
Mood Anxiety measures
Depression measures
Fine motor control Santa Ana Manual Dexterity Test
Pursuit Aiming
Grooved Pegboard
AMIPB = Adult Memory and Information Processing Battery; WAIS = Wechsler Adult Intelligence
Scale.
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APPENDIX 2 – MEASURES
Exposure Questionnaire
Physical Health Questionnaire
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Exposure questionnaire
Name / Code No: _________________________
DOB: ____________________
TEL: __________________________________
A.Occupation
1) Which of the following best describes your occupation (tick)?
Farm Owner __
Farm Tenant __
Farm Manager __
Farm Worker __
Sheep dip contractor __
Other (state) _________________________
2) So are / were you
- employed __ ?
- self-employed __ ?
3) How many years in farming? ______________________________
4) Are you
- working __ ?
- retired __ ?
- semi-retired __ ?
- Changed occupation __ ?
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B. Type of work carried out whilst farming (circle number)
TASK Go to
1 Sheep dipping C
2 Shearing / Handling recently dipped (within 3 weeks) sheep / fleeces D
3 Treating cattle for warble fly / handle treated cattle E
4 Crop / weed spraying F
5 Treating grain or working with treated grain G
6 Working in orchards H
7 Domestic use of pesticides
1) Headlice treatment
2) Pet treatment
3) Fly killer
4) Fumigation
5) Timber treatment
6) Other - specify
I
8 Other work with pesticides J
9 Using solvents (excluding those in sheep dip) K
10 Using lead L
11 Using vibrating equipment M
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C. Sheep Dipping
Go
to
Time scale and extent of exposure
1 When was the last time you
were exposed to sheep dip
product?
2
2 Have you ever applied sheep
dip product using sprays or
showers?
Yes __ State which:
No __
3
4
3 Over what years? State _________________ 4
4 Between what years have you
been involved in dipping
sheep?
5
5 How many times each year? State years if variation: 6
6 For how many days each time? State years if variation: 7
7 For how many hours each day? State years if variation: 8
8 What was the average flock
size (inc. lambs)?
State years if variation: 9
9 Whilst sheep dipping, what was
your main role? (circle)
(a) Dunking / plunging
(b) Chucking
(c) Dry herding
(d) Wet herding
(e) Mixing concentrate
10
10 Did you ever do any of the
following tasks not circled in
9.?
(a) Dunking / plunging
(b) Chucking
(c) Dry herding
(d) Wet herding
(e) Mixing concentrate
11
11 Which of the following did you
most regularly use to submerge
the sheep?
(a) Implement __
(b) Hands __
(c) Feet __
(d) Other (state) __
_______________________
12
12
Did you ever have to go into
the dipping bath, e.g. to rescue
sheep?
Yes __
No __
Years:
__________
13
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Accidents
13 How often did you get splashed
with sheep dip on any part of
the body? (circle)
(a) Always
(b) Usually
(c) Sometimes
(d) Never
14
15
14 Where did you get splashed
most frequently? (circle)
(a) Hands
(b) Arms
(c) Feet
(d) Legs
(e) Face / Neck
(f) Head
(g) Torso / upper body
15
15 How often did you get soaked
to the skin on any part of the
body? (circle)
(a) Always
(b) Usually
(c) Sometimes
(d) Never
16
17
16 Where did you get soaked to
the skin most frequently?
(circle)
(a) Hands
(b) Arms
(c) Feet
(d) Legs
(e) Face / Neck
(f) Head
(g) Torso / upper body
17
17 When did you wash the
splashed or soaked areas of
skin?
Area (a-g)
(a) Immediately
(b) End of dipping
(c) Before breaks
- meals
- smoking
(d) Other - specify
____________
18
18 What washing facilities were
used?
(a) Open tank
(b) Bucket
(c) Hosepipe
(d) Cold running water
(e) Hot running water
(f) Shower
(g) Soap
(h) Other specify:
19
19 Have you ever fallen into the
dipping bath?
Yes __
No __
20
21
20 When did you fall in? Years: 21
243
Health following exposure
21 Did you ever suffer from
‘Dippers Flu’ after dipping
sheep?
Yes __
No __
22
23
22 How often did you suffer from
‘Dippers Flu’?
Frequency: 22
23 Did you ever feel any other ill
health symptoms following
sheep dipping?
Yes __
No __
24
25
24 What were these symptoms and
how often did you suffer from
them?
Symptoms:
1)
2)
3)
4)
5)
Frequency: 25
25 Did you ever have to seek
medical help after dipping?
Yes __
No __
26
28
26 With whom did you seek
medical help?
(a) Local GP __
(b) Local Nurse __
(c) Hospital A&E __
(d) Specialist __
(e) Other __ Please state:
_______________________
27
27 How soon afterwards after each
symptom appeared did you
seek medical help?
Symptom:
(a) < 24 hours
(b) < 48 hours
(c) < 72 hours
(d) < 1 week
(e) < 2 weeks
Frequency: 28
Sheep dipping area and dipping method
28
Location of bath? (a) Within building
(b) Within mobile trailer
(c) Outside exposed
(d) Outside sheltered
(e) Covered (open sides)
(f) Other state___________
Years:
29
29 Was there a screen to deflect
splashes across (a) Dip bath entry
(b) Sides of dip bath
(c) Dip bath exit
Years: 30
30 How many times per day did
you have to replenish the bath?
(a) 0
(b) 1
(c) 2
(d) 3+
31
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Sheep dip concentrate
31 Did you work with sheep dip
concentrate?
Yes __
No __
32
38
32
Approximately how much
concentrate did you normally
use in a single dipping session?
(Specify pints/litres/gallons)
Name:
amount:
Name:
amount:
Name:
amount:
Years: 33
33
Can you remember the strength
(% active ingredient in) the
pesticide concentrate you used?
(or write in ‘strong’ / ‘weak’)
%
%
%
Years: 34
34 How often did you get splashed
with sheep dip concentrate on
any part of the body? (circle)
(a) Always
(b) Usually
(c) Sometimes
(d) Never
35
38
35 If any of (a)-(c) above, how
often did you wash off the
concentrate?
(a) Always
(b) Usually
(c) Sometimes
(d) Never
36
36 How soon after the spillage? (a) Immediately
(b) Within minutes
(c) Within hours
37
37 On average, how many times
per dipping period were you
involved in any accidents (e.g.
spillage) with concentrate?
(a) 0
(b) 1
(c) 2
(d) 3+
38
Maintenance of the dip
38 Did you use meter systems to
transfer concentrate to the bath?
Yes __ No __ 39
39 Have you ever been involved in
emptying the dipping bath?
Yes __ No __ 40
40 How did you empty the bath? (a) Slurry tanker
(b) Pails
(c) Other state __________
41
41 How often have you been
involved in cleaning the
dipping bath?
(a) Never
(b) Once
(c) 2-3 times
(d) Other frequency – state:
____________________
(e) Every dipping session
42
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46) Which of the following protective clothing and safety equipment did you use when both
sheep dipping and using concentrate? (For each circled item, ask i-iv)
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47) Please read the following list of sheep dip products and place a tick next to the products
you have previously used, and between what dates.
PRODUCT NAME
Have you used this product?
YEARS USEDYES NO
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D. Shearing / Handling recently dipped sheep / fleeces
Go to
1 Have you ever worked with (a) Recently dipped sheep
(b) Fleeces of recently
dipped sheep
2
2 Between what years? 3
3 How soon after the sheep had
been dipped were you handling
them?
4
4 What activity were you doing
with the sheep or fleeces?
(a) Shearing
(b) Handling fleeces
(c) Inspecting Sheep
(d) Other. State:________
5
5 What protective clothing did you
wear whilst handling the dipped
sheep, and over how many
years?
(a) Waterproof trousers
(b) Waterproof footwear
(c) Waterproof overalls
(d) Waterproof jacket
(e) Waterproof gloves
(f) Visor / face shield
(g) Hat
(h) Bib / Apron
(i) None
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
---
7
7
7
7
6
7
7
7
7
6 What type of gloves were they? (a) rubber
(b) nitrile
(c) plastic
(d) leather
(e) Other. State:_________
7
7 Approximately how many hours
did each contact last for?
8
8 How many years did you do this
for?
9
9 How many times a year did you
do this activity?
End
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E. Treating cattle for warble fly / handle treated cattle
Go to
1 Between what years did you use
pesticide to treat warble fly on
cattle?
2
2 How many times per year? 3
3 Over how many days? 4
4 How was the product applied to
the cattle?
(a) Dip
(b) Spray
(c) Pour on
(d) Other (specify)
5
5 What protective clothing did you
wear whilst using the treatment
and over how many years?
(a) Waterproof trousers
(b) Waterproof footwear
(c) Waterproof overalls
(d) Waterproof jacket
(e) Waterproof gloves
(f) Visor / face shield
(g) Hat
(h) Bib / Apron
(i) None
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
---
6
6 Did you dilute the pesticide? Yes __ No __ 7
7 Was the chemical used an
organophosphate pesticide?
Yes __ No __ 8
8 What were the names of the
pesticides you used?
9
9 Did you handle the treated
cattle?
Yes __
No __
10
End
10 How many days per year did you
work with the treated cattle?
11
11 How many hours per day? End
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F. Crop / weed spraying
Go to
1 Between what years did you
apply pesticide to arable crops,
fodder crops or grassland?
2
2 How many times per year? 3
3 Over how many days? 4
4 How was the pesticide applied?
(circle)
(a) Aerial spray
(b) Tractor spray
(c) Other (specify)
____________________
_
5
5 What protective clothing did you
wear whilst using the pestcide
and over how many years?
(circle)
(a) Waterproof trousers
(b) Waterproof footwear
(c) Waterproof overalls
(d) Waterproof jacket
(e) Waterproof gloves
(f) Visor / face shield
(g) Hat
(h) Bib / Apron
(i) None
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
---
6
6 Did you dilute the pesticide? Yes __ No __ 7
7 Was the chemical used an
organophosphate pesticide?
Yes __ No __ 8
8 What were the names of the
pesticides you used?
9
9 Did you handle the treated crops
or enter the treated fields?
Yes __
No __
Details: End
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G. Treating grain or working with treated grain
Go to
1 Between what years did you use
insecticide to treat grain?
2
2 How many times per year? 3
3 Over how many days? 4
4 How was the insecticide
applied? (circle)
(a) Spray
(b) Smoke bomb
(c) Other (specify)
_____________________
5
5 What protective clothing did you
wear whilst using the insecticide
and over how many years?
(circle)
(a) Waterproof trousers
(b) Waterproof footwear
(c) Waterproof overalls
(d) Waterproof jacket
(e) Waterproof gloves
(f) Visor / face shield
(g) Hat
(h) Bib / Apron
(i) None
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
---
6
6 Did you dilute the insecticide? Yes __ No __ 7
7 Was the chemical used an
organophosphate?
Yes __ No __ 8
8 What were the names of the
insecticides you used?
9
9 How soon after treatment did
you enter the store? (Specify) ______________ hrs / days
10
10 In the 2 weeks following the
treatment, how many days did
you work there?
End
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H. Working in orchards
Go to
1 Between what years did you use
pesticides in orchards?
2
2 How many times per year? 3
3 Over how many days? 4
4 How was the pesticide applied?
(circle)
(a) Spray
(b) Tractor
(c) Other (specify)
_____________________
5
5 What protective clothing did you
wear whilst using the insecticide
and over how many years?
(circle)
(a) Waterproof trousers
(b) Waterproof footwear
(c) Waterproof overalls
(d) Waterproof jacket
(e) Waterproof gloves
(f) Visor / face shield
(g) Hat
(h) Bib / Apron
(i) None
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
---
6
6 Did you dilute the pesticide? Yes __ No __ 7
7 Was the chemical used an
organophosphate?
Yes __ No __ 8
8 What were the names of the
pesticides you used?
9
9 How soon after it had been
sprayed did you pick the fruit?
(Specify)
______________ hrs / days
10
10 How many days did you spend
picking the treated fruit?
End
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I. Domestic use of pesticides
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J. Other work with pesticides
Go to
1 For what purpose were the
pesticides used?
2
2 Over how many years? 3
3 How many times per year? 4
4 How many hours per day? 5
5 How was the pesticide applied?
(circle)
Specify _______________ 6
6 What protective clothing did you
wear and over how many years?
(circle)
(a) Waterproof trousers
(b) Waterproof footwear
(c) Waterproof overalls
(d) Waterproof jacket
(e) Waterproof gloves
(f) Visor / face shield
(g) Hat
(h) Bib / Apron
(i) None
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
Yrs
---
7
7 Did you dilute the pesticide? Yes __ No __ 8
8 Was the chemical used an
organophosphate?
Yes __ No __ 9
9 What were the names of the
pesticides you used?
End
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K. Using Solvents
Go to
1 For what purpose were the
solvents used?
2
2 Over how many years? 3
3 How many times per year? 4
4 How many hours per day? 5
5 How was the solvent applied?
(circle)
Specify _______________ 6
6 Did you wear either of the
following? And over what
years?
(a) Gloves
(b) respirator
Yrs
Yrs
7
7 How much solvent did you
and others working near to you
use each day?
(a) <50ml
(<1.75 floz)
(b) 50-500 ml
(1.76-17.6 floz)
(c) 501-2000
(17.7 floz–3.5 pints)
(d) > 2 litres
(>3.5 pints)
8
8 Did you do this work in (a) a large well ventilated room
(b) a large poorly ventilated
room
(c) a small well ventilated
room
(d) a small poorly ventilated
room
(e) outside
9
9 Were there any measures in
the workplace to control your
exposure to solvents?
Yes __ No __ 10
10 What were the names of the
solvents you used?
End
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L. Using Lead
Go to
1 For what purpose was the lead
used?
2
2 Over how many years? 3
3 How many times per year? 4
4 How many hours per day? 5
5 Did you wear either of the
following? And over what
years?
(a) Gloves
(b) respirator
Yrs
Yrs
6
6 Was the lead heated in the
process?
(a) Yes
(b) No
(c) Don’t know
7
7 Did you do this work in (a) a large well ventilated room
(b) a large poorly ventilated
room
(c) a small well ventilated
room
(d) a small poorly ventilated
room
(e) outside
8
8 Were there any measures in
the workplace to control your
exposure to solvents?
Yes __ No __ 9
9 What were the names of the
lead products you used?
End
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M. Using vibrating equipment
Go to
1 What type of equipment / tool
did you use?
2
2 For what purpose was the tool
/ equipment used?
3
3 Over how many years? 4
4 How many times per year? 5
5 How many hours per day? 6
6 Was the tool very noisy? (a) Yes
(b) No
7
7 What was the source of
vibration?
8
8 Were you sitting or standing
on the vibrating surface?
(a) Sitting
(b) Standing
9
9 Were there any measures in
the workplace to control your
exposure to vibrating
equipment?
Yes __ No __ End
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Physical Health
This questionnaire asks for your views about your health. It asks how you feel and how well
you are able to do your usual activities.
1. In general, would you say your health is: (Please tick one box)
Excellent 1
Very Good 2
Good 3
Fair 4
Poor 5
2. During the past 4 weeks, have you had any of the following problems with your work
or other regular daily activities as a result of your physical health? (Please circle
Yes or No)
2a. Reduced the amount of time you spent on work or other activities Yes No
2b. Accomplished less than you would like Yes No
2c. Were limited in the kind of work or other activities Yes No
2d. Had difficulty performing the work or other activities (for example,
it took extra effort) Yes No
3. During the past 4 weeks, to what extent has your physical health interfered with your
normal social activities with family, friends, neighbours, groups etc? (Please tick one
box)
Not at all 0 Quite a bit 3
Slightly 1 Extremely 4
Moderately 2
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4. How much bodily pain have you had in the last 4 weeks? (Please tick one box)
None 0 Moderate 3
Very mild 1 Severe 4
Mild 2 Very Severe 5
5. During the past 4 weeks, how much did pain interfere with your normal work
(including both work outside the home and household tasks)? (Please tick one box)
Not at all 0 Quite a bit 3
A little bit 1 Extremely 4
Moderately 2
6. Physical symptoms: During the last 4 weeks have you suffered from any of the
following symptoms? (Please circle a response in the column headed How often?)
In addition, for those symptoms that you have experienced, please tell us when the
symptom first appeared and indicate how severe and how distressing you find each
symptom by circling the most appropriate responses separately for each symptom.
Please also circle a response in the final column for each symptom you have
experienced to rate the impact you feel it has had on your ability to carry out your
normal daily activities.
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Symptom How often? Date
symptom
first
appeared?
How
severe?
How
distressing
do you find
this
symptom?
Does it interfere
with daily
activities? (for
example
housekeeping,
work, leisure)
Problems controlling
temperature/sweating
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Headaches 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Toothaches 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Loss of sensation in
fingers and toes
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Blurred vision 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Numbness or tingling in
any part of the body
(Please state where
_____________________
_____________________
____________________)
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
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Symptom How often? Date
symptom
first
appeared?
How
severe?
How
distressing
do you find
this
symptom?
Does it interfere
with daily
activities? (for
example
housekeeping,
work, leisure)
Fatigue 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Loss of balance/co-
ordination
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Dizziness 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Problems with sexual
functioning (e.g.
impotence, loss of
interest in sex)
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Ringing in ears 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Skin complaints 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
261
Symptom How often? Date
symptom
first
appeared?
How
severe?
How
distressing
do you find
this
symptom?
Does it interfere
with daily
activities? (for
example
housekeeping,
work, leisure)
Temporary deafness or
hard of hearing
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Joint stiffness or pain
(Please state where)
_____________________
_____________________
_____________________
_____________________
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Sleep problems
(difficulty sleeping or too
much sleep, please
elaborate)_________
_____________________
_____________________
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Muscle tremors 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Nausea 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Swollen glands 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
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Symptom How often? Date
symptom
first
appeared?
How
severe?
How
distressing
do you find
this
symptom?
Does it interfere
with daily
activities? (for
example
housekeeping,
work, leisure)
Pain in hands or feet 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Difficulty
remembering/concentrat
ing
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Dry mouth 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Chest pains/tightness 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Feeling disorientated 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Muscle weakness (Please
state where
_____________________
_____________________
____________________)
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
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Symptom How often? Date
symptom
first
appeared?
How
severe?
How
distressing
do you find
this
symptom?
Does it interfere
with daily
activities? (for
example
housekeeping,
work, leisure)
Burning sensation
(Please state where
_____________
_____________________
____________________)
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Shortness of breath 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Decrease in sensitivity to
touch/pain/temperature
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Feeling slowed down
(mentally)
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Feeling feverish 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Unintended weight loss
or gain
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
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Symptom How often? Date
symptom
first
appeared?
How
severe?
How
distressing
do you find
this
symptom?
Does it interfere
with daily
activities? (for
example
housekeeping,
work, leisure)
Gastro-intestinal
problems ( Please
elaborate)____________
_____________________
_____________________
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Diarrhoea/Constipation 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Hay fever or allergies 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Irritability/temper
control problems
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Coughing 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Cramps (Please state
where)
_____________________
_____________________
_____________________
_____________________
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
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Symptom How often? Date
symptom
first
appeared?
How
severe?
How
distressing
do you find
this
symptom?
Does it interfere
with daily
activities? (for
example
housekeeping,
work, leisure)
Muscle twitching 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Chemical/alcohol
intolerance
0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
Urinary problems 0 Never
1 Sometimes
2 Usually
3 All of the time
1 Mild
2 Moderate
3 Severe
0 Not at all
1 A little
2 Moderately
3 Extremely
0 No
1 Sometimes
2 Usually
3 All the time
If there are any symptoms not covered above please use the space below to tell us about
them. Please also give any further details about any of the symptoms above that you would
like to add:
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APPENDIX 3 – ETHICAL APPROVAL
